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INTRODUCTIONARY 
Section I 

INTRODUCTION 
Chapter I 
History 
The concept that hyperthennia may be useful as a modality for the treatment of 
malignant tumours is not as recent as it may seem. The history of the use of 
increased temperature for tumour treatment has been described by a mnnber of 
authors and one of these reviews dates fran 1927! (Westenna.rk, 1927) As long 
ago as around 2000 years BC, Rarnajana used ferrum candens to extirpate tu-
rrours. Cauterisation of small and non-ulcerating tumours was also recarrnended 
by Hippocrates (460-377 BC). In the 15th century, Leonides employed heat for 
the treatment of large ulcerating tumours, particularly for tumours of the 
breast. Ferrum candens was used both for destruction of the tumour and to con-
trol the bleeding. Fernnn candens was only infrequently used after this period 
as increasing skill in controlling haemorrhaging by blood vessel ligation 
resulted in growing use of the scalpel. HOwever, the high temperature used in 
the above mentioned techniques, is quite different fran the temperature range 
used nowadays in the treatment of cancer. 
The concept that tumour tissue can be destroyed by a temperature increase of 
only a few degrees above the normal physiological level also has a long 
history. Kluger (1980) describes how, in the 4th century AC, Rufus of Ephesus 
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had observed the beneficial role of fever, and had advocated the use of fever 
induction for the treatment of, anong other diseases, malignant tumours. In 
the 19th century, two pUblications appeared reporting tumour regression and 
even cure of patients follc:Ming infection accompanied with high fever (Busch 
1866, Bruns 1888). At the end of the 19th century, Coley was administering 
bacterial pyrogens to induce pyrexia in cancer patients. In a review, his 
daughter (Nauts, 19828) states that cauplete regression and five-year survival 
had occurred in 46% of 523 inoperable cases and in 51% of 374 operable cases. 
'!he beneficial effects of such fever therapy are attributed, according to sane 
imrnunotherapists (Mastrangelo et al, 1984), to stimulation of the immu-
nological system. The observation that results improved When higher tempera-
tures were attained (Nauts, 19828), however, can be interpreted by the finding 
that heat itself is a cytotoxic agent. In the last decade of the 19th century, 
several observations were made that are relevant to the present-day status of 
F 
Fi~t. 2. 
Fig. I - 1 HYPERTHERMIA A NEW CANCER TREATMENT MODALITY ? 
The system used by Westermark ( 1898 ! ) to heat malignant tumours of the 
uterine cervix. Water heated in the cylinder ("fig. 1") flows through the 
coil ("fig. 2") which is placed against the cervical tumour. WesJermark 
observed good palliative results when tumour temperatures of 42-44 C were 
achieved. 
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hyperthermia. 
In 1898 Westermark (westermark, 1898) described the results following treat-
ment of uterine tumours, using hot water circulating within a metal tube 
placed around the cervix (figure I-1). He reported that by using temperatures 
of at least 42°C within the tube, the symptoms of large ulcerating and bleed-
ing tumours could be alleviated. He also found that, When higher temperatures 
were employed, the time necessary for syrrptan release became shorter. 
In the period 1900-1966, publications on hyperthermia began to appear sanewhat 
more frequently. These reports include investigations on the effect of 
hyperthermia in experimental tumour systems, both in vivo and in vitro, fever 
therapy, high frequency induction of hyperthermia, comparisons of nonnal and 
tumour cell sensitivity, the time-temperature relationship with regard to 
hyperthermia effect, the combination of hyperthermia and radiotherapy, and 
many more topics that are even now still being investigated. 
The relatively low level of interest in hyperthermia before 1967 was probably 
due to the rapid developments in cancer treatment modalities sudh as surgery, 
radiotherapy and chemotherapy. M:lreover, any existing interest was hindered by 
the many technical difficulties involved in the application of hyperthermia. 
The present revival of research into hyperthermia is believed to start with 
Cavaliere's publication in 1967, in Which he describes how animal tumour cells 
are damaged by heat to a greater extent than nonnal cells, and how hyper-
thermic regional perfusion in limbs of patients (41.5°C - 43.5°C) resulted in 
complete disappearance of tumour in 10 of 22 patients (Cavaliere et al, 1967). 
Since 1967, the increase in interest in hyperthermia, as measured by the num-
ber of publications and the number of participants in (international) meet-
ings, seems to follow an exponential curve. A large number of investigations 
was perfonned on the effect of hyperthermia in experimental tumour systems, on 
cellular as well as tissular level. The aims of these studies were, and still 
are, to learn how hyperthermia acts and, finally, how hyperthermia can be ap-
plied optimally to patients. The outccme of these investigations has been 
premising fran the start: hyperthermia results in cell death and, thanks to 
physiological differences between tumour tissue and nonnal tissue, results 
specifically in tumour cell death up to a certain dose level. Furthennore, 
hyperthermia effect appeared to be carq:>lementary to radiotherapy effect in 
tumour tissue, thus providing a desirable addition to local tumour treatment 
(see Chapter II). These premising results of experimental researCh -were, 
almost immediately, followed by an increasing number of clinical inves-
tigations. 
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Participation in the hyperthermia research at the Rotterdam R:tdio-Therapeutic 
Institute originates fran 1976, when we received, by courtesy fran Messrs 
Siemens, a "hyperthermia cabin", an apparatus with Which hot air, radio-
frequency and microwave energy could be simultaneously used to induce in-
creased temperatures in tumours in patients. 
Objectives 
'!he ultimate aim of the Rotterdam investigation was the hyperthermic treatment 
of human tumours, in order to eliminate those cell populations Which are 
resistant to other treatment modalities. By the time that this investigation 
was started, only few publications on the clinical application of local hyper-
thermia had appeared (Holt 1975, LeVeen et al 1976, Hornback et al 1977). In 
these publications information on tumour temperatures achieved generally was 
missing. cne of the problems anticipated to occur during local hyperthermia 
was the influence of blood flow on temperature distribution. The cells around 
a blood vessel entering the tumour, which transports blood at core tempera-
ture, will not be heated much above that core terrperature which is about 37°C 
under physiologic circumstances (Cater et al 1964) • In order to ensure a 
temperature increase up to higher levels for all tumour cells, the blood 
entering the tumour has to be prewa:rmed. This was the reason that a study was 
designed to develop a technique for, and investigate the benefits of, the 
clinical application of whole body hyperthermia (WBHT) in caribination with ad-
ditional local tumour heating. Even with this caribinatian, the tumour cells in 
well oxygenated areas probably will survive a hyperthermia dose of 2 hours at 
41.8 - 42°C, Which may be the lowest dose achieved within the tumour. There-
fore the need for simultaneous administration of other cell killing agents 
(radiotherapy, chenotherapy) was anticipated. 
'!he questions to be answered by our investigation were concerned with various 
topics. In the first place, it had to be established how the equipment avail-
able could be used optimally in order to obtain WBHT as rapid, haoogeneous and 
safe as possible, and if the technique would be cooparable to other techniques 
used for induction of WBHI'. The first step in this feasibility study was done 
by performing animal experiments, Which are described in chapter IV. On the 
basis of the outcane of these animal experiments it was decided which tech-
nique would be used in the clinical stlrly. Initial experience in thennanetry 
during WBHT in humans was obtained by participation in hyperthermic treatment 
of 3 patients in two other clinics. This feasibility study was continued 
during the clinical stlrly 'until patient no. 10; the treatment technique was 
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irnprove:l gradually on the basis of experience obtaine:l. 
Fbr the clinical study (describe:l in chapter V, VI and VII), patients were 
selecte:l for whan the available -convential- therapy was judge:l insufficient 
to achieve good results, whether palliative or curative. 
The objective of the clinical study covere:l also the question of patient's 
tolerance: v.ould the patients tolerate the treatment, whether WEHr alone or in 
canbination with radiotherapy or cherrotherapy, and v.ould it be .:possible to 
conclude on any further selection parameters than those known fran previous 
publications on WEHr. The clinical study further incl ude:l questions about 
.:positive effects of the treatment such as objective turrour res.:ponse and pain 
relief. As patients with various kinds of turrours were admitte:l to the study, 
differences in sensitivity to hyperthermia between the various turrours as 
confinne:l by histology might beccxne apparent. The ultimate question of this 
study was whether WEHr treatment v.ould result in a profit to the individual 
patients or not, which could be estimate:l by weighing the costs against the 
profits. The question about the future of WEHr as induce:l by our "adapte:l Panp 
Siemens cabin method", finally, could be answere:l by the evaluation of the 
overall results in the whole group of patients. 
Before the description of our study is starte:l, sane introductional infor-
mation is given. In chapter II, sane relevant aspects of thermobiology are 
presented to give a background of knowledge about cellular and tissue 
reactions to hyperthermia. In chapter III, the .:potential techniques for the 
induction of hyperthermia are describe:l, including infonnation on 
thermophysiology, thenronetry and a review of WEHr investigations perfonne:l by 
others. 
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THERMOBIOLOGY 
Chapter II 
'Ihenrobiology 
An increase in the temperature of biological materials of only a few degrees 
above nonnothennia already causes damage to the cells and even cell death. 
Several reviews on this subject have appeared in the last years (Field and 
Bleehen 1979, Dewey et al. 1980, Stewart and Gibbs 1984). '!he degree of damage 
depends on many factors. Firstly, the "dose" of hyperthennia administered to 
cells is of great irrportance. Hyperthennia dosage can be described as a func-
tion of the te:nperature and the exposure time. Westermark (1898) has already 
described how treatment duration can be shortened "When higher temperatures are 
applied. Westermark junior (1927) presented the relationship between time and 
temperature for destruction of rat tumours, and introduced the use of a for-
mula derived from the Arrhenius equation in his description of a hyperthennia 
dose-effect relationship. 'Ihe time-te:nperature relationship for iso-effect can 
be mathe:natically described as 
R(TO - Tl) 
(in which t 0 = time at reference temperature; t 1 = time at temperature 
measured; T0 = reference temperature; T1 = te:nperature measured and R being a 
constant) (sapareto 1982). 
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The above fonnula has been shown to be applicable for the damaging effect 
found for both turrour and nonnal tissues in experimental systems, in vitro and 
in vivo. A review by Field and tvb=is (1983) on time-temperature relationships 
has recently appeared. The findings are in general that with an increase of 
terperature of 1°C within a certain range, the treatment duration can be 
halved to obtain the same effect. tvbst investigators have found in addition 
that at rooderate to low temperatures, ~low 42 to 43°C, this relationship 
changes such that a 1 °c decrease in terperature must, in order to obtain the 
same level of effect, be ccmpensated by an increase in treatment duration of a 
factor ranging from 2. 7 to 33, with a mean value of 6. These findings are 
partly based on clonogenic cell survival studies, of which the results can be 
presented by cell survival curves. An example of cell survival curves is given 
in figure II-1. On the abscissa the dose is given and on the ordinate the sur-
time at 45.5 oc (min) 
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Fig. II - 1 CLONOGENIC CELL SURVIVAL AFTER HEAT AND RADIATION 
Survival of T1-cells (a human kidney cell line) following radiotherapy (~), 
hyperthermia C(>l and a combination of both treatment modalities ( 10 minutes 
hyperthermia and radiotherapy;e). Hyperthermia dose is given as minutes at 
45.5°C. This figure shows how the "shoulder" of the survival curve of the 
radiation-alone treatment disappears and the survival curve becomes steeper 
when hyperthermia is given additionally. 
Data from Westra, 1971. 
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viving fraction of cells, on a logarithmic scale. A cell survival curve fol-
lowing radiotherapy is generally characterized by a "shoulder" and a part 
Which is straight on the semilogarithmic scale, the exponential part. The 
Shoulder is characterized by a value for D : the point of intersection of the q 
straight part with the level of 100% survival (in dose). The exponential part 
can be described by its slope Which is given as D
0
: the increment of dose 
necessary to reduce the surviving fraction to 37%. The use of these math-
ematics renders the comparison between various survival curves possible. 
Secondly, there is a great variation bet"Ween different cell types in their 
sensitivity to heat, sane cells being a factor of 10 or :rrore higher in sensi-
tivity than others, expressed as the D value of the exposure time (Raaphorst 
0 
et al. 1979). The stage of the cell in the mitotic cycle also influences cell 
sensitivity to heat. In contrast with cell sensitivity to X-rays, cells in 
S-phase (synthetising DNA) appear the :rrost sensitive to heat (Westra and 
De"Wey, 1971). 
Thirdly, it has been demonstrated that environmental factors are of major 
importance in cellular response to heat treatment. HYPoxic cells and cells in 
an acidic or nutrient-deficient environment are :rrore sensitive to hyper-
thermia. (Overgaard and Nielsen 1980, Hahn 1982, Wike-H::loley et al. 1984B). 
Fourthly, the degree of thennal damage is influenced by previous heat treat-
ment. It has been demonstrated that thenrotolerance, a term used to describe 
the relative resistance to hyperthermia, is induced When cells are either 
heated continuously for :rrore than 3 hours at terrperatures of 4Q-42.5°C, or 
receive a second heat treatment following a primary dose. Thenrotolerance 
develops rapidly after a first heat treatment, reaching a maximum within 24 
hours. Thereafter thenrotolerance decays slowly over a period varying fran 3 
to over 14 days. The decay of thenrotolerance was observed to be slower in 
normal tissue than in tumour tissue, Which again may result in a selective 
effect of heat on tU!rour tissue (Urano and Kahn 1986) When hyperthermia is 
given fractionated. 'lher:rrotolerance also arises When step-up heating is per-
formed, i.e. heating at a relatively low terrperature prior to heating at a 
higher temperature. (Henle and Dethlefsen 1978, Urano 1986, Hahn and Shiu 
1983B). 
On the contrary, thermal sensitivity can be increased by using step-down 
heating, i.e. heating for a short time at a high temperature prior to heating 
at a lower temperature. (Nielsen et al. 1982, Urano and Kahn 1983). 
Mechanisms Which were observed to be involved in the effect of hyperthermia 
are listed in table II-1. 
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Table II-1 OBSERVED MEGIANISMS OF HY.PERI'HERMIA EFFEcr 
- In jury to cell membrane 
- Inhibition of respiration 
- Inhibition of ribosomal RNA synthesis 
- Denaturation to chromosomal proteins 
- Inhibition of INA synthesis 
- Inhibition of protein synthesis 
- Release of hydrolytic enzymes frcm the lysosames 
- Induction of vascular stasis 
Frcm reviews by Dewey et al. (1977), Reinhold and Endrich (1986), and 
Streffer ( 1985) . 
Some investigations have suggested that neoplastic cells may be intrinsically 
more sensitive to heat than normal cells (Giovanella et al. 1976, Flentje et 
al. 1984), but this apparent difference has not been confirmed in more 
detailed studies (Dewey et al. 1977). Anyhow, as conditions such as hyp::>xia, 
low environmental fH and nutrient deficiency are 1 ikely to occur in turrours 
(see next paragraph) due to the relative insufficiency of tumour circulation, 
these factors are more i:mp::>rtant for the effects of hyperthermia acting as a 
tumour specific treatment modality. 
Tumour physiology under normothermic conditions 
Tumours are composed of tumour cells and supporting tissues. Generally, the 
supporting tissues originate from the normal host tissues. Tumour cells 
proliferate intensively and easily overgrow their vascular system (Shubik 
1982). Endrich et al. (1982) describe how, in an experimental melanana, the 
capillary density per unit of tissue decreases with increasing turrour sizes. 
Interstitial edema, caused by filtration of fluid into the extravascular 
space, combined with an increase in nunber of turrour cells by proliferation, 
compress a great number of nutrition capillaries. The result is a self-
destruction of tumour due to deficiency of oxygen and nutrients. This process 
is less outspoken at the margins of the turour, Where proliferation with 
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accompanying infiltration occurs without causing compression. 
Therefore, tumour blcx:xl flow is heterogeneous, in general the peripheral 
regions of tumours are well perfused whereas in the inner regions pxlrly 
perfused areas exist (Tannock 1972). This was experimentally demonstrated, 
e.g., by Endrich (1979). Overall tumour blcx:xl flow is often lower than the 
blood flow of normal tissue. This has also been demonstrated for human 
tumours, using the 133xe clearance technique (Mantyla 1979). 
The relative insufficiency of perfusion in turrours has the consequence that, 
in parts of the tumour, tumour cells have a deficient oxygen and nutrient 
supply. It was shown that the oxygen diffusion distance from a sup}X)rting 
capillary varied fran 50-230 urn (Thomlinson and Gray 1955, !bag 1969, Tannock 
1972). Past this distance, cells become hypoxic and nutrient-deprived. This 
can further result in necrosis. 
Hypoxia necessitates anaerobic glycolysis for the production of energy, 
resulting in the forming of lactic acid and other metabolites. As lactic acid 
is inefficiently removed, the interstitial Iii decreases. Tumour Iii has been 
dem:mstrated to be lower than normal tissue fH in many experimental turrour 
systems and also in human tumours (Van den Berg et al. 1982, Wike-Hooley et 
al. 1985). This heterogeneous composition of turrours has further been con-
firmed by observations following treatment by hyperthermia alone of experimen-
tal and hunan tumours. In the experimental sandwich-tumour-system, Reinhold et 
al. (1978) observed the central parts of the tumour to become necrotic follow-
ing hyperthermia treatment of 1 hr at 42.5°C. In human turrours, regression has 
been observed following hyperthermic treatment at various levels, either whole 
lxldy (Van der Zee et al. 1983), local or regional perfusion hyperthermia (Van 
der Zee tmpublished data), followed by regrowth from the tumour margins after 
a period of about 3 weeks. These findings may daronstrate the specific heat 
sensitivity of the probably hypoxic cells in the centre of tunours. 
M:lreover, the lower bloodflow in turrours in comparison to that of normal 
tissues, will result in higher temperature increase in tumour tissue when a 
local heating technique is externally applied, as the cooling which depends 
mainly on tissue blcx:xl flow will be less in tunour tissue than in normal 
tissue. This higher temperature results, during local hyperthermia, once rrore 
in a specific tumour cell killing effect. 
Hyperthermia effects on turour physiology 
The physiological reaction of normal living tissues to a rise in temperature 
is a change in blcx:xl flow, the arrount of which depends on the level of tan-
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Fig. II - 2 BLOOD FLOW CHANGES 
Blood flow changes in skin
0 
( 0), muscle (~) and tumour (V) during local 
hyperthermia ( 1 hour at 43 C) of a Walker 256 carcinoma bearing rat leg. 
The dotted line shows the blood flow changes in a rat mammary adenocarcinoma 
(13762A) during and following a similar hyperthermia treatment. 
Data from Song et al, 1980A and Rappaport and Song, 1983. 
perature increase and the duration of hyperthennia. The initial reaction is an 
increase of blood flow Which, with increasing hyperthennia dose, may be fol-
lowed by a decrease as a result of damage developed. There is a quantitative 
difference between this response for normal and tumour tissues. Tumour circu-
lation shows less or no increase during hyperthermia and collapses following 
lower hyperthennia doses, than normal tissue circulation (Song et al. 1980A; 
see figure II-2). 
The decrease of tunour blood flow following hyperthennia has been observed by 
many investigators. Reviews of these findings were recently given by Song 
(1984) and Reinhold and Endrich (1986). 
Tumour vascular stasis was observed in sane experimental systems already 
following heat doses as low as 1 hr at 40°C whereas skin and Imlscle circu-
lation still show an increase following 2 hours at 43-44°c. 
Consequences of vascular collapse are that the tumour cell environment changes 
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tc:Mards an increased hypoxia and acidity, which renders the cells even more 
sensitive to hyperthermia (Eicher et al. 1980), and secondly that cell death 
continues after the end of hyperthermic treatment as cells became completely 
isolated fran the supply of oxygen and nutrients (Stewart and Gibbs 1984, 
Fajardo et al. 1980). It is questionable, however, if circulation collapse 
plays a major role for tumour response following Whole body hyperthermia Where 
the temperature should not exceed 42°C. 
:Hyperthermia in corribination with radiotherapy 
'lhe survival curve for cells Which have received a corribined treatment of heat 
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Fig. II - 3 THE INFLUENCE OF THE TIME INTERVAL ON TER 
The thermal enhancement ratio (TER) is the factor with which radiotherapy 
(RT) effect is enhanced by the addition of hyperthermia (HT). This figure 
shows the TER for both normal tissue (mouse skin, 0) and tumour tissue (mouse 
mammary adenocarcinoma, II) as a function of time-interval between radio-
therapy and hyperthermia (60 minutes at 42.5°C). 
When tumour tissue and normal tissues receive the same hyperthermia dose, 
hyperthermia given 4 hours following radiotherapy gives the maximum thera-
peutic gain. When however tumour tissue is preferentially heated, simul-
taneous administration is preferable. 
Data from Overgaard, 1980. 
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Fig. II - 4 CONCEPTS CONCERNING HYPERTHERMIA IMPROVING LOCAL CANCER 
TREATMENT 
This schedule shows the mechanisms through which hyperthermia, either alone 
or in combination with radiotherapy, leads to therapeutic gain: a cell 
killing effect preferentially in tumour tissue. 
and radiation has, in comparison with that for cells which have received 
radiotherapy only, a steeper slope and often also a reduced shoulder (Thrall 
et al. 1976, Harisiadis et al. 1975, Westra 1971; see figure II-1). It has 
been demonstrated that hyperthermia decreases the capacity of cells to repair 
X-ray sublethal and potentially lethal damage (Ben Hur et al., 1974). 
Together with these radiosensitizing effects, hyperthermia has an additive 
effect to that of radiation. As described above, the relatively radioresistant 
cells in S-phase are rrore sensitive to hyperthermia. Furtherrrore, the environ-
mental conditions which occur in tumours, rendering cells more resistant to 
X-irradiation, enhance the thermal sensitivity of the cells. The sequencing of 
the two rrodalities may also be of importance for the effect of the combined 
treatment. It has been shown in in vitro studies, that when the hyperthermia 
dose was sufficient to induce thermal killing, hyperthermia preceeding X-irra-
diation was slightly more effective than hyperthermia following X-irradiation 
(Sapareto et al. 1978). However, when a lcwer dose of hyperthermia was given, 
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v.ihich is only sensitizing the radiotherapy effect, hyperthermia following 
radiotherapy was most effective (Dewey et al. 1977). OVergaard investigated 
the importance of sequencing in an in vivo system with respect to both tumour 
response and normal tissue reaction. He found that the largest therapeutic 
effect was obtained when hyperthennia followed radiotherapy, with a thera-
peutic gain without enhancement of normal tissue reaction if the time interval 
was at least 4 hours (OVergaard 1980, see figure II-3). Hume and Field also 
demonstrated, in various normal animal tissues, that there was no thermal 
enhancement of X-irradiation v.ihen radiotherapy preceeded hyperthermia by 4 or 
5 hours (Hume and Field, 1978). The mechanisms through v.ihich hyperthennia 
alone and in combination with radiotherapy can lead to therapeutic gain are 
summarized in figure II-4. 
Hyperthennia combined with cherrotherapy 
a) Effects on the cellular level. 
In vitro studies have shown that the effect of many commonly used cytotoxic 
agents is enhanced at elevated temperatures. Reviews on this subject were 
given by Hahn (1979), M3.rrror (1979) and more recently, Bleehen (1984) and 
Landberg (1985). Several mechanisms are probably involved in this enhanced 
cell kill, such as those listed in Table II-2. 
'!here are also several agents v.ihich are non-toxic at norrrothennia, v.ihich 
becane cytotoxic at increased temperature such as hypoxic radiation sensi-
tizers, alcohols, local anaesthetics, and solvents for cytotoxic drugs 
(Landberg 1985, Li et al. 1977). The degree of cell kill enhancement depends 
not only on the hyperthennia dose, but also on various complicating factors, 
such as 
the time-sequence of hyperthermia and chemotherapy; 
the history of heat treatment, such as the temperature increase rate or 
step down heating; 
the cellular environment (hypoxia, pH) . 
HYPerthermic potentiation of cell killing effect may gradually increase with 
increasing temperature, but for sane agents (for exarrple bleanycin) poten-
tiation was found only above a threshold temperature of 42-43°C v.ihich renders 
the combination unsuitable for whole body hyperthermia (Marrror et al. 1979). 
For 5-FU a similar threshold temperature may exist, regarding the results of 
the few studies done with this drug. Mizuno et al. (1980) found no enhanced 
mouse leukemia cell kill by combining 5-FU with hyperthermia at 42.0°C. Rose 
et al. (1979) also found no enhancement of 5-FU induced mouse tumour re-
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Table II-2 MEGIANISMS I:N\QLVED IN IQTENriATION OF CYT08rl{!'IC DRU3S BY 
HYPERI'HERMIA 
- Acceleration of chenical processes involve:J. in the action of chemotherapy 
(a general law in chEmical processes). 
- Alterations in cellular membrane functions, resulting in increase:J. cellular 
uptake (cis Pt (Alberts et al. 1980), adriamycin (Hahn et al. 1975), 
methotrexate (Herman et al . 1981, Mikkelsen and Wallach 1982) . 
Increase:J. binding to INA (cis pt (Brouwer et al. 1982)), ble:.xnycin (Chapnan 
et al . 1983) ) . 
Inhibit ion of repair processes (bl e:.xnycin (Hahn et al . 1975, Kubota et al . 
1979)). 
Inhibition of degradation of the cytotoxic agent (blecmycin (Lin et al. 
1983B)). 
gression by hyperthermia at 41.5 - 42.4°C, whereas Daly et al. (1982) found a 
synergistic effect of 5-FU and WBHT at 43°C in the liver of dogs. On the other 
hand, Lange et al. (1984) report that 5-FU cytotoxicity was enhanced in tY.O 
human colon adenocarcinoma cell lines at 41.8°C in comparison to cytotoxicity 
at 37°C, which indicates that treatment of patients with WBHI' and 5-FU may be 
valuable. 
For adriarnycin and actinomycin D, drug resistance was induced by previous 
hyperthermia (Hahn and strande 1976, Donaldson et al. 1978), whereas sterrdown 
heating was found to increase potentiation of cell kill for continuing heat 
treatment. at lower temperatures in presence of cytotoxic drugs (Herman et al. 
1984). 
pH-decrease was found to increase hyperthermic potentiation of cell kill by 
BCNU and blecmycin (Hahn and Shiu 1983A) . Hypoxia enhanced the hyperthermic 
potentiation of cell kill by mitomycin (Teicher et al. 1981). 
Finally, the enhancenent of cytotoxic oell kill by hyperthermia appears to be 
different for various cell lines (Neumann et al. 1985). 
b) Effect on the tissular level. 
~e in vivo situation is even more complex. Drug dosage at the tumour site 
depends on phannaco-kinetics, such as distribution, blood flow, metal::olism and 
excretion which may be influenced by hyperthermia (Ballard 1974). It is to be 
expected that different heating techniques (WBHT, local hyperthermia) will 
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influence pharmaco-kinetics in different ways. Decreased elimination rates 
were daronstrated under whole l:x:xly hyperthermic conditions for melphalan and 
methotrexate (Honess et al. 1985, Daly et al. 1984), whereas increased intra-
turour concentration was found for melphalan (Flbness et al. 1985) • Tunour 
environmental factors are unknown and also may be influenced by hyperthennia. 
Scme but not all drugs which were found to be potentiated in vitro showed 
potentiation in vivo (M:umor 1979). 
'lhe most important question for the clinical situation is, of course, whether 
therapeutic gain can be achieved, i.e., whether the enhancement in turour 
tissue is larger than in normal tissue. This question has been investigated 
only scarcely. 
'lherapeutic gain was demonstrated by Dahl and Mella (1982, 1983) for cyclo-
phosphamide and BCNU for a neurogenic turour in rats with local hyperthermia 
at 44°C, but could not be found for the same cytotoxic agents by Honess and 
Bleehen (1982, 1985) for 2 different turour systems in mice with WBHT at 41°C. 
Neither was therapeutic gain found for CCNU by Honess in the same mouse 
system; the only drug with which therapeutic gain was achieved in this system 
was melphalan, for which bone marrow toxicity decreased, whereas the effect on 
the turours was enhanced by a factor 2. 5 to 3. 9. For cis-Platinum, therapeutic 
gain was daronstrated by Alberts et al. (1980) in leucaemic bone marrow (vs 
normal b:>ne marrow) following WBHT at 42°C but Wile et al. (1983) found the 
opposite in rabbits with carcinoma treated by isolated hyperthermic perfusion 
at 42°C. 
Magin et al. (1980) demonstrated therapeutic gain for adriamycin in mice with 
rnaiiJt1arY carcinoma following local hyperthermia at 43°c. 
So far, these findings are not conclusive. The consequence is that clinical 
application has to be perfonned very cautiously with either reduced drug 
dosages or drugs with minor toxicity. 
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Introduction 
TECHNIQUES INVOLVED 
IN THE APPLICATION OF 
HYPERTHERMIA 
Chapter Ill 
The problem of how to induce hyperthermia cannot be discussed without first 
discussing sane basic thennophysiology. The body temperature is kept within 
narrow limits. Because the rate of chemical reactions varies with the tempera-
ture and the enzyme systems of the body function optimally within narrow tem-
perature ranges, normal body function depends upon a relatively constant body 
temperature. In order to remain thermal equilibrium, the heat gained by the 
body must balance its losses. Each violation of this equilibrium will be fol-
l~d by physiological reactions. 
Heat loss to the environment fran the skin surface produces a temperature 
gradient between the core and skin surface (shell). The magnitude of the 
temperature difference between the various parts of the body varies with the 
environmental temperature. The core temperature, represented by, for instance, 
the rectal temperature, is the temperature that varies least with changes in 
environmental tanperature. Understanding of these mechanisms is also important 
with regard to the decision where to place therm:::rnetry probes. (References for 
the first part of this chapter: Ganong 1971, Ingram and Mount 1975, Nadel 1977 
and Fmslie-Srnith et al. 1983). 
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'Iherrrophysiology in man 
A) ~chanisms for heat gain (see table III -1) 
M:m gains heat rrostly fran metabolic sources, at rest (basal metabolism, 
food-induced thermogenesis), during exercise and While shivering. 
The most active sites of heat production are the skeletal muscles, the 
liver and other intra-abdaninal organs and the brain. 
In cold environments, shivering can increase metabolism. Muscular tone 
increases in distal parts and this increased tone rroves proximally Which 
results in visible shivering. Shivering can increase the metabolic rate by 
a factor of 2 to 5. 
Non-metabolic sources for heat gain are mainly by infrared radiation: 
short-wave fran the sun, long-wave fran the surroundings. Ingestion of hot 
food and drink, ventilation in a hot environment and, during immersion in 
hot water, conduction of heat can contribute to heat gain. 
B) ~chanisms for heat loss (see table III-1) 
The loss of heat fran the skin is greatly influenced by environmental con-
ditions such as the ambient temperature, relative humidity and air move-
ments. It also depends on the heat conductance of the skin, depending on 
skin blood flow. 
Heat is lost by convection, radiation, conduction and evaporation. If the 
subject is in air, the loss takes place mainly by convection and radiation, 
the arrount depending upon ambient temperature and currents in air. 
Cbnduction is negligible here. Heat loss by conduction is important during 
.i.mnersion in cold water. 
If these passive mechanisms for heat loss are insufficient for maintaining 
thennal equilibrium, then cooling through evaporation of water becanes an 
important contribution. 
Ni:>nnally there is an "insensible" water loss Which takes place partly 
through skin; water vapour diffuses continually through the skin without 
wetting it. water is also lost fran the respiratory tract: water fran the 
mucous membranes of the rrouth and the respiratory passages vaporizes in the 
respiratory air and is lost with each expiration. 'Ihe arrount of the insen-
sible water loss, thus heat loss, depends on the hunidity of the environ-
ment and the inspired gases, respectively. 
Therrroregulatory sweating involves the evaporation of large arrounts of 
water by the eccrine ~at glands. Eccrine sweat glands are capable of 
producing over 4 litres dilute salt solution per hour. 'Ihe water in sweat 
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evaporates on the skin, so reducing the skin temperature, as long as the 
ambient relative humidity and air current allow such. 
Table III -1 TEMPERA'IURE REGUIATION MECHANISMS 
(1) Mechanisms activated by cold 
- increasing heat production: shivering 
hunger 
- decreasing heat loss 
increased voluntary activity 
increased secretion of TSH, norepinephrine 
and epinephrine 
cutaneous vasoconstriction 
curling up 
horripilation 
(2) Mechanisms activated by heat 
- increasing heat loss cutaneous vasodilation 
sweating 
increased respiration 
- decreasing heat production: anorexia 
apathy and inertia 
decreased secretion of TSH 
Thermoregulatory responses, including autonanic, sanatic, endocrine and 
behavioural changes. 
Fran w.F. Ganong, 1971. 
Thermoregulation 
A) Central 
The deep body temperature is kept around 37°C with great precision. Both 
brain damage and various central acting drugs can modify or even abolish 
nonnal thermoregulation. These suggest the existence of a central mechanism 
that is probably localized in the nervous system. 
Many hypotheses on thermoregulation have been proposed varying fran 
29 
relatively simple to exceedingly complicated. 
The basic facts are that in and around the hypothalamus three types of 
nerve cells have been identified: firstly cells which are sensitive for the 
terqperature of the blood perfusing the hypothalamus, secondly cells which, 
when stimulated, send impulses to organs and tissues involved in the gain 
or loss of heat and thirdly cells which _intermediate between the sensor and 
activator cells and excite or irihibit the activators. This third group of 
cells receive impulses fran the sensors in the hypothalamus as well as fran 
therrroreceptors in the skin. 
Hypothalamic thermoregulation acts as if there were a thermostat and 
set-point. 
B) Peripheral 
The central mechanism initiates peripheral action, mainly through the 
autonanic nervous system. 
Peripheral thermoregulation is centred on the thermal conductivity of the 
skin, which is dependent on changes in cutaneous blood flow. 
Thermal conductance of the skin of man is defined as the rate of change of 
heat per °C difference in temperature between that of his body and his 
surroundings. The thennal conductance can be varied rapidly by redistribu-
tion of blood flow. Vasoconstriction reduces the transfer of heat fran the 
core to the surface so that the surface of the skin beccmes ischaemic and 
less heat is lost by convection, radiation and conduction. Cutaneous vaso-
dilatation has the OfPOsite effect. The superficial blood flow may increase 
to as much as 100 times the minimum flow. 
Body temperature 
A useful concept of body temperature distribution is assuming the existence of 
a warm, central core within which the temperature remains almost constant and 
a peripheral shell through which tissues there is a temperature gradient. The 
temperature gradient between core and skin surface varies by changes in the 
thermal conductance of the skin by alterations in blood flow, dependent on the 
arribient temperature and the core temperature. The size of the core, i.e., the 
area with a temperature of about 37°C, is much larger when the environment of 
the body is at high ternperature than when it is at lower temperature. 
Man can influence the arribient temperature, i.e. the temperature directly 
adjoining the skin, by behavioural actions as clothing and heating. 
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'Iherrra:netry 
During a treatment with whole body hyperthennia, the accurate measurement of 
temperatures Which are representative for the temperature in organs which are 
especially heat sensitive, is of vital importance. 
Two relevant questions are therefore: 
- where to measure? 
-how to measure? 
l) Sites of measurement 
'!his first question is related to the temperature distribution in the body. 
Temperatures of the various tissues vary depending on the rate of metab-
olism, the efficiency with which the heat can flow away and the distance to 
the body surface. 
During normothermia, or during a steady-state hyper- or hypothermia, the 
rectal temperature may be regarded as representative for core temperature. 
'!he response to change in temperature, however, is relatively slow, which 
makes the use of rectal temperature less advisable for control during the 
heating phase. 
The temperature in the part of the oesophagus which lies next to the aorta, 
shows a rapid response to changes of the temperature of the blood earning 
from the left ventricle and therefore is a better representative for mean 
core temperature, than rectal temperature. 
The tympanic menbrane temperature is expected to reflect hypothalamic 
temperature (Benzinger and Taylor 1963, Cabanac and Caputa 1979), and thus 
the temperature of the central nervous system. This is imp::)rtant, as the 
brain may be especially susceptible for heat damage, as brain function 
disturbances are frequently seen in heat stress victims and 
brain edema has been observed after WBHl' treatments. 
Cabanac and Caputa subjected healthy volunteers to heat stress, with or 
without facial cooling. When facial cooling was applied, the tympanic 
temperature decreased while the oesofhageal temperature increased. An 
explanation for this finding is that there is a connection bet"Ween the 
branches of the facial vein and the cavernous sinus (via the ophthalmic 
veins, the deep facial vein and the pterygoid plexus) , through which cooler 
blood enters the skull and subsequently cools the brain tissue. 
In our case, during the induction of WBHT in the Siemens cabin, the head of 
the patient is outside the cabin and surrounded by air at roc:m temperature. 
The situation of facial cooling thus may occur and influence the brain 
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tE!"llperature. 
Temperature gradients during WBHI' in pigs induced by heating lights, a 
heating blanket, warmed humidified gases and insulation, were studied by 
Dickson et al. (1979). They found persistent temperature gradients during 
the various phases (heating, steady state and cooling) of the WBHT 
procedure. Temperatures recorded by rectal, deep oesopoageal or tympanic 
membrane probes provided a reliable index of core t6"ll)?erature, inclooing 
brain temperature during steady-state conditions at 42°C, but the rectal 
temperature lagged behind the other core temperatures too much to be 
reliable during the heating phase. The liver temperature was consistently 
O.l-0.4°C higher than the rectal temperature, but the difference became 
less when heating time progressed. The temperatures of the deeply seated 
sites of the body were always higher than that of the superficial tissues 
(muscle and subcutaneous fat). 
It is clear, too, that the different techniques used for the induction of 
WBHT results in Characteristic temperature distributions. It is therefore 
:i.rrg;lortant to measure terrperatures at multiple (as many as possible) sites 
during WBHT, because only then it is possible to evaluate the overall 
temperature distribution, which is of importance with regard to patient 
toxicity or tumour response. 
2) Technique 
When considering the required characteristics for a thermometry system used 
in WBHT in combination with local hyperthennia one can list the following 
prerequisites: 
- it should have a relatively small response time (~ 1 second); 
- it should have a continuously read out for the critical sites of 
measurement; 
- it should have an accuracy of O.l°C; 
- it should not be disturbed by electranagnetic heating; 
- it should be easy to introduce to the site of measurement; 
- at least two separate systems should be used independently in order to 
remain operationally in the case of breakdown of one of the systems. 
In order to meet all requirements, four systems were used simultaneously in 
these investigations: 
1) The "Ellab" thennocouple system 
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The essential part of the thennocouples consists of a junction between a 
copper and a constantan wire. The voltage between the two wires is 
terrperature dependent. The Ellab COir!J?anY delivers these thenrocouples in 
probes of many shapes, suitable fOr various applications. 
During our WBHI' treatments the follONing probes were used (see figure 
III-1): 
- rectal (type A-Rl): placed in the rectum after bc:1.vel emptying; 
oesophageal (type A-OSG): placed in the oesophagus and in the 
nasopharyngeal space; 
- needles (type A-Kl9 and A-K8), length 3 ans, width 0.5 rrm and length 5 
ems, width 0.7 mm respectively , for measuring sub-
cutaneous, intramuscular and intratumoural temperatures; 
- tympanic (type A-El2): a flexible probe which was introduced into the 
outer acoustic meatus against the tympanic membrane, and 
insulated fran the environmental air by a plug of cotton 
\\001; 
- flexible small teflon coated probes (type A-F6) for placement on the 
skin. 
These probes were connected to the Ellab Universal Digital thermometer type 
DU-3. 
rectal probe 
fO 5.5 mm, length 44 mm 
needle probe 
fO 0.5 mm, length 30 mm 
tympanic membrane probe 
oesophageal probe 
50 3.4 mm 
needle probe 
fJ' 0.7 mm, length 50 mm 
flexible teflon coated probe 
ff 0.8 m m, length 50 em 
Fig. III - 1 THERMOCOUPLE PROBES USED DURING WBHT 
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The electronic read out part of the Ellah system was disturbed during the use 
of electrcmagnetic energy. With the use of 433 MHz electranagnetic radiation, 
the needle probes have to be introduced such that the longitudinal axis is 
placed rectangularly to the electrical field lines in order to avoid heating 
of the metal. During additional microwave heating, temperature measurements 
could only be perfonned with the generators switched off. 
In order to ensure continuous control of several critical temperatures at the 
same t.ime a multiple thenoocouple display was developed and built by the 
Central Research Vbrkshop of the Medical Faculty of the Erasmus University. 
This was based on a continuing sequential reading out of 10 thenoocouple 
temperatures at the time, each with its separate display. 'lhe accuracy of this 
system is 0.1°c. 
2) The Hewlett Packard CO"IlfXlCt monitor 78341A which we used for cardio-
vascular monitoring also provided the possibility for temperature 
measurement, by 2 different thermistor probes. Temperature measurement 
by thermistors is based on the change in electrical resistance with 
temperature. The accuracy of this system is 0.2°C. 'lhe flexible probe 
was introduced into the oesophagus in order to have a second temperature 
control, to avoid a calamity as described by Pettigrew (Pettigrew et 
al., 1974A). He reported that one patient died as a consequence of an 
error in temperature measurement Which caused an unobserved rise in core 
0 temperature up to 43 c. 
3) Liquid crystal optical fiber system (I.COF), rrodel LCr-1 of Ramal Inc. 
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Temperature measurement is based on the principle that the absorption of 
light depends on the temperature of a suspension of liquid crystals. 'lhe 
absorption increases with increasing temperature. The liquid crystal 
suspension, contained in a small glass bulb and the glass fiber which 
transports the light is not influenced by electrcmagnetic heating. It 
turned out h<:Mever that the electronic read out part of the system was 
disturbed by electranagnetic radiation l A continuous read out was only 
possible by placing the read out parts in an additional Faraday cage. 
Disadvantages of this system were the large size of the probes, which 
renders the impossibility to introduce them into the body, and the 
chemical degradation of the liquid crystal which makes it necessary to 
verify the temperature trajects immediately before and after treatment 
using water baths. 
Using this procedure, an accuracy of 0.5°C could be obtained. 
This system was used only for measurement of tU!!Our surface temperature 
in patient no. 1, in whom WBHI' and local hyperthermia were canbined. 
4) A third, independent, system for a reliable measurement of core 
terrperature became available with the rronitoring of cardiac output. '!his 
measurement is based on the integration of a thermodilution curve 
following injection of a bolus cold fluid in the pulrronary artery. '!he 
build-in thermistor can provide a continuous read out of the pulmonary 
artery temperature. '!his thermanetry probe has an ac=acy of 0.2°C. 
Techniques for the induction of hypertilennia 
Hyperthermia can be applied at 3 levels, i.e., 
-The level of tumour: local (LHT). Only the tumour and the surrounding 
tissues are heated; 
- The level of organ: regional (RHT). '!he extremity, part of the body, or the 
organ in which the turour is situated is heated; 
- The level of body: whole body (WBHI') • '!he patient's whole body temperature 
is increased. 
In view of the restricted subject of this thesis, the techniques for appli-
cation of local and regional hyperthermia will be discussed only briefly, 
whilst rrore attention will be paid to whole body hyperthermia. 
local hyperthermia 
'!he terrperatures which can be achieved in turrours using local hyperthermia are 
limited by: 
a) the arrount of energy which can be deposited in the tumour 
b) the amount of energy which is carried fran the turrour, which mainly takes 
place via blood flow. (See table III-2). 
UiT can be achieved by both invasive and non-invasive methods (for a review, 
see Hand and Ter Haar, 1981, Hand 1981 and Ter Haar 1981). Tumours which 
extend no more than a few millimeters in depth can be heated by contact 
application of e.g. hot water (bath or mattress). In clinical practice this 
is, however, insufficient. '!he methods which have the greatest potential for 
inducing local hyperthermia are those in which electranagnetic waves or ultra-
sound are employed. 
In the case of non-ionizing electranagnetic radiation, the level of energy 
absorbed by tissue depends on the wavelength of the radiation and the 
dielectric properties of the tissue. 
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Table III-2 FACI'ORS INVOLVED IN TEW'ERATURFS ACHIEVED DURING 
LOCAL HYPERI'HERMIA 
(1) energy disposition 
- wave lenght - frequency 
- applicator used, coupling to the tissue 
- tissue - anatomy 
- dielectric properties 
(2) heat dissipation 
- blood flow 
- thennal properties of the tissues heated 
- environmental temperature - adjacing tissues 
- outside the body 
Many of these factor unknown for human tissues. 
Same of the parameters change with changing temperature. 
'Ihe latter vary according to the wavelength used. Electrcmagnetic heating can 
be achieved using radiofrequency (0.5 - 30 MHz) or microwaves (300 - > 1000 
MHz) • fbv.lever, the use of electrcmagnetic waves is restricted, in the absence 
of a shielded roan, to frequencies v.ihich are allocated by the government for 
medical application. In the Netherlands these are 27, 433 and 2450 MHz. 
The penetration depth of electrcmagnetic radiation is defined as the depth at 
v.ihich the power density of a wave has decreased to l/e2 of its value at the 
surface. Ebr 2450 and 433 MHz the penetration depths are 1. 7 and 3. 6 ans in 
muscle and 11.2 and 26.2 ans in fat respectively. <Xlly superficial turrours can 
be heated using these two microwave frequencies When radiating sources or 
contact applicators are used. It is also possible to introduce coaxial 
applicators into body cavities, e.g., the oesophageal lunen or the bladder. 
Coaxial applicators with a very small diameter can be introduced directly into 
tissue. 'Ihis fonn of local heating can be very useful When caribined with 
interstitial radiotherapy. 
Radiofrequency heating can be achieved using either capacitive or inductive 
coupling, or localised current fields. Fbr capacitive coupling the tissue to 
be heated is placed between two electrodes. cne of the problems encountered 
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with this method is that the energy disposition depends mainly on the 
electrical resistance of the tissue. This makes that, When the two electrodes 
are placed opposite around the trunk, fat tissues are more easily heated than 
the underlying tissues with a higher water content. This restricts the 
possibilities of this system for deep heating. 
In inductive coupling, a radio frequency coil is placed above or around the 
tissue to be heated. With this method the wet tissues with the highest water 
content are preferentially heated. The penetration depth of these methods 
however is small. 
Lower frequencies, 100 KHz - 10 MHz, may be used to induce local current 
fields. These can be applied by electrodes Which can be superficially placed, 
in direct contact with the skin, or interstitially or using a combination of 
these arrangements. It is also possible to place a cylindrical electrode 
within the lumen of e.g. the oesophagus and a second, large electrode, 
externally around the trunk. 
It is not possible to obtain homogeneous tissue heating by using any of the 
methods discussed for local hyperthermia induction. Because energy is absorbed 
within the tissues, the energy level decreases with increasing depth. Tissue 
inhomogeneities within the volume to be heated influence the shape of the 
energy distribution obtained. Local differences in dielectric properties 
within a tissue type cause inhomogeneities in absorbed energy. Furthennore, 
the rate at Which heat is cleared away from the tissue is of great importance 
to the final terrperature distribution. 
It is generally assumed that the blood flow in tumours of a detectable size is 
lower than that in nonna.l tissue {Jain and ward-Hartley, 1984). l'Dreover, an 
increase in blood flow as a physiological reaction to heat, may occur in a 
lower rate in tumours than in nonna.l tissues {see chapter II) . 
In experimental tumours that have, from the clinician's point of view, a small 
volume { < 2 g) , Song observed that the blood flow in the centre of the tumour 
decreased by 10% following 1 hr. at 43°C, while the blood flow in the 
surrounding muscle increased by 177% {Song, 1984). As blood flow is the major 
factor determining the amount of energy carried from tissues, this implies 
that the application of a homogeneous energy distribution to the tissue, 
should preferentially heat tumours. All the above mentioned factors 
concerning inhomogeneous tissue heating, emphasise the necessity of measuring 
tissue temperatures during local hyperthermia. Thermometry in the presence of 
electromagnetic fields however presents still considerable problems. 
In the first place, metallic thermocouple or thermistor probes within a 
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needle, suitable for insertion into tissues, interfere with electromagnetic 
fields. This interference can be minimized in the microwave frequency range, 
by orientating the probe insertion perpendicularly to the electrical field 
lines. 
Secondly, electromagnetic fields interfere with electronic read-out apparatus. 
'Ihe way to avoid this problem is to switch off the generator for a few seconds 
during which the temperatures can be read-off. Recently some types of 
non-perturbing probes have been developed, based on the principles of optical 
thermometry, using glass or glass like fibers in combination with e.g. liquid 
crystals or Gallium Arsenide crystals. These probes cannot be inserted 
directly into tissue, but have to be placed within a catheter. 
Ultrasound (0.5 - 5 MHz) can also be used for induction of local hyperthermia. 
It has to be applied via a coupling medium. Penetration depth is, depending on 
frequency, 3. 7 - 14 em in fat and 1.4 - 12.5 em in muscle. 'Ihe ultrasonic beam 
has a lower tendency to scatter through the tissue than either microwave or 
radiofrequency beams have. This characteristic makes it possible to use 
focussing teChniques for heating well defined volumes, and it therefore seems 
the method of choice. H::lwever, serious disadvantages of ultrasound are that it 
does not penetrate through gas or bone, and that reflections at gas/tissue and 
bone/soft tissue interfaces occur. As many sites in the bcdy are characterized 
by the presence of gas and bones, the applicability of ultrasound is therefore 
limited. Interference-free thermometry can be perfonned during ultrasound 
heating using thermocouples. In clinical practice, ultrasound is rarely used. 
Regional hyperthermia 
In regional hyperthermia the entire organ, extremity or region in whidh the 
tt.m:>ur is situated, is heated. Regional hyperthermia has been applied 
clinically especially for extremities, by perfusion, and bladder and stomach, 
by irrigation. 
Organs or extremities can be heated by isolated perfusion, the relevant artery 
and vein being connected to a perfusion machine by surgical procedure. 
Collateral circulation vessels are blocked by externally applied pressure. 'lhe 
perfusate is heated and, in the case of an extremity, the skin is thenna.lly 
isolated from the environment in order to obtain a rrore hc:m.Jgeneous 
temperature distribution. In this way, the heated perfusate heats the tissue 
whidh is provided by and drained fran blood by the isolated vessel system. 
This method is often used in combination with cytotoxic agents, which are 
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added to the perfusate. Tissue temperatures of up to 45°C have been reached in 
linibs (Cavaliere et al. 1967). Hollow visceral organs can also be heated by 
irrigation. '!his has been perfomed in the urinary bladder and stcrnach. '!his 
method however only achieves an adequate temperature increase over the first 
few millimeters of the inner surface of the organ wall. Ludgate et al. (1979) 
mentions a gradient of 1 °C per rrm tissue in urinary bladder. 
Intraperitoneal perfusion can also be perfomed using heated fluid. Because 
the surface area heated is very large, heating of the whole body Ili3.Y easily 
occur. In fact, Priesching {1976) applied peritoneal perfusion in order to 
obtain whole bodyhyperthemia. 
JEep local heating (non-invasive) can also be regarded as regional heating and 
it is called as such presently. It is not yet possible to concentrate energy 
into a deep seated tumour without losing most of the energy to the overlying 
tissues. Deep local heating of extensive tUIIDurs in the thoracic, ab:lominal or 
pelvic regions will therefore be accanpanied by an in=ease in the patient's 
core temperature, the degree depending on the level of energy required and the 
volume of blood fleMing through the region. 
Preliminary experience has shown that whole body hyperthemia is more likely 
to occur during deep local heating in the thoracic region than in the 
aroominal or pelvic regions (Perez et al. 1984). 
Whole body hypertilemia 
In whole body hyperthemia, the temperature of the patient' s whole body is 
raised. '!he modem approach is to both introduce thennal energy into the body 
and reduce heat losses from the patient. 
'!he Ili3.Xiroum temperature tolerated lies around 41.8 - 42°C (Pettigrew et al. 
1974A). Whole body hyperthemia is the only method with which a homogeneous 
temperature distribution can be reached within a deep seated tUIIDur, although 
unfortunately the tumour cannot be heated preferentially, and the tumour 
treatment temperature is limited to a relatively low level. 
General considerations 
Many methods have been and are still being used to apply whole body hyper-
themia. The oldest one is fever induction by administration of bacteria or 
bacterial toxins, thus causing the patient's thermostat to reset at a higher 
set-point (Coley 1893, Nauts 1982A). 
Before raising the body temperature of a subject, it is useful to compile a 
heat balance. 
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Table III -3 SCME APPROXIMATE VALUES RELEVANT FOR WHOLE BODY HYPERI'HERMIA 
TREA'IMENT OF A 70 kg PERSCN* 
Heat production 
Metabolic rate 300 kJ.hr-l (80 Watts) 
N.B. 'Ihe metabolic rate increases about 10% per degree increase 
in body terrq:>erature ! 
Heat loss under nonnal conditions 
via irradiation 60% 
via conduction and convection 15% 
via insensible perspiration 25% 
100% 
Main potential areas of addition heat loss during WBHI': 
via perspiration 500 ml.hr -l 1200 kJ .hr -l (300 Watts) 
via i.v. infusions 500 ml.hr-l 46 kJ.hr-l ( 12 Watts) 
via respiration (mainly via 
rroisture) 100 kJ.hr-l 25 Watts) 
Required for heating (70 kg person) 
assuming a specific heat of 3.5 kJ.kg-1 •0 c-l 245 kJ. 0 c-l.hr-l 
*These approximate values were derived fran textbooks (Guyton, 1981; Wright, 
1982) and data by Pettigrew and Ludgate (1977) and Volpe and Jain (1982). 
Table III-3 indicates the following: 
1. Under nonnal conditions the canbined heat loss equals the heat 
production. 
0 -1 2. In the case of no heat loss the temperature increases by about 1 C.hr 
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Variation in the various physiological parameters between individuals is huge, 
for example, the metabolic rate between men and women differs substantially. 
Also terrperature regulation mechanisms (sweating, breathing rates) show 
considerable differences, depending on age, physical condition, body weight, 
etc. Fbr the purp::>se of plainness, it must suffice to canpile an average based 
on approximate values (table III-3). 
M:!thods that dep::>sit energy into the body can be divided into tv.o categories -
invasive and non-invasive. Techniques are reviewed in table III-4 and figure 
III-2, including references. In non-invasive methods the energy is applied to 
the body surface. The energy is then absorbed by the blood and transported 
through the whole body. '!he non-invasive techniques that have been employed 
include: the use of hot air, hot water or wax, either in direct contact with 
the skin or within bags, mattresses or suits; radiation such as infra-red or 
ANAESTH. 
ANAESTH. 
~)WATER 
 
ANAESTH. ~· 
ANAESTH. 
RF OR WATER 
The molten-wax method. 
The water-suits and 
blankets. 
The extracorporeal 
method. 
The immersion-flow bath. 
The Pomp-Siemens 
cabin. 
The radiant-heat device. 
Fig. III - 2 THE VARIOUS WHOLE BODY HEATING DEVICES 
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Table III -4 MEI'HODS USED AND IN USE FOR WBHI' INDUCI'ION 
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MJlten Wax 
water Blanket or SUit 
Infra-red 
Siemens/Panp cabin 
waterbath 
TRANSCUTANEDUS 
Pettigrew et al.(l974A and B)(Newcastle) 
Blair and Levin (1978) (South Africa) 
Greenlaw et al. (1980A) (M:trshfield, Wis=nsin) 
Barlogie et al. (1979) (Houston) 
Bull et al. (1979) (NCI and Houston) 
Larkin et al. (1977) (Albuquerque) 
Moricca et al.(l979) (Rome) 
Herman et al. (1982) (Tucson) 
Gerad et al. (1984) (Baltirrore) 
Heckel and Heckel (1979) (Esslingen/Neckar) 
Robins et al. (1984) (M:tdison) 
Priesching (1976) (Vienna) 
Panp (1978) (Hamburg and Essen) 
Engelhardt et al. (1982) (Freiburg) 
Vander Zee et al. (present study) (Rotterdam) 
Kirsch and Schmidt ( 1966) Dresden 
Wlist et al. (1975) (MUnster) 
Von Ardenne (1980) (Dresden) 
Versteegh (1980) (Leiden) 
via :EXI'RACORPOREAL CIRCUIT 
Fenoral A-V shunt 
Peritoneal irrigation 
Parks et al.(1979) (Jackson, Mississippi) 
Herman et al. (1982) (Tucson) 
Lange et a1.(1983) (Munidh) 
Priesching (1976) (Vienna) 
electromagnetic radiation; or a combination of two or more of these methods. 
The imnersion of the patient in hot water or wax irrpl ies simultaneous blockage 
of the patient 1 s cooling mechanisms. With the alternative methods, additional 
isolation is necessary, e.g. with a plastic or aluminium sheet or a blanket. 
Invasive techniques for energy deposition are e.g. extracorporeal circulation 
or, as mentioned before, peritoneal irrigation with heated fluids. The tem-
perature increase that can be achieved by these methods is restricted by the 
function and thermo-sensitivity of same critical systems, especially of heart 
and lungs, liver and brain. The maximum tolerable temperature is generally 
assumed to be 42°C, although treatments at higher te:nperatures have been 
reported (Herman et al. 1982, Kirsch and Sclmtidt 1966, Parks et al. 1979). 
In general, if temperatures above 41°C are used, it is preferred to perform 
the treatment under general anaesthesia. This is necessary for the follov.ring 
reasons. Firstly, the attachment of the monitoring lines necessary for safety 
control (therm:metry, cardiovascular functioning), is unpleasant for the 
patient. 
Secondly, the high body temperature and the resulting tachycardia and 
tachypnoe makes the patient feel very uncomfortable. Furthermore, to prevent 
hyperventilation it may be indicated to use artificial respiration. 
The drawback of general anaesthesia is that, when no preventive measures are 
taken, the patient cools rapidly after the initiation of the anaesthesia, 
before heating is started. This may be not much of a problem when surgery has 
to be performed, but during a WEHr session this must be avoided in order to 
minimize the warming-up time. 
Energy input can further be increased by heating all infusion fluids, and 
energy losses can be diminished by warming and humidifying the respiratory 
gases. 
Review of WEHr investigations 
The earliest report on the use of an external heat supply to induce WEHr is 
that of Warren, 1935. Warren was irrpressed by the thought that fever might 
have a destructive influence on malignant turours, but decided to develop a 
sirrple and safe method for the production of a high body te:nperature. He used 
"radiant energy" (incandescent bulbs) as an energy source. 
The patient 1 s te:nperature was maintained at 41 - 41. 5°C for 5-21 hours. He 
gives no information on the use of sedation or anaesthesia, the time required 
to reach the target te:nperature, or the toxicity. In 16 of 32 cases with 
"hopeless malignant disease" treated, the WEHr treatment, in 10 cases combined 
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with radiotherapy, resulted in marked to moderate improvement: (marked) 
shrinkage of turrour with (very) slow recurrence. 
Hyperthermia, induced by infra-red radiation, was also administered by Heckel 
(Heckel and Heckel 1979). Clinical indications for treatment with "Whole body 
hyperthermia were, in addition to malignant turrours, chronical prostatitis, 
allergic and rheumatic diseases and epilepsia. The warming-up phase (to 40°C) 
required al::out 100 minutes. Fburty-six patients, of vvhan 23 had malignant 
turrours, received 479 treatments in "Which the rectal temperature was increased 
to 39 - 41.4°C. These treatments resulted in the patients with malignant 
disease in sane palliation. Recently, the use of radiant heat was investigated 
by Robins. The patient lies in a tubular chamber, the wall of which is 
surrounded by an electric heating =il, with the head outside. When the target 
tatperature is reached, the patient is removed fran the coil and =vered with 
blankets to maintain his tatperature. lbbins achieved a heating rate of al::out 
4.8°C/hour (Robins et al. 1984). The patient is not anaesthetized during the 
procedure. Recently, lbbins reported no toxicity in over 170 treatments at 
41.8°C (Robins et al. 1986). 
The v.urk of von Ardenne requires particular mentioning. Since 1965 he has 
performed a great deal of experimental v.urk in support of his proposed cancer 
multistep therapy (CMI') (von Ardenne and Kruger 1980). CMl' is a complicated 
and theoretical treatment, =nsisting of a large nurriber of "steps". Sane of 
these "steps" are turrour hyperacidification, achieved by the infusion of 
glu=se, in combination with two-step hyperthermia - Whole body hyperthermia 
at 40.5°C and additional local hyperthermia at 42.5°C. 
Von Ardenne claims that his treatment schedule results in irreversible 
occlusion of tumour vasculature by stiffened erythrocytes. He speculates that 
the stiffening of erythrocytes is the =nsequence of changes in rigidity of 
the erythrocyte wall, brought al::out by the If! reduction resulting fran glucose 
infusion. This is followed by se=ndary damage to the turrour cells. In many of 
his publications a complicated schedule for the simultaneous administration of 
WEHT, radiotherapy, cytotoxic agents gl u=se, vitamins and other therapeutic 
measures is described. 
In 1966 Kirsch, Who was inspired by von Ardenne, reports his investigations on 
Whole body hyperthermia (Kirsch 1966). He started off testing various 
techniques on dogs, and found that heating by hot waterbaths was less toxic 
than heating by extra=rporeal blood heating methods: more dogs survived the 
former method at mean tatperatures of up to 43. 9°C. 
Based on these experiments he started the clinical application of Whole body 
44 
hyperthermia. The patient was anaesthetized and placed in a waterbath at 45°C 
with the head lying in an adjacent cold bath for selective cooling of the 
head. Only once in a series of 120 treatments was a serious complication ob-
served. This consisted of a cardiac arrest, Which occurred during hyper-
thermia, but this was reversed by (irrmediate) cooling. Kirsch reports that he 
was able to maintain the patient's temperature at 44°C for 30 minutes with no 
serious toxicity. Nevertheless, in view of the poor condition of most of his 
patients, he decided to restrict treatments to 42°C for one or more hours. 
W3.terbath heating was later clinically investigated by Versteegh (1980). He 
achieved a temperature increase of 6.0°C/hour. This meant that the warming-up 
period (to 42°C) was restricted to less than 1 hour. He observed no serious 
toxicity following 10 treatments in 4 patients. 
In 1969 the first, very concise, report on the Porrp-Siemens cabin appeared 
(Panp and Franz 1969). In this cabin hot air, radiofrequency and microwave 
energies can be used simultaneously to heat the patient. In 1978 Panp reported 
that a core temperature of 40 - 42°C could be reached within half an hour 
(Panp 1978) . Seven of these cabins were placed in various clinics in Europe. A 
revie'v (Reinhold et al. 1980), shows that the warming-up time varies from 25 
to 130 minutes, depending on the target temperature chosen and the use of the 
various built-in energy sources. The cabin has been used by l?clnp, Priesching, 
Wust, Engelhardt, Ivbricca, Dietzel and Wallach. At this time the cabin is 
still being used by Engelhardt's group in Freiburg. 
The use of paraffin wax for energy input was introduced by Pettigrew 
(Pettigrew et al. 1974A). The patient is anaesthetized and artificially 
ventilated, sealed in a plastic bag and placed in a bath. Ivblten paraffin wax, 
heated to 50°C, is then pmnped around the patient. The body heating rate with 
this method is 3 - 6°C/hour, depending on body weight. '!he part of wax that is 
still in the liquid state when the oesophageal temperature reaches 41°C, is 
rem:::>ved, leaving the salified wax around the body as an insulating layer. '!he 
patient's temperature can be controlled by varying the area of skin exposed to 
the air. '!his technique was later used by Levin and Blair ( 1978) and Greenlaw 
et al. (1980A) • Levin & Blair used a modification of Pettigrew's technique; 
the wax was applied within plastic bags, Which had the advantages of causing 
less spillage of wax and enabling the rem:::>val of all the wax, so that the 
patient could be managed more easily during subsequent irradiation. 
In addition to the use of the Panp-Siemens cabin, Priesching (1976) also 
investigated hypertherrnic peritoneal perfusion. When the peritoneal perfusate 
is heated to 45°C, the warming-up time required (to 42°C) was 2 - 2.5 hour. 
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He preferred to use peritoneal perfusion -in patients with peritoneal met-
astases, because selective turrour heating could be achieved in nodules smaller 
than 5 rrm diameter. 
Many investigators use hot water, either in blankets or suits, as a caloric 
source. The most important reports of this method are by Larkin et al. (1977), 
Morrica et al. (1979), Bull et al. (1979) and Barlogie et al. (1979). Using 
this method a core temperature of 42°C can be achieved within 2 hours. In 
general, the patient is anaesthetized. 
A method which has relatively recently cane into use is that of extracorporeal 
circulation, with direct heating of the blo:d. Fbr this method an 
arteriovenous shunt must first be constructed. Drring the warming-up phase the 
blo:d is heated to 45°C by a heat-exchanger in the extracorporeal circulation. 
The maintenance of the target terrperature can be autanatically regulated. With 
this method, the oesophageal tenperature can be increased to 41. 5°C in as 
little as 22 minutes (Parks et al. 1979), although Lange et al. (1983) report 
a warming-up time, to 41.8°C, of 60 - 120 minutes. 
In 1976, when the investigations on applicability of WBHl' in the Rotterdam 
Radiotherapeutic Institute were started, only few of the above mentioned 
experience was published. '!he Pomp Siemens cabin appeared to offer some major 
advantages such as continuous visual control of the patient, easy patient care 
and possibilities for simultaneous local heating. '!he experience with this 
system is described in the following chapters. 
46 
INITIAL RESEARCH 
Section II 

History 
DEVELOPMENT OF THE 
ADAPTED POMP-SIEMENS 
CABIN METHOD 
Chapter IV 
Fran September · 1976 animal experiments were perfonned in order to learn to 
know the optimal use of the cabin and to get sane experience with the heating 
of living bodies. This investigation was done mainly on dogs. Later on, the 
experiments with dogs were extended with measurement of brain terrperature and 
intracranial pressure during WBHT. 
In 1978 sane experience was obtained with temperature measurements in human 
patients undergoing fever therapy induced by the injection of c. parvum in the 
Antoni van Leeuwenhoek Hospital in Amsterdam. A visit paid to Dr. Ollendiek in 
his private hyperthermia clinic in Bad Neuheim, Gennany, revealed sane of the 
practical problems encountered with the clinical administration of WBHT. 
In June 1978 the first patient was treated in Rotterdam. Until patient 10, the 
heating method was adjusted on the basis of experience obtained. 
The Pcmp--Siemens cabin 
The Ponp-Siemens hyperthermia cabin consists of a bed-like structure covered 
by a semi-cylindrical perspex hood. The construction is schematically 
represented in figure IV-1. 
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Fig. IV - 1 THE POMP-SIEMENS HYPERTHERMIA CABIN 
The Pomp-Siemens hyperthermia cabin. Size of the main body (without head 
rest), 187 em long and 92 em wide. (A) sensor for thermostat; (B) air 
heating elements; (C) axial ventilator (not shown in left diagram); (D) 
adjustable holder for microwave applicators (applicators not shown); (E) 
ports for handling infusions, etc (sliding doors not shown); (F) adjustable 
plastic roller top; (G) place for radiofrequency coil under patient; and 
(H) holder for sealing cloth. 
In the head end of the hood an opening is provided through which the patient • s 
hea~ can be positioned outside the cabin. There is a holder around this 
opening to all 0\'1 sealing of the area between the patient's neck and the edges 
of the opening. There are ports laterally in the wall of the hood, through 
which handling of infusion and monitoring lines is possible. 
These ports can be closed by sliding doors. The cranial part of the hood has a 
plastic roller top, which can be opened for manoeuvring the microwave 
applicator holder system. 
The hood can be opened by hinges placed laterally. This was changed by us by 
the construction of a lifting tackle, with which the hood could be reroved 
vertically, allOYling the approach of the patient fran both sides. 
There are three sources of energy which can be used to heat the patient. 
1) Air system 
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Between the mattress on which the patient is positioned and the sides of 
the cabin is a space of about 10 em. This area is covered by an 
appropriately shaped pl~ board with slits. In the area bel0\'1 the level 
of the mattress, two 1.2 kW electrical air heaters are located on each 
side. The hot air rises through the slits and surrounds the patient. The 
air is recirculated through a long axial ventilator located below the foot 
end of the lower air space. The:rnostatic oontrol is provided by a sensor 
located in the upper part of the dane of the hood. The temperature of the 
air within the cabin can be read off fran an aloohol therrrometer located 
in the same area as the the:rnostatic oontrol sensor. 
2) Radio frequency system 
In the mattress, on which the patient lies, a single flat loop of a 
radiofrequency ooil (size about 40 x 50 em) is inoorporated horizontally 
at the level of the patient's torso. This coil can be connected to a 27 
Miz generator, delivering maximally 400 w. 
3) Microwave system 
A microwave appl icator can be manoeuvered within the cabin such that 
microwave energy can be directed to nost sites of the ventral upper part 
of the l:ody. There are three types of antennas available, which can be 
oonnected to a 433 Miz generator, which can deliver up to 250 w. 
With the heating equipment available, we were faced with the following 
questions to be answered: 
- which of the 3 heating systems, e.g. warm air, radiofrequency and 
microwave, or which combination, would provide the highest heating rate 
and at which levels of energy output; 
how would the use of any combination influence the temperature 
distribution; 
- how easy would the temperature control be with the equipnent, for exan:ple 
at the end of the heating phase (overshoot should be avoided at any 
price!) and during the plateau phase; 
- in which amount would the use of electromagnetic energy disturb the 
temperature and physiology nonitoring lines and, if this would be not 
acceptable, oould this disturbance be avoided ? 
To answer these questions, a series of dog experiments was performed. This 
also made it p::>ssible to investigate organ toxicity following WHIT at various 
levels. 
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Animal experiments 
I Investigation of operational aspects and heating capaci!f of the cabin 
and general toxicity of WEHI' in dogs 
This part of the study is base:l on the raw data obtaine:l by the group when it 
consiste:l of mrs. L. l?onke-Spit, drs. A. Felius and ing. G.C. van Rhoon. 
Ten rrongrel dogs of either sex (body weight 23-37, mean 30.0 kg, age 2-5 
years) were subjecte:l to 45 experiments, including 5 control and 40 heating 
sessions. 
Anaesthesia was induced in fasted animals by intramuscular injection of 
ketamine and vetranquil (4.5/0.5 ml) and maintained using smaller doses. 
If tachycardia (heart rate > 180) occurred a Beta blocker (propanolol hydro-
chloride 1 mg; Inderal ICI Ltd) was given. The dogs were intubated to prevent 
excessive cooling via the tongue by panting (which is the main cooling 
mechanism in dogs), but were allowe:l to breathe spontaneously. Following 
intubation the ECG was connected and an intravenous catheter was established 
fOr the infusion of fluids (0.45% NaCl/2.5% glucose). 
Terrperature measurements were perfO:rme:l in the rectum during each experiment. 
Other sites fOr temperature measurements were the oesopbagus 
(n = 25), the external acoustic meatus (n = 25), intramuscularly (n = 31) and 
subcutaneously (n = 31). For these measurements the Ellab the:rmocouple system 
as described elseWhere (cbapter III) was used. When electromagnetic heating 
_was used temperature data were coll ecterl with the generator switched off. 
Hyperthermia was induced in the Pomp Siemens cabin using one of or a 
caribination of the three techniques: warm air, terrperature 30 - 70°C, 27 Miz 
radiofrequency and 433 Miz microwaves, as is indicated in table IV-3. The 
rectal temperature strive:l for during the hyperthe:rmia experiments was 40.5 2:_ 
0 0.2 C (n = 3), 41.0 2:_ 0.2 (n = 4), 41.5 2:_ 0.2 (n = 14), 42.0 2:_ 0.2 (n = 12) 
0 
and 42.5 2:_ 0.2 C (n = 6) respectively. This temperature generally was 
maintained for two hours. In one dog accidentally an overshoot in core 
temperature up to 44°C occurred. 
Blood samples were taken before the start of treatment and afterwards 
immediately and at 24 hour time intervals up to 4 days after treatment. 
Results 
A) Evaluation of the heating technique 
1) Thenncmetry 
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During 25 heating experiments, rectal as well as oesopbageal and tympanic 
maribrane temperatures were measure:l. The maximum value of each of these 
tenperatures was considere:l to be indicative for the safety level of 
treatment. These maximum levels, and the differences between these values 
are given in table IV-1. 
Table IV-1 THE HIGHEST TEMPERATURES MEASURED DURING WBHI' IN DCGS AT THE 
VARIOUS LEVELS, AND THE DIFFERENCES BEIWEEN THE TEMPERA'IURES 
MEASURED AT THE VARIOUS a:>RE SITES 
range mean s.d. 
rectum 40.6 - 42.5 41.81 0.44 
oesophagus 40.6 - 42.4 41.76 0.44 
tyrrpanic membrane 39.9 - 42.2 41.41 0.51 
A (T oesophagus - T rectum) - 0.6 - + 0.2 - 0.05 0.17 
A (T tyrrpanic membrane - T oesophagus) - 1.0 - + 0.3 - 0.35 0.27 
A (T tympanic me:nbrane - T rectum) - l.l- 0 - 0.4 0.22 
The mean difference between rectal and oesophageal maximum tenperature of 
0.05°C is negligible. Besides, in 23 of 25 experiments, the difference was 
less than 0.2°C. The tympanic menbrane temperature is considerably lower 
than rectal or oesophageal temperature. This difference with oesophageal 
and rectal tenperature was less than 0.2°C in only 7 and 4 experiments 
respectively. In only 1 experiment the maximum tympanic tenperature was 
higher than oesophageal tenperature. 
The rate of temperature increase, in °C per hour, varie:l from 0.9 to 5.8 
and from 0.8 to 2.5 for rectal and oesophageal temperature respectively. 
The value of 5. 8°C/hour was observe:l in a dog in which a high 1 evel of 
energy was introduce:l by 27 Mfz radiofrequency, resulting in, at the 
start, a very high temperature in the superficial tissues and, despite 
ending energy input, an overshoot of rectal temperature up to 44°C with as 
a result the death of the dog. In this dog no oesophageal temperature was 
measure:l. This experiment was exclude:l from analysis, leaving a maximum 
value for rectal tenperature increase of 3.1°C per hour. This experience 
learne:l us to avoid local high energy input during subsequent experimental 
and clinical WEHr treatment. 
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In 25 experiments the rectal as well as the oesophageal temperature was 
recorded. In 3 experiments there was no difference between the rate of 
temperature increase. The rate was higher for rectal than for oesopb.ageal 
temperature in 4 and the op_F.Osite was found in 18 experiments 
respectively. The difference varied from- 0.1 to 0.5°C per hour with the 
oesophageal rate being mean 0.12°C (s.d. 0.15) per hour higher than the 
rectal rate. When at the end of the heating period the energy input is 
decreased, the lead of oesophageal temperature is rapidly overtaken by 
rectal temperature. 
2) Efficiency of heating method 
Rectal heating rate was found to depend not only on technique used, but 
also on the body weight of the heated animal. This is demonstrated in 
table IV-2, Where the heating rates are given for tw::> levels of cabin air 
temperature. The heating rate for dogs with a body weight below 30 kg is 
for both air temperatures higher than that for dogs weighing :rrore than 30 
kg. The efficiency of the heating method used can therefore be established 
by dividing the rate of temperature increase by the body mass to be 
heated, i.e., the body weight in kg. 
As rectal temperature was measured during each of the experiments and 
there was a significant correlation between rate in in=ease of tem-
perature in the oesophagus and in the rectum (r = 0.937; p < 0.001), only 
Table IV-2 RECTAL HEATING RATE IN DOGS IN RELATION 'TO BODY WEIGH!' 
air temperature (°C) body weight (kg) n heating rate (°Cjhr) 
mean sd 
--
45- 55 < 30 6 1.40 0.09 
> 30 4 1.10 0.18 
55 - 70 < 30 8 2.16 0.43 
> 30 4 1. 70 0.08 
Heating was achieved by the use of warm air only. 
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the rectal temperature increase rate was used in this analysis. The mean's 
and s . d. 's for rectal temperature increase rate per kg. l:ody weight for 
each of the heating methods is represented in table IV-3. The highest 
value was obtained using high cabin air temperature (> 55°C) only, 
although there is no significant difference with the value obtained using 
cabin air at 35-45°C in =mbination with 27 and 433 Miz electranagnetic 
heating. 
The body weight was found to be related square to temperature increase 
rate. As heating is perfonned through the skin surface and the ratio l:ody 
mass to skin surface decreases with increasing l:ody weight, this 
relationship is not surprising. 
In figure IV-2 the relation between temperature increase rate per kg. l:ody 
weight and the l:ody weight in kg. is presented for the experiments in 
which an air temperature of 2_ 45°C, whether or not in corribination with 
local 433 Miz heating, was used. The =rrelation =efficient of these data 
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Fig. IV - 2 RECTAL HEATING RATE IN DOGS; ARRANGED TO BODY WEIGHT 
Rectal heating rate (°C/hour/kg bodyweight) for 8 individual dogs, arranged 
in order of body weight. This figure shows the means, standard deviation and 
the regression line. The number of data available for each dog is given in 
parenthesis. 
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Table IV-3 REcrAL HEATING RATE PER KG BODY WEIGHT IN IXlGS FOR THE VARIOUS 
TECHNIQUES USED 
air temperature (0 c) 
< 35 
35 - 45 
45- 55 
55 - 70 
0.1 
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....., 
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....., 
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0.0 
27 MHz 433 MHz n heating rate 
mean 
+ + 1 0.043 
+ 6 0.045 
+ + 3 0.068 
+ 2 0.057 
10 0.042 
12 0.070 
+ 5 0.053 
+ 17 0.065 
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Fig. IV - 3 RECTAL HEATING RATE IN DOGS 
(°C/hr/kg) 
sd 
0.013 
0.032 
0.006 
O.Oll 
0.023 
0.019 
0.022 
Rectal heating rate (°C/hour/kg body weight) in three individual dogs, 
obtained with warm air only at two different temperature levels. 
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was found to be -0.776 (2p < 0.05). 
In three dogs it was possible to compare the mean values for rectal 
temperature increase rates at two different heating techniques: air 
temperature of 45-55°C and 55-70°C respectively. These values are given in 
figure IV-3. The dog with a body weight of 36 kg is considerably slower 
with increasing rectal temperature than the dogs of 28 kg, but the 
increase in rate with a higher level of energy applied is equal. 
3) Temperature distribution 
The differences between the temperatures measured at sites representative 
for core are discussed above. 
The difference between the maximum temperature for any location in the 
shell, i.e., intramuscular or subcutaneous, and the maximum rectal tem-
perature varied fra:n - 0.3 to + 3. 7°C. The core-shell differences were 
conpared for the heating methods including and without the use of electro-
magnetic radiation respectively. 
The mean difference between rectal temperature and highest shell tempera-
ture for heating with hot air only was 0.24°C, SEM 0.06 (n = 21). The mean 
difference for the methods including electromagnetic heating was 1.15, SEM 
0.27 (n=15). The highest differences were seen when 27 MHz radiofrequency 
heating was used. These results indicate that heating with hot air only 
provides the best temperature hanogeneity. 
4) Interference of electromagnetic (E.M.) radiation with rronitoring equipnent 
Interference occurs when the rronitoring read-out systems pick up the E .M. 
radiation waves, and beca:nes a serious problem when the energy of the E.M. 
signal is so high that the signal given by the rronitoring probe cannot be 
distinguished. 
Electric apparatuses used during the WfHl' experiments include: 
- the HP canpact unit for rronitoring ECG, respiration and core tempera-
ture; 
- the Ellab 003 therrrocouple read-out system; 
- the Ramal 1 iquid crystal fiber optic (IillF) read-out system; 
- a 4-channel recorder. 
Interference was observed for each of these apparatuses. Interference 
could be prevented only for the LCDF read-out system, which probe is 
transparent for E.M. radiation, by isolating the read out system within a 
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Faraday cage. Continuous rronitoring of vital parameters, however, was 
impossible during the use of electromagnetic heating. 
Conclusions 
lliring the heating phase the monitoring of both oesophageal and rectal 
temperature is necessary for a safe administration of Whole body hyper-
thennia. The difference between the maximum value of both temperatures is 
negligible which can be explained by the rapid gain of rectal to 
oesophageal temperature after the energy input is decreased When nearing 
the set-point. During steady state the =ntrol of rectal temperature 
provides safety. 
The finding that the highest value for temperature increase rate was 
obtained using bot air only, corribined with the observations that the 
temperature distribution is inhomogeneous and the electronic monitoring 
equipment is disturbed when electromagnetic heating is used, points 
towards the choice for the clinical heating method: hot air only. In 
patients with a superficial turrour on the ventral part of the body, 433 
MHz local heating may be administered additionally during steady state 
periods. 
B) Toxicity of WEHr in dogs 
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Four dogs died following WHll' treatment. In three cases this was following 
WBHT at maximum levels of rectal temperature of 41.6 to 42.5°C. In the 
fourth dog, this was caused by failure of the heating method. In this 
case, radiofrequency power was used during the heating phase up to the 
maximum level possible. This resulted in a very high rectal temperature 
increase rate (5.8°C per bour, body weight 27 kg). Rectal temperature 
=ntinued to increase, even after the generator was switched off and 
cooling with ice cubes was starterl, up to a maximum value of 44°C. This 
must have been caused by a very high local temperature increase in the 
tissues close to the radiofrequency =il and a rerlistribution of energy by 
the bloodflow after switching off the generator. One hour after the rectal 
temperature started decreasing, heart and respiration stopperl. Reanimation 
attempts were without success. Post rrorten examination showed disseminated 
intravascular =agulation througbout the Whole body. From this experiment 
it was concl uderl that WEHI' at 44°C implicates the risk of 1 ethal i ty in 
dogs. 
Two dogs died shortly after tennination of the WEHI' treatment. One dog 
treated with a heat dose of ~ hours alx>ve 41°C, maximum rectal tem-
perature 4l.6°C, became ccmatous and died on the evening following wmr. 
Gross FQst morten examination did not reveal the cause of death. The 
second dog was treated for 2~ hours above 42°C, maximum rectal temperature 
42.5°C. One hour after cooling was started, the dog became comatous; 
inspection of the retinae revealed excavation of the papillas, indicating 
brain oedena. 
A fourth dog died 5 days after WEHr, 2~ hours alx>ve 42°C, maximum rectal 
temperature 42.2°C. This dog was treated with anticoagulants in order to 
prevent DIC, from 3 days before W1HI' till the time of death. Cause of 
death was shown to be haemorrhage in the mediastinum. 
In all dogs, post mortem examination of the brains (Prof. Stefanko, 
Medical Faculty of the Erasmus University Rotterdam) showed aspecific 
changes in brain tissue. The total weight had increased to 85 - 90 g (from 
a nonnal weight 75 g), red blood cells were found perivascularly and small 
foci with haemorrhage and/or DIC were seen. These findings were rrost con-
sistent with brain oedena, Which might have contributed to the death of 
the dogs. 
Circulatory and respiratory changes 
Heart rate increased during WEHr up to maximum 153% of its starting value 
(mean rate at t = 0, mean temperature 38.6°C, was 119 beats per minute). 
The heart rate increased with 14 beats per minute with each 1°C 
temperature increase (see figure IV-4). The correlation coefficient for 
the relation between tEmperature and heart rate was found to be 0.847 (2p 
< 0.05). 
Respiratory rate increased enorrrously up to 20 times its starting value 
(mean respiratory rate at t = 0 was 27). As dogs cool by increasing the 
air flow over the tongue, this phenanenon is not expected to occur at the 
same arrount during patient treatments. The respiration rate also appears 
temperature dependent, see figure IV-4. The correlation coefficient of 
this relation was fiound to be 0.982 (2p < 0.001). During plateau phase 
(the phase of steady state WEHI' at the pi anned I eve!) changes in acid-base 
balance were observed. fH shifts to higher values with increasing tem-
peratures Whereas peo2 dropped (figure IV-5) . The acidosis expected on the 
base of the increased metalx>l ism during hyperthermia appears to be cc:m-
pensated by the increase in respiration. 
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beats I min. 
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(45) 
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Respiration rate 
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37 38 39 40 41 42 43 37 38 39 40 41 42 43 
Mean temperature during plateau phase (°C) 
Fig. IV - 4 HEART RATE AND RESPIRATION RATE DURING WBHT IN DOGS 
In this figure the means and standard deviations are shown for each 
hyperthermia level. The number of data available for each temperature is 
given in parenthesis. 
60 
r..a:toratory 
The important changes are given in table IV-4. Some of the m::>st important 
findings will be discussed below, grouped according to the type. 
Electrolyte changes 
There were no changes in Na+ and Cl- blood values. K+ dropped to minimun 
83-88% of its nonnal value only after WIHI' at tarperatures above 4L3°C. 
Ca ++ showed minor decreases also after the control experiments. These 
electrolyte changes were maximum within 24 hours following WEHT. As 
sweating, causing loss of electrolytes, is not part of the cooling mec~ 
anism in dogs, electrolyte changes after hunan WIHI' may be expected to be 
of greater importance. 
control (5) 
time 0 (44) 
temp. 40.5 X (1) D 
temp. 41.0 (4) --e--
temp. 41.5 (14) 
temp. 42.0 (12) 
temp. 42.5 (4} 
7.3 7.4 7.5 7.6 7.7 10 20 30 40 50 
Venous blood pH Venous blood pC02 (mm Hg) 
Fig. IV - 5 ACID - BASE BALANCE CHANGES DURING WBHT IN DOGS 
Means and ranges for venous blood values of pH and pC02 during WBHT (plateau phase) in dogs, at various levels of hyperthermia dose. The number of data 
available for each temperature level is given in parenthesis. 
Haematology and ooagulation 
The nunber of 1 eukocytes increased up to 262% of the nonnal value, the 
rnaximun was reached usually after 24 hours. 
The nunber of platelets decreased to 4 7 and 13% of the starting value 
after WIHI' at 42 ...:!:._ 0.2 and 42.5 ...:!:._ 0.2°C respectively. The decrease fol-
lowing WIHI' at tarperatures lower than 42°C was less obvious; the nunber 
of platelets stayed within the range of nonnal value. 
Disse:ninated intravascular ooagulation (DIC) was observed in one of the 
dogs that died; the phenanenon was not diagnosed in the surviving dogs on 
the basis of laboratory changes. Although fibrinogen degradation products 
(FDP) increased up to alnost a factor 8 higher than the starting value, 
fibrinogen showed no oonsistent decrease. 
Liver damage 
Liver damage was judged acoording to changes in the eneymes SGJI', SGPI', 
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Table IV-4 MAXIMUM CHANGES (IN % OF STARriNG VALUE) OF VARIOUS PHYSIOLOOICAL PARAMEI'ERS FOLI.a'liNG WBHT IN JX)3S 
starting values control WBHT TREA'IMENI' I 'lWJ HOURS EXPOSURE 
temperature (0 c) 38.6 38.7 40.5 + 0.2 41.0 + 0.2 41.5 + 0.2 42 + 0.2 42.5 + 0.2 
n=44 n=5 n=3 n=4 n=l4 n=l2 n=5 
mean sd mean% mean% mean% mean% mean% mean% 
-- --
Heart rate 119 26 - 153 132 136 141 149 
Respiratory rate 27 13 - 633 1082 1224 1066 2028 
'lbtal ca (rmol/1) 2.39 0.009 95 - 93 93 - 97 
K+ (rmol/1) 4.17 0.45 
- - - 83 83 88 
alk.phosphatase (U/1) 40.5 55.9 - - - 377 714 2456 
soor (U/1) 23.7 13.3 406 284 1018 949 1083 1615 
SGPI' (U/1) 52.7 53.4 - - 282 439 528 964 
LOO (U/1) 113 65 276 - - 260 
Urea (rmo1/l) 6.3 1.3 - - - - 146 
Leucocytes (106 /1) 5439 1313 167 147 140 162 214 262 
Platelets (109/1) 223 94 - - - - 47 13 
Fibrinogen (g/1) 1.51 1.22 
FDP (rrg/1) 52.7 52.8 447 344 400 547 670 775 
Ol.anges are only reported when they exceed the range of starting values. 
LDH and alkaline phosphatase. 
SGOr and SGPI' increased with increasing plateau te:rperature, the latter 
showing increase from a treatment level of 40.8°C. Fbr both enzymes a 
dose-effect relationship was indicated. These changes may be ascribed to 
1 iver damage as well as to damage to other organs. 
LDH showed no important changes, even at the highest treatment 1 evel. 
Values for alkaline phosphatase showed significant in=eases only after 
treatment temperatures of 41.3°C. Enzyme levels had returned to normal 
within 96 hours following w.mr. 
Kidney function 
As there were no changes in creatinine blood I evel s up to the highest 
level of W1HI' (42.5 _..:!:.._ 0.2°C), the kidney function seems not to be in-
fluenced by the treatment procedure. Blood urea value was increased by 46% 
0 
only in the group of WHIT at 42 _..:!:.._ 0.2 C, but this elevation most likely 
reflects tissue damage. 
CJ::mcl usions 
The experimental WEHr treatments in dogs learned that WEHr up to 42.5°C is 
tolerated by these animals without major toxicity on most organ systems. 
The demands on the cardiovascular and respiratory system are I arge as dem-
onstrated by an in=ease in heart and respiratory rates; patient selection 
should therefore include investigation of the capacity of both systems. 
Considerable liver damage has been reported after WEHr at temperatures 
above 41.5°C (Pettigrew 1974B, Levin and Blair 1978) but no irreversible 
damage was observed in these experiments. 
Brain oedema was observed in 4 dogs for which the experiment ended 
fatally. This finding urged us to perform further experiments. These 
experiments, which were carried out in the course of 1 year and which in 
time overlapped the clinical study, will first be discussed in this exper-
imental section. 
II Measurement of cerebral temperature and epidural pressure during WEHr in 
dogs. 
In this study 13 beagles of either sex (body weight 8-12 kg, age 1-2 
years) were used. 
Anaesthesia and ventilation measures were equal to those in the first 
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series of experiments. 
Following intubation the ECG was connected, and to enable pressure moni-
toring catheters were introduced into the common carotid artery and the 
faroral vein. The catheters were connected to Hewlett Packard roodel 1280 c 
pressure transducers and an appropriate readout apparatus. An i . v. cath-
eter was established for the infusion of fluids: 
0.45% NaCl-2.5% glucose; 0,13 ~ 0.06 1/hr (mean~ 1 SD). The skin over the 
skull was incised and the parietal bone cleared of overlying muscle and 
fascia, then a hole was drilled on each side of the skull, approximately 1 
ern from the midi ine, taking care not to damage the dura. The epidural 
pressure was monitored with a rnicrotip pressure transducer (Millar Mikro-
Tip, roodel PC-370). It was zero balanced at 38.5°C or 40.0°C prior to each 
experiment. Zero drift was 0.05kPa (0.4 rrmHg) per hour, and temperature 
drift was 0.05 kPa per 0 c. 
This pressure monitoring system was made available to us by H. Karneraat 
and P. van der Kemp, dept. of Medical Electronics, Zuiderziekenhuis 
Rotterdam, and the technique by Prof. C.J.J. Avezaat and dr. J.H.M. van 
Eindhoven, depts. of Neurosurgery and Neurology, Medical Faculty, Erasmus 
University Rotterdam. 
The transducer was inserted 1.5-2 an through the hole (diameter 7-10 rrrn) 
on the right-hand side of the skull and was carefully .[X)Sitioned between 
the dura and the skull with its sensitive tip resting against the dura 
(figure IV-6). 
The temperature measuring system (Ellab DU-3) was calibrated to an accu-
racy of 0.1°C against a 0.05°C precision mercury ther.mameter (Eichamt flir 
Glasmessgerate Darmstadt, FRG). Needle thermocouples (Ellab AK19, diameter 
0.5 rrrn), for cerebral and epidural temperature measurements, were inserted 
via the same hole as was used for the pressure transducer (see figure 
IV-6) . The therrnocoupl e for the epidural measurements was rounded at the 
tip and preshaped to the measuring site. The hole on the left-hand side of 
the skull had a diameter of only 2 rrrn and was used solely for the inser-
tion of a second intracerebral therrnocoupl e. The intracerebral thermo-
couples were inserted in both hemispheres to a depth of 3.0 an in the 
first six dogs and 1.5 an in the other six. One dog in the control group 
had no thermocouples inserted into the brain. After placement of the 
probes the cranial defects were closed with bone wax. In all cases the 
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Fig. IV - 6 BRAIN TEMPERATURES AND EPIDURAL PRESSURE DURING WBHT IN DOGS 
This X -ray shows the brain thermocouples ( 1 , 2, 3) , the oesophageal thermo-
couple (5) and the pressure transducer (4) in position. 
rectal and oesophageal temperatures were measurai. The rectal therrrocoupl e 
was insertai to a minimum of 5 an, and the oesophageal thennocoupl e was 
placed in the lower third of the oesophagus. To induce hyperthermia the 
dog was then placai in a cabin in which hot air (60°C) was circulating. 
The animal was p:>si tionai on its 1 eft side, with its head outside the 
cabin, so that the head was not being exp:>sai to the hot air. These pre-
parations requirai about 3 hours, then the heating carmencai and after 
another 2-3 h the plannai rectal tarperature was attainai. This tsnpera-
ture could be maintained by adjusting the temperature of the air circu-
lating in the cabin. The animal was held at plateau tarperature for at 
least 2 hours unless it diai earlier due to respiration problems. Tenr-
perature and pressure measurements were taken every 10 minutes. 
Results 
Of the six dogs with cerebral therrrocouples insertai to a depth of 3.0 an, 
only two ccmpletai the 2 h at the planned maximum rectal tE!:!perature. The 
other four developed respiration problems, three dogs before the start of 
plateau and one dog during the plateau period. These respiratory problems 
probably had been caused by damage inflicted by the needle to the netlr'O-
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Table IV-5 TEMPERATURES IN ANAFSTHEI'IZED, INI'UBATED J:XX3S DURING A 2-H PERIOD OF WOOLE-BODY HYPERI'HERMIA 
Location 
Rectal 
OesoJ:hagal 
Cerebral left 
Cerebral right 
Epidural 
Plateau period 
Start 
Heated 
(n=7)b 
42.1 + 0.82 
42.2 + 0.85 
42.5 + 0.8la 
42.4 + 0.78 
42.0 + 1.2 
-
COntrol 
(IF2)c 
38.9 
39.0 
39.2 
39.2 
38.5 
-
The data presented are the mean.±. 1 SD in °c 
1 hr 
Heated 
(n=6)b 
42.2 + 0.59 
42.6 + 0.54 
42.6 + 0.45a 
42.4 + 0.55 
42.2 + 0.48 
2 hr 
COntrol Heated COntrol 
(n=2)c (n=6)b (IF2)c 
39.3 42.3 + 0.32 39.1 
39.4 42.6 + 0.51 39.1 
39.8 42.7 + 0.44 39.4 
39.8 42.6 + 0.44 39.4 
38.9 42.2 + 0.35 38.6 
a The paired mean difference with the rectal temperature is statistically significant (2p < 0.05) 
b The nunber of measurements for the oesophagus is 6, 5 and 5, respectively 
c One of the control dogs had no intracerebral thenrocouples inserted 
logical respiration control system; we observed no further respiratory 
probl ens wheh. the insertion depth of the needles was 1 imi ted to 1. 5 an. It 
was decided that use of the data collected up to 20 min before start of 
respiration problems was justified, as no influence up:m the course of the 
treatment be£ore this point could be seen, and once problems arose they 
developed very rapidly. All six dogs with cerebral thenrocouples 1.5 an 
deep and the one dog with no cerebral thenrocoupl es ccmpl eted the exper-
iment without problems. The mean rate of terrperature increase was 2.3 + 
0.55°C/h. At normotemperature, 38.0-39.0°C, there were significant (2p < 
0.05) differences of 0.8 and o.Pc between the rectal and the cerebral 
temperature at depths of 3.0 and 1.5 em, respectively, on both the right 
and left hand side of the brain. The difference of 0.5°C between the cer-
ebral temperature at 3.0 and 1.5 an depth, measured in different animals, 
is also statistically significant (2p < 0.05). As the terrperature in-
creased this difference became smaller. Once the plateau temperature had 
been reached only the cerebral temperature on the left-hand side at 1.5 em 
depth was still significantly higher (0.4°C) than the rectal terrperature. 
The oesophageal and epidural temperatures were within the range of the 
rectal temperature. The paired mean differences with the tanperature for 
the various measuring sites at the start of plateau, and after 1 and 2h at 
plateau are shown in Table IV-5. 
Fbr each ,PJint in time the data for heated dogs are given on the left, and 
on the right the control values £or tY-D dogs with a terrperature below 
40°C. The different plateau temperatures were of no influence on the 
gradients obtained. The left-hand side of the brain was consistently 0.4°C 
higher than the rectal temperature. This difference is statistically sig-
nificant (Student's t-test, 2p < 0.05) during the first 90 nun of plateau. 
The temperature on the right-hand side of the brain was also higher than 
the rectal temperature, but the difference (0.3°C) is not significant. The 
mean oesophageal terrperature was higher than the rectal terrperature, but 
this difference was highly dependent UPJn correct positioning of the oeso-
phageal probe. Table IV-6 summarizes the results of the epidural and ar-
terial pressure measurements per£ormed on all dogs. The pressures given 
0 
are: at a rectal terrperature of 38,5 C (reference), dogs heated for 2 hr, 
and two control dogs that were sham-treated £or 2hr. The mean epidural 
pressure remained within normal values during the whole treatment session, 
in all dogs, irrespective of temperature and treatment time, although the 
mean diastolic epidural pressure decreased by a factor of nearly 2 (0.99+ 
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Table IV-6 EPIOORAL AND ARI'ERIAL PRESSURE IN IXX3S DURING WHJLE-BODY HYPERI'HERMIA 
Plateau period 
Tenq_:>. {OC) 
Press. {kPa) 
~idural 
syst. 
diast. 
mean 
Arterial 
syst. 
diast. 
mean 
n= 
Normal 
38.5 
1.51 + 0.36 
0.99 + 0.32 
1.16 + 0.33 
12.0 + 1.2 
-
8.6 + 1.3 
9. 73 + 1.3 
7 
- -
Start 
Heated 
42.1 + 0·.8 
1. 75 + 0.49 
0.75 + 0.39 
1.08 + 0.42 
12.4 + 1.9 
6.2 + 2.9 
8.3 + 2.6 
7 
- - -
The data presented are the mean ±. 1 SO in kPa 
1 kPa = 7.5 rrm Hg 
n= nunber of measuranents 
-
1 hr 
O:mtrol Heated 
38.9 42.2 + 0.6 
1.93 
1.27 
1.49 
11.7 
6.9 
8.5 
2 
- -
1.57 + 0.52 
0.47 + 0.25 
0.84 + 0.34 
11.3 + 2.8 
4.3 + 2.0 
6.6 + 2.3 
6 
- - -
control 
39.0 
LBO 
1.27 
1.45 
12.0 
8.1 
9.4 
2 
- - -
2hr 
Heated COntrol 
42.3 + 0.3 39.0 
1.36 + 0.49 1.87 
0.49 + 0.31 1.47 
0.78 + 0.37 1.60 
10.8 + 2.3 12.1 
4.7 + 1.9 8.3 
6.7 + 2.0 9.6 
6 2 
- - -
0.32 kPa to 0.49±Q.31 kPa). This effect was, however, in close correlation 
with the change in the mean diastolic arterial pressure, which decreased 
by the same factor. The mean systolic arterial pressure remained at a nor-
mal 1 evel (Van Rhoon and Van der Zee 1983) . 
Conclusions 
In dogs, WEHr, with a rectal temperature of up to 42.5°C for 2 hours, ob-
viously does not cause an increase in epidural pressure during the treat-
ment time. 
The initial cerebral temperature is sane.-.ihat higher than rectal and oeso-
phageal temperature respectively, but the differences while apparently 
still existing, are no more statistically different during the plateau 
phase. 
Cooling of the part of the head exposed to the surrounding air appears to 
influence cerebral temperature as demonstrated by the consistent higher 
temperature in that side of the brain on which the dog was lying. 
The oesophageal temperature appears to reflect the brain temperature bet-
ter than rectal temperature. 
Temperature measurements in sane patients under hyperthermic conditions 
This part of the study is based on the data obtained by te group when it 
consisted of mrs. L. Bonke-Spit, drs. A. Felius and ing. G.c. van Rhoon. 
In order to obtain experience in the measurement of temperatures in 
patients under hyperthermic conditions, we took the opp:>rtunity given to 
us by Dr S.P. Israels from the Antoni van Leeuwenhoek Ziekenhuis in 
Amsterdam and by Dr Ollendiek fran the Bristol-Klinik in Bad Nauheim, to 
attend and to participate in patient treatments. 
1) Temperature measurements during C.parvum fever therapy 
In the Antoni van Leeuwenhoek Hospital, a study was performed on the ef-
fects of fever therapy, induced by c. parvun, in caribination with melfha-
lan. 
The first patient in whan we participated in the treatment was a 57-year-
old female with a 14-m:>nth-history of malignant melanana, previously 
treated with chemotherapy by isolated perfusion, cryosurgery, radiotherapy 
and surgical removal of lymph node metastasis. Pretreatment status in-
cluded multiple subcutaneous metastasis with no evidence of metastasis 
elsewhere. 
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The second patient was a 35-year-old male with a 22-month-history of 
malignant melancroa, previously treated with surgery of the primary turrour 
and various metastasis and immunologic therapy by BCG scarification. The 
pretreatment status included multiple subcutaneous and lung metastasis. 
In both patients COrynebacterium parvun was administered by intravenous 
infusion lasting 35-45 minutes. Temperature increase was observed 60-90 
minutes after the start of infusion. Patient 1 was insulated using 
blankets; in the second patient aluminium £oil and an electrical heating 
blanket were used. 
Melphalan 50 rng was injected intravenously in both patients at oesophageal 
tarperatures of 40.3 and 40.8°C respectively. A temperature above 40°C was 
maintained for a period of 195 and 145 minutes in the first and second 
patient respectively. 
In both patients temperatures were measured in the oesophagus, the rectum, 
the acoustic meatus and subcutaneously. In patient 2 an additional intra-
muscular temperature was measured. 
Temperatures were measured using the Ellab medical thermocouple system, 
described elsewhere in this thesis. (chapter III). 
Characteristics of temperature increase are given in table rv-7. 
Table IV-7 CHARACI'ERISI'ICS OF TEMPERATURE INCREASE DURING C. PARVUM FEVER 
THERAPY 
Site of temperature 
measurement 
oesophagus 
rectum 
external acoustic meatus 
subcutaneously 
intramuscular 
70 
Ptl Pt2 
40.8 40.8 
40.8 41.0 
40.5 40.3 
38.9 38.3 
39.2 
time to reach 
40 °C (min) 
fran start 
increasing T 
Ptl Pt2 
40 50 
85 75 
55 95 
Ptl Pt2 
195 145 
195 200 
165 75 
The oesophageal tffi!Perature increases the rrost rapid, followed by the tem-
perature in the external acoustic meatus in patient 1 and the rectal tem-
perature in patient 2 with a delay of 15 and 25 minutes respectively. In 
both patients the maximum tffi!Perature in the external acoustic meatus is 
lower than the oesophageal and the rectum tanperatures. The shell tanpera-
tures, measured intramuscularly and subcutaneously ranain, despite of in-
sulating, far below 40°C in both patients. The use of aluminium foil and a 
heating blanket seans to give no benefit. 
The treatment procedure was tolerated reasonably well by both patients. 
Toxicity included severe pancytopenia in patient 1 and leukopenia and 
moderate tem_p:)rary liver disturbances, established by an increase in liver 
enzyme levels, accanpanied by icterus, in patient 2. 
In patient 1 a 3 weeks lasting tumour regression of 30-40% was observed. 
In patient 2 no effect was observed. 
2) Temperature measuranents in a patient treated in a peripheral clinic 
Dr Ollendiek in his private Bristol-Klinik in Bad Nauheim, treats patients 
with WIHT, in ccrnbination with stimulation of the immune system by thymus-
abstract and, in most cases, endoxan. 
The anaesthetized patient is heated using a mattress perfused with water 
at a tanperature of 46°c. The patient is insulated using an electrical 
heating blanket in canbination with aluminium foil. Ollendiek standard 
only measures oesophageal tffi!Perature by a thermistor. Additional measure-
ments were performed by us with Ellab therrrocouples in the rectum, the 
external acoustic meatus, subcutaneously and intramuscularly. When the 
oesophageal tffi!Perature reaches 41°C, the watertanperature in the mattress 
is decreased to 40°C and the heating blanket is switched off. At an oeso-
phageal tffi!Perature of 41 . 4°C part of the body surface is exposed to rocm 
tffi!Perature. The oesophageal temperature is maintained at 41.5 ±. 0.5°C for 
5 hours with heating by the electrical blanket and cooling by exposing 
body surface to rocm temperature. After this period the patient is cooled 
by flowing of cold water through the mattress, blowing air over the skin 
and wetting the skin. The rate of tffi!Perature increase sh::>uld depend on 
body weight. The weight of the patient in whom we measured was 65 kg, the 
temperature increase was 1.5°C per h::>ur. In tw::> other patients with a 
weight of 50-60 kg, treated at the same time in the. same rocm, the tem-
perature increase was±. 2.3°C per h::>ur. 
The desired tanperature level during plateau phase can be kept constant 
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relatively easily with this method. The increase in oesophageal tempera-
ture was, again, the most rapid: 40°C was reached in 95 minutes. The 
rectal temperature was second to reach 40°C : 100 minutes. The acoustic 
meatus, subcutanoous and intramuscular temperatures reached 40°C after 
llO, 120 and 120 minutes respectively. 
The temperature distribution within the body was rather hc:m::Jgene::>usly: 
with maximum achieved temperatures of 41.8°C for oesophagus, rectum and 
muscle, 41,5°C fOr subcutanoous tissue and 41.2°C fOr the external acous-
tic meatus respectively. The time above 41°C varied from 210 (acoustic 
meatus) to 275 (oesophagus) minutes. 
O::mcl us ions 
The above described experience can lead only to some tentative con-
clusions. Fever therapy provides a relatively slow temperature increase, 
up to 1 evels Which are considered insufficient to cause cell death. The 
temperature distribution is very inhc:m::Jgene::>us with a core-shell tem-
perature difference as large as 1.6 - 2. 7 °c. Dr" Ollendiek' s method pro-
vides a better W1Hl' treatment with reJard to heating rate, hyperthermia 
dose and hc:m::Jgeneity of temperature respectively. With both methods, oeso-
phageal temperature increase is faster than rectal temperature increase. 
This finding stresses, again, the importance of monitoring oesophageal 
temperature during the heating phase. 
The lbtterdam patient series 
D..Iring the patient series, the treatment set-up and scheduling was adapted on 
the basis of experience obtained. This was particularly of importance with 
reJard to the policy on additional local heating and on additional treatment 
with other treatment modalities. 
Additional local hyperthermia 
The original design was to induce Whole body hyperthermia by hot air up to a 
level Which was tolerated by the unanaesthetized patient and was safe with 
reJard to nonnal tissue tolerance, and to administer additional heating by 433 
MHz to the site of the turrour. 
This approach had cc:rrpletely changed after the third treatment of the first 
patient. This first patient was a 53-year-old female, with locally recurrent 
breast cancer. There was an extensive turour involvement of the hc:m:>lateral 
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thoracic wall, surrmmde:l by a zone of cutaneous carcinanatous lymphangitis. 
Conventional therapy of all kinds had been given previously and was exhauste:l. 
The first W1HI' treatment was given to a maximum rectal temperature of 40. 5°C 
with the patient se:late:l, combined with additional electromagnetic heating of 
the tumour mass on the chest wall • The whole proce:lure took over 8 hours. The 
patient felt uneasy, suffering palpitations and shortness of breath and she 
state:l the treatment unbearable. It was decide:l to give subsequent treatments 
under general anaesthesia. 
The second treatment inclu:le:l a maximum rectal temperature of 41.4°C and a 
maximum tumour temperature of 43,8°C, obtaine:l under general anaesthesia, and 
yielded no problems. 
D.rring the third treatment session, however, a very rapid increase in tumour 
tanperature su:ldenly occurred; resulting in the developnent of a severe third 
degree burn of the thoracic wall, incl u:ling necrosis of an area of rib carti-
lage. The cause of the su:lden high temperature increase may have been a stand-
ing wave, by reflection on underlying ribs, or a stoppage of the local cir-
culation effecte:l by the hyperthermia dose administere:l to the re:~ion. As it 
is known now, the tanperature distribution within an area heated with electro-
magnetic radiation may be very inharogeneous and the developnent of a local 
hot sp::>t can not be ruled out by the, clinically limite:l, nunber of tempera-
ture measurements. If the patient had not been anaesthetize:l, she \\Ould have 
no doubt warned that the local tanperature increase was much too high. It was 
decided to never again use local hyperthermia by el ectranagnetic heating in an 
anaesthetize:l patient unless better temperature monitoring systems should be 
developed. 
Management of heating technique 
D.rring subsequent treatments, W1HI' was induce:l using wann air at 60 - 65°C 
only. During the first WERT treatment in patient no. 4, the heating rate was 
relatively low (1.4°C/hr.). This was ascribe:l to the excessive sweating mani-
fest in this patient. At that time the sweating was attanpted to be restraine:l 
by the administration of high dosages of atropin. 
It was realise:l then that this cooling mechanism \\OUld inevitably play a 
heating rate limiting role during induction of W1HI' in each patient. It was 
decide:l that fran that time on, cooling by evap::>ration of sweat was to be pre-
vente:l by wrapping the patient in plastic foil. 
Later during the treatment series, when it appeare:l that the heating rate 
remaine:l relatively low, it was realise:l that energy transp::>rt to the body 
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IAOuld becane much more efficient when not only the ventral part but also the 
dorsal part of the skin surface IAOuld be used as heat exchanger. From patient 
oo. 10, a mattress with circulating warm water became part of the heating 
equipnent; properly this mattress replaced the original 27 MHz radiofrequency 
coil. With these t\AO adjustments, the "adapted Pornp-Sianens cabin method" was 
canpleted. 
Addition to other treatment IOC>dalities 
From the beginning, the concept was that hyperthermia up to 42°C by itself 
1ADuld not be able to destroy all tum::>ur cells. When it was observed in the 
first three patients that, in the case that tumour regression could be induced 
(in patient 2 and 3 of 50 and 20% respectively), it lasted for only a fe;v 
weeks and thus was no real benefit to the patient, it was decided to combine 
WIHl' with either chem::>therapy or radiotherapy. The ca:nbination with radio-
therapy was considered to be most promising, based on the data as described in 
the thermobiology chapter. 
When the patient had previously received radiotherapy, with curative inten-
tion, the additional radiation dose to be given in cornbination with WEST was 
necessarily 1 imited to 15-20 Gy. In four not previously irradiated patients 
the radiotherapy dose was also limited to about 20 Gy: tiAO patients with 
mesothelioma who received irradiation of one whole 1 ung inclu:ling mediastinum 
and tiAO patients with a large abdaninal tum::>ur who were treated preoperatively 
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with the combination of WlEI' and radiotherapy. 
During WEST selective turour cell killing can not be expected on the base of 
selective tumour heating but rather on the differences in physiology between 
turour and oonnal tissue. Therefore WIHl' treatment has to be given in a way 
that radiotherapy effect on nonnal tissue is not enhanced. This selective 
enhancement of radiotherapy in tum::>ur tissue only has been obtained experimen-
tally by giving the tiAO treatment IOC>dalities with a time interval of at least 
4 hours (OVergaard 1980). The most practical solution for achieving this con-
dition was to omit the radiation treatment at the day of the WlEI' session. 
In 5 patients WIHI' was given in ca:nbination with chem::>therapy. The koowledge 
on the combination of hyperthermia with chem::>therapy was, and still is, very 
limited, especially with regard to the in vivo situation. Critera for the 
choice of an antitunour agent were that toxicity should be relatively mild and 
that effectiveness should have been demonstrated against the specific tumour 
type in clinical studies. This resulted in the choice of Melphalan for 
patients with breast carcinoma who had been treated before with chem::>therapy, 
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and of 5 flooro-uracil for patients with colon or lung adenocarcinoma. These 
agents were administered by intravenous infusion at the moment that a rectal 
tenperature of 4l,0°c was reached. In order to avoid unexpected toxicity, it 
was decided to give reduced dosages only of these drugs. 
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THE CLINICAL TREATMENT 
Section Ill 

MATERIALS AND METHODS 
Chapter V 
Criteria for selection 
In 1978, when the first patient was treated with WBHI', there was hardly any 
infOrmation on toxicity to be expected, nor on measures to prevent toxicity. 
'!here were only few published reports on the clinical results of WBHT induced 
for cancer treatment. 'Ihe variation of reported techniques of heating, anaes-
thesia, terrperature level and treatment duration was extensive so that it was 
by that time not possible to draw a conclusive protcx:::ol in which toxicity 
-would not appear. A sunmary of toxicity following WBHT reported in the period 
1974-1980 is given in table V-1. The other possible source of reports of heat 
toxicity, i.e. the publications on the syndrane of heat stroke rrostly lacked 
i.rrportant information such as the body (core) terrperature of the patients and 
the exposure time. 
'Ihe data obtained in the experiments with dogs provided sane guidelines but 
could not be directly translated into safe levels of hyperthermia in humans, 
since therrrophysiology is different in humans and dogs. In general one might 
expect that the sensitivity of the whole body to heat must be higher than that 
of its CCJt!POSing elements, i.e., cells, proteins, etc. 
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The following was taken into account for the planning of pretreatment 
evaluation and treatment. 
Table V-1 REPORI'ED TOXICITY WITH WBHI' 
cardiovascular system hyp:>tension 
organs 
* reported lethality 
electrolyte disturbances 
capillary leak syndrane with pulm::>nary oedema 
* brain oedema 
* cardiac arythmias and/or arrest 
. * disseminated intravascular coagulation 
respiratory failure 
* liver failure 
decubitus 
* 
peripheral neuropathy 
diarrhoea 
* 
Data fran Greenlaw et al. (l980B), Priesching (1976), Pettigrew et al. (1974A), 
Larkin et al. (1977), Moricca et al. (1979), Bullet al. (1979). 
cardiovascular system 
The cardiovascular problems as observed in heat stroke are due to a cc:mplex of 
factors. Dehydration in combination with a redistribution of blood flow to the 
skin causes hyp:>tension (Costrini et al.1979), followed by failing oxygenation 
of the tissues. During controlled whole body hyperthermia treatment, dehy-
dration can be prevented by the infusion of fluids, and blood pressure can be 
controlled by volume replacement and use of drugs. 
Priesching (1976) described t-wo fatal cc:mplications in a series of 28 patients 
because of impairment of circulation. 
Pettigrew et al. (1974A) observed fatal ventricle fibrillation in 1 patient in 
Whan core temperature had increased up to 43°c. 
Larkin et al. (1977) fOund a 15% incidence of cardiac arrythmias, ventricular 
in origin, in 58 treatments. These were occasionally difficult to control with 
usual doses of anti-arrythmic agents, such as xylocain, and in one case 
cooling and cessation of the treatment was required. 
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As mentioned in chapter IV, in the experiments with dogs the cardiovascular 
system was found not to be the limiting factor at temperatures up to 42.5°C. 
The heart rate in dogs increased with mean 14 beats min-1 with each 1°C 
increase in temperature. 
It was decided that only patients with good cardiac function would be eligible 
for treatment with WEHr. 
Respiratory system 
The oxygen requirements increase with increasing temperature. In heat stroke, 
hyperventilation with resulting respiratory alkalosis is a ccmnon symptc:rn 
(Sprung et al.1980). Pettigrew et al. (1974B) describe how two children with an 
advanced fonn of cancer died shortly after WEHr treatment due to respiratory 
ccrnp1ications. They were given opiates for relief of distress Whidh may have 
depressed respiration and so contributed to the fatal outcc:rne. 
Another one of his patients died of fibrosing alveolitis, possibly due to the 
use of hot rroist ventilating gases and impainnent of the pulrronary surfactant 
system. Priesching {1976) describes four patients developing lung oedema, of 
Whcm one died. This canpl ication seems to be rrore frequent in patients with 
carcinomatous lymphangitis (Larkin, personal canrnunication 1979). 
Larkin et al. {1977) observed lung atelectasis, once progressing to pneumonia, 
in a few of their "early cases", heated in a heat chamber without artificial 
ventilation. This complication was not seen in the series treated under 
general endotracheal anaesthesia. 
As mentioned in chapter IV, it was observed in the dogs that the respiration 
rate in=eased frc:rn 20-30 at norrrotemperature to a mean value of 303 per 
minute at the highest hyperthennic I evel. As hyperventilation is known to be a 
cooling medhanism in dogs, and not in humans, this finding has no consequences 
for cl inical WIHI'. 
It was concluded that only patients with a good lung function would be 
considered for WHIT treatment and that during and following WEHr treatment, 
lung function had to be controlled by serial gas analysis. 
Central nervous system 
Heat stroke can be accanpanied by confusion, desorientation, cc:rna, delirium 
and/or convulsions (Marty and Samii 1983). Part of this syndrome can be 
explained by electrolyte disturbances, Whidh are often seen following heat 
stroke as well as WEHr (hypocalcaemia, hypophosphataemia, hypanagnesaemia; 
Sprung et al.1980, Larkin et al 1977, Barlogie et al.1979, Herman et al.1982). 
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In a publication on ten lethal heat stroke victims, Chao et al (1981) describe 
how the brain in 8 out of 9 patients investigated showed histopathological 
changes such as local haemorrhages, thranbi and congestion. 
In tv.o patients in Priesching' s WEHr series brain oedena was fatal (Priesching 
1976). Death followed after a period of organic psychosyndrane, based on acute 
brain cbrtex degeneration. These patients both had received WEHl' in 
canbination with hyperglycaemia of 24 hours duration and multi-chemotherapy, 
Which makes conclusions on the precise cause of toxicity impossible. Another 
of Priesching' s patients died When acute necrosis of a subarachnoidal located 
metastasis of malignant melanana ensued, resulting in intracerebral 
haemorrhage. 
J'Vbricca et al. (1979) observed brain oedena in t-wo patients. Dr. Ollendiek 
(personal carmunication 1978), Who has been treating many patients first in 
Bad Homburg and later in the Bristol Clinic Bad Neuheim, Germany, also 
observed lethal brain canplications, which might have been oedena as well as 
haemorrhage in a metastasis; in his hospital no pathohistologic studies were 
performed. 
As described in chapter V, four dogs in our first series of animal experiments 
that had died showed aspecific pathology of the brain. The weight had 
increased and the histology resembled oedema. There were also signs of 
intravascular coagulation. 
_A second series of experiments with dogs was performed later. Intracerebral 
tenperature and epidural pressure was measured during WEHl'. In contrast to the 
expectation, only small changes in epidural pressure were observed during the 
2 hours period at maximum tenperature (41.5-42.5°C); the values renainerl 
within 1 SD of the mean at norrrotemperature. Apparently, brain oerlena is not 
developing in dogs during WEHr treatment at levels up to 42.5°C. However, we 
did not continue the measurement of cerebral pressure during the cooling phase 
and afterwards. Therefore it can not be excluded that brain oerlena may develop 
following WEH!'. Fbr the future patient treatments it was decided that patients 
with brain metastasis would be excluded from the clinical study, to avoid the 
possibility of running into problens by the development of oerlena or haemor-
rhage within the intracranial metastasis. 
Liver 
In heat stroke victims, liver centrilobular necrosis is a frequent observation 
(Marty and Sarnii 1983) . 
Pettigrew et al. (1974B) observerl liver enzyme abnormalities in patients Who 
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underwent W!HI' at temperatures above 41.8°C. This finding could not be con-
firmed by Mackenzie et al. (1975) who used the same technique (hot wax) and 
treated all patients at terrperatures above 42°C. They observed increased liver 
enzyme values but these were no limiting factor for the level of hyperthermia. 
Blair and Levin (1978) report liver damage (in 5 patients) as the major com-
plication following W!HI' in a series of 18 patients. This toxicity becanes 
important at temperature levels above 42°C. The danger of liver damage seems 
to increase by previous consumption of alcohol or the use of enzyme-inducing 
drugs such as phenobarbital • 
As mentioned in chapter IV an increase of 1 evel s of 1 i ver enzymes was seen in 
the dogs with a maximum value at 24 hours. At treatment terrperatures of 42°c 
the increase was 5 to 10 times the starting value. It was conclt.rled that liver 
toxicity in patients could be avoided by giving WEHT at a maximum terrperature 
of 42°C provided they had normal liver functioning prior to treatment. 
Blood coagulation 
In many heat stroke victims diffuse intravascular coagulation (DIC) was found 
at post mortem examination (Chao et al.1981). 
Pettigrew et al. (1974B) report on 4 patients dying with DIC within 48 hours of 
treatment. Three of these patients showed massive tumour necrosis. This 
suggested a causative relation between tumour regression and DIC, which is 
supported by another finding of the same group namely that platelets did not 
decrease in patients who did not show tumour regression (Ludgate et al.1976). 
Priesching (1976) observed haemorrhage of tumour twice, resulting in death of 
the patients. The haemorrhage may have been the effect of either tumour 
necrosis, DIC or a combination of both. 
In our initial experiments with dogs (chapter IV), a decrease in number of 
platelets with a mean value of 75% was observed, conibined with an increase in 
fibrinogen degradation products (FDP). One dog died due to the occurrence of 
DIC. 
Consequently, monitoring of coagulation parameters was included in the sched-
ule of pre-, durante - and post- W!HI' treatment patient care. 
Decubitus 
Priesching (1976) observed decubitus in 6 of his (48) patients. During core 
temperatures of 42°C, induced in the hyperthermia cabin or by peritoneal per-
fusion, necrosis very easily develops at sites of pressure, e.g., where in-
fusion systems or ventilation tubes are fixed or at the sacrum of the patient. 
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This is a consequence of local hypoxia, which renders cells rrore sensitive for 
hyperthermia. 
011 endiek (personal carmunication, 1978) also stressed the importance of 
avoiding pressure with the installation of the patient. 
In the dogs no decubitus was observed. It was decided to avoid the occurrence 
of pressure sites during the future patient treatments by the use of a special 
mattress and cushions. 
Based on the above mentioned information, the following criteria for patient 
acceptance were drafted. Age was not considered to be a limiting factor, 
presuming the general condition of the patient was according to the selection 
criteria. 
The cardiovascular and respiratory systems should be able to meet the demands 
imposed by WHiT. This was investigated by previous history (no symptcms of 
reyocardiac hypoxia), X-ray of the chest and, later in the series, by erganetry 
(perfonnance up to 120 Watts). 
As the liver might be especially sensitive to heat, patients with severe liver 
abnormalities, revealed either by laboratory tests, or isotope scanning, were 
excl u:led. 
A brain isotope scan was done in order to exclude patients with brain met-
astasis, as this carries the risk of a fatal complication due to bleeding or 
developnent of oedana in the intracranial tumour. 
Ooagulation factors should be normal. 
The developnent of decubitus should be prevented by the avoidance of pressure 
sites during the WEHr treatment procedure. 
On the basis of the knowledge described in the chapters II, III and IV and the 
considerations described above, we designed the clinical study as follows. 
1. As the experimental studies indicate that hyperthermia is a very premising 
modality for the treatment of malignant turrours, it was considered justi-
fied to offer the treatment to patients for Whom the conventional therapy 
was judged insufficiently to achieve good -either palliative or curative-
results. 
2. It had been de:ronstrated that the R:>mp Sienens cabin was suitable for the 
induction of WIHI'. 
3. Criteria for patient eligibility had been drafted. 
The first step in the approach of the patient always was obtaining infonned 
consent. The patient was told that the WIHI' treatment was experimental in 
terms of unknown toxicity and unknown results, and the procedure of the 
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pretreatment examination, the treatment itself and the treatment rroni toring 
measures were explained. 
Only after acceptance by the patient the procedure was started. 
Patients not accepted 
Fifty patients for whom WEHr treatment was considered, did not meet all cri-
teria for acceptance. The decision to choose for WEHr was made in three stages 
which are discussed separately. 
Stage I; before the patient was acquainted to the consideration. 
In 5 patients the choice was in favour of other antiturrour therapy, in 1 
patient with disabling pain and a short life expectancy, chordotomy was suc-
cessful. WBH1' was deened not justified in 2 patients as there was no p::>ssi-
bility for canbination with a second treatment modality and in 6 patients 
where canbination with local radiotherapy on part of the turrour was p::>ssible 
but in whom the quality of life in the near future was expected to be deter-
mined rrostly by rapidly progressing metastasis elsewhere. In 4 patients WEHr 
was not administered as the tunour resp::>nse v.ould not be evaluable due to tu-
rrour size not measurable (n=l), unknown primary tum::>ur (n=l) or a mul tirrodal 
Table V-2 PATIENTS NOr ELIGIBLE FOR WBHl' TREA'IMENT 
rectum and colon 
lung and trachea 
kidney 
various sarcomata 
head and neck 
bladder and urethra 
malignant melanana. 
mesotheliana. 
breast 
uterine cervix and uterus 
Hodgkin's disease 
oesophagus 
pancreas 
n=7 
n=8 
n=6 
n=7 
n=S 
n=3 
n=3 
n=2 
n = 2 
n=2 
n=2 
n=2 
n=l 
n = 50 
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Table V-3 SUMMARY OF PATIENI'S ACCEPrED FOR WBHl' TREATMENI' 
Patient tumour histology previous current therapy no of WEHr 
sex age therapy sessions 
1 F 53 undifferentiated breast ca S,R,C,H HI'* 2 
HI'**+ c (1) 1 
2 F 62 breast adena ca S,R,C,H H1' 1 
HI' + c (1) 1 
3M 30 malignant melanana S,C H1' 1 
4 M 50 mal ignant melanoma S,R,C HI' 3 
HI' +R (30) 
5 M 51 1 ung adena ca none HI' +R (24-49) 3 
6 M 42 1 ung adeno ca none HI' +R (50) 2 
7 M 57 1 ung squarrous cell ca none HI' + R (46) 2 
8 F 54 rectum adeno ca S,R,C HI' +R (20) 2 
9 F 52 breast adena ca S,R,C,H H1' 1 
HI' +R (18) 
10M 44 =lon adena ca S,R HI' +R (19.5) 2 
HI' +C (2) 1 
11 M 62 pleural mesothel iana none HI' +R (19.5) 1 
12 M 20 osteosarcoma S,R,C HI' 1 
HI' +R (67) 
13 F 34 pharyngeal adenocystous ca R HI' +R (55-65) 1 
14M 35 fibrosarcoma none HI' + R (60) 1 
15 F 39 cervical squamous cell ca R,C HI' +R (20) 2 
16 F 62 =lon adena ca S,R HI' + c (2) 3 
17M 51 1 ung adena ca none HI' +C (2) 1 
18 F 51 sinus adenocystous ca S,R HI' + R (9) 1 
19M 44 leianyosarcana s HI'** + R (20) 1 
20 F 56 =lon adena ca s HI' +R ( 64.5) +C (2) 2 
21 M 51 pleural mesothel iana none HI' +R (24) 1 
22 M 57 rectum adeno ca S,R,C HI' +R (15-20) 1 
23M 38 leianyosarcana s HI' +R (60) 2 
24 M 56 gastric adeno ca s HI' +R (20) 1 
25 F 65 kidney adena ca S,R HI' +R (15-20) 2 
26 F 51 kidney adena ca S,R,H HI' +R (15) 1 
27 M 69 pleural mesothel iana none HI' +R (2) 1 
- - - - - -
The used abbreviations in this ti'lble are: 
F = female; M = male; S = surgery, R( ) =radiotherapy (dose in Gy); C( ) = 
cherrotherapy (1 =melPhalan, 25 rrg; 2 = 5 fhnrouracil, 10 rrg/kg body weight); 
H = horm::mal therapy; HI' =hyperthermia, *40.5°C, **41.5°C, remaining sessions 
41.8- 42.o0 c. 
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treatment, administered at the same time (ccmbination of cherotherapy, radio-
therapy and misonidazole, n = 2). In 17 patients the previous history gave 
evidence of insufficient heart- and/or lung function or of liver metastasis. 
TY.O patients had been treated previously with vinca-alkaloids, which might 
render them sensitive to the occurrence of neuropathy follcwing WEHr treat-
ment, as was described by Barlogie et al. {1979). 
One patient was considered to be uneligible as he was mentally disabled and 
not fit to pass informed =nsent. 
Stage II; informed =nsent. 
Ebur patients refused WlH1' as they felt averse to be treated with a non-
established therapy. 
Stage III; screening. 
In 7 patients the screening procedure revealed obstacles. These =nsisted of 
insufficiency of heart function (n = 1) or lung function (n = 1), liver 
metastasis including liver function disturbance (n = 2) or brain metastasis (n 
= 3). In 1 patient turrour progression caused a spinal =rd lesion, which made 
him unable to undergo the WIH1.' procedure. 
Turrour origins in the group of patients uneligible for WHiT treatment are 
listed in table V-2. 
Patients accepted 
Twenty-seven patients, 11 female and 16 male, aged 20 - 69 years with a mean 
of 49.5 years, were accepted for WHiT treatment. These patients, their turrour 
histologies and a surmnary of previous history and present therapy, are 1 isted 
in table V-3. Detailed infonnation on each patient is given in the paragraPh 
"Case rep::>rts". 
The WIHI' treatment procedure 
The procedure was gradually improved over the patient series, therefore the 
treatment procedure was not as extensive in the first patient as it was in the 
last patients. 
The procedure as described belcw is the final result of this developnent. 
Once the patient had passed informed =nsent and pretreatment examinations, 
the procedure was planned. One day before WEHr the patient was admitted to the 
hospital. On this day =ntrol X ray photografhs of the thorax and an ECG 
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record were done, zero time blood samples were collected and tunour dimensions 
were measured. The patient was seen by the anaesthetist and the procedure was, 
again, discussed with the patient. 
On the day of WIHI' the following preparatory measures were taken: 
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The rectun was emptied by enema to ensure reliable rectal temperature 
:rronitoring. 
The patient was given premedication (papaveretun 0.3 - 0.4 rng/kg bXly 
weight and scopalarnine 0.004 - 0.006 mg/kg body weight intramuscularly) 
and prevented fran cooling by use of an aluninium foil blanket. 
Starting with patient 19, following sedation with intravenously admin-
istered diazepam (0.1 - 0.2 rng/kg bXly weight), a 7 French 80 an long 
Cbrdis fem::>ro-renal A2 catheter was inserted into the left fem::>ral vein in 
the groin and advanced, under X-ray control, until its tip was positioned 
in one of the hepatic veins. 
The patient was placed on a water mattress kept at a temperature of 44-
460C (using a Churchill Ther:rrocirculator DrSM ther:rrostatically controlled 
heater circulator). The water mattress rested on an antidecubitus mattress 
filled with polystyrene grains. 
ECG :rronitoring electrodes were fixed on the thoracic wall. 
An intra-arterial catheter was introduced into the radial artery and 
advanced into the brachial artery, a 7 French gauge KMA ther:rrodilution 
swan Ganz catheter via the 1 eft subclavian vein into the pul:rronary artery 
and an intravenous catheter into one of the fore arm veins. The fluids 
administered intraverously were heated to a temperature of 42°C following 
passage through a heat-exchanger (Treonic H150 haemoheater model 114). 
Anaesthesia was induced with methohexitone; the patient was paralysed, 
intubated with a cuffed endotracheal tube and ventilated using a Siemens 
El erna servo-ventilator 900A. Anaesthesia was maintained with an N20/02_ 
(66%/33%) mixture, humidified and warmed to 40-42°C. This was suwlemented 
with fluothane or enflurane in sane patients. 
Rectal, oesophageal , nasopharyngeal , intrarnuscul ar and subcutaneous 
ther:rrocouple probes were placed; probes were also placed between the skin 
and the water mattress, against the tympanic membrane and, where possible, 
in the tumour. FOr safety reasons an additional, independent, thermistor, 
part of the Hewlett-Packard ccmpact monitor, was placed in the oesophagus. 
A bladder catheter was introduced to enable :rronitoring of urine output 
during hyperthermia. 
In some patients it was possible to place one or more pH electrodes 
(Philips C902S tissue pH electrode) into the tumour, using the method de-
scribed by van den Berg et al. (1982). Fbllowing sterilization in Cidex 
sol uti on (Johnson and Johnson, Benelux B. V.) , the electrode was calibrated 
in sterile NBS buffers at pH = 6.841 and 7 .385. To allow the introduction 
of the ( fragi I e) electrode into tissue, a small incision in the skin, 
mucosa or tumour surface was made. The pH was measured with a Knick pH-
meter (model 645; input impedance 2.1o12 n) in conjunction with a chart 
recorder. 
Special cushions filled with polystyrene grains were placed at pressure 
sites to protect against decubitus. Pressure points arising between 
monitoring lines and skin were avoided by folded gauzes if indicated. 
Finally, the patient was wrapped in plastic film. 
Heating was started by closing the hood of the cabin and raising the air tem-
perature in the cabin to 60-65°C. The circulating water in the mattress was 
kept at a tenperature of 44 -46°C. When the intraoesophageal temperature 
reached 41°C the temperature of the air and of the water in the mattress was 
Fig. V - 1 THE ADAPTED POMP SIEMENS CABIN METHOD 
This photograph shows the application of a WBHT treatment. The patient lies 
in the cabin on a warm water mattress, surrounded by warm air and wrapped in 
plastic foil, with the head outside. At the background the anaesthesia and 
physiology monitoring equipment is visible; left in the front the thermometry 
monitoring equipment. 
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decreased to about 36°C. The patient's core temperature was maintained at 
41.8-42°C fOr 2 hours (plateau Phase) by adjusting the air and water tempera-
ture. The clinical set up of the WEHr treatment is presented in figure V-1. 
The various phases during a WEHr session, i.e. "heating", "plateau phase" and 
"cooling" are indicated in figure V-2. 
Cooling at the end of treatment was achieved by a caribination of opening the 
cabin, re:roving the plastic fOil, blowing cool air over the unwrapped patient 
and circulating cold water through the mattress. 
When the intraoesophageal temperature had decreased below 40°C, the anaes-
thesia was terminated and the patient regained consciousness. Ebllowing WEHr 
the patient was transferred to the intensive care unit, Where rronitoring of 
pulrronary artery and wedge pressure, cardiac output and arterial pressure was 
continued. 
If no complications arose, the patient was transmitted to a standard hospital 
room on the next day and dismissed from the hospital 2-3 days following 
treatment. 
Monitoring procedures 
Monitoring of particularly cardiovascular and physiological parameters during 
WEHr treatment became gradually rrore extensive throughout the study. After a 
patient (no. 18) had died due to hepatic necrosis following WIHI', monitoring 
in one of the hepatic veins became part of the procedure. The following de-
scribes the final monitoring procedure: 
Temperatures. 
Temperatures were monitored continuously and registered every 10 minutes, fran 
the start of heating till 30-60 minutes after the start of cooling, When the 
core temperature had decreased below 40°C. During only one treatment the tem-
perature in the hepatic vein was also measured. 
Blood sarnpl es. 
Arterial, venous, mixed venous and hepatic venous blood samples were taken at 
various "marker" times befOre, during and after WHIT treatments, as far as the 
respective canpartrnents were accessible (Fai thfull 1983). These marker times 
were 
1) before induction of anaesthesia, 2) at the start of heating, 3) When the 
plateau temperature of 41.8°C was reached, 4) after 1 hour at plateau, 
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5) at the end of plateau and 6), 7) and 8) 15, 30 and 45 minutes, respect-
ively, following the start of cooling. Marker times 2 - 7 are indicated in 
figure V-2. I.aooratory analysis included blood gases, electrolytes, haena-
tology and biochenical parameters. 
Temperature 
in oc 
43 
- _-..._ 
*4 
plateau phase 
*5*6*7 
cooling 
36 r--.-~~-.--.--,--.-~--.--,--.-~---r--r--r--.-~--~~ 
0 60 120 180 240 270 
Time in minutes 
Fig. V - 2 COURSE OF TEMPERATURE DURING A WBHT SESSION 
Course of rectal and oesophageal temperatures during WBHT in patient no. 13: 
--rectal and - -- oesophageal temperature. 
* (2 - 7): marker times; the points of time where blood samples were taken 
for analysis of blood gases, electrolytes, haematological and biochemical 
parameters. 
Cardiovascular systen. 
Every 10-15 minutes the following parameters were recorded: heart rate, 
systolic, diastolic and mean arterial and pulmonary artery pressures, cardiac 
output, pulmonary capillary wedge pressure and central venous pressure 
(Faithful! 1983). 
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Respiration. 
Measurements were taken of expire:l carbon dioxide percentage 'Which was main-
tained between 3 and 4% by adjusting the tidal volume, and of carbon dioxide 
minute production (Faithfull 1983). 
Urinary production. 
Urinary production was measured and call ected from 24 hours before the start 
of heating, 'When the patient was hospitalize:l. At the day of WEHr, urine was 
collected in 2 hour portions from the start of heating till 12 hours after-
wards. Analysis of electrolyte concentrations in the urine was perfome:l. 
fH. 
When p::>ssible, intratumour fH was measured, beginning after the induction of 
anaesthesia. Besides, several subcutaneous fH measurements were performed. 
Because the time require:l to reach equilibrium following insertion of the 
electrode was found to be in the order of 30-90 minutes, the values obtained 
during the heating phase were considere:l unreliable (Wik~ooley et al.1985). 
Measurements were recorde:l continuously. 
Hepatic clearance of ICG 
Hepatic damage was a frequently observed canplication following WlHI', as evi-
dent from increases in serum transaminase (SGJI'). This was previously rep::>rte:l 
by other investigators ((Pettigrew et al. 1974A, Mackenzie et al. 1975), and ob-
served by us in the first series of experiments with dogs and during the 
clinical study in many patients. In one patient liver damage even ended 
fatally. The impression was that disturbe:l tissue oxygenation might have 
played a role. For this reason it was decided to attempt measurement of 
hepatic blood flow (HBF) during hyperthermia. The continuous infusion tech-
nique introduce:l by Bradley et al. (1945) is a universally accepted one for the 
measurement of HBF on the basis of the Fick principle (the volume of blood 
passing through an organ is equivalent to the ratio of the amount of "marker" 
taken up by the organ and the difference between arterial and venous concen-
tration of the "marker"). These investigators used brornsulphalein (BSP), but 
indocyanine green (ICG) is now rrore camonly used, as this dye (under IX)rmo-
themic conditions) has been shown to have no extrahepatic extraction routes 
(Cherrick et al.1960; Caesar et al. 1961), 'Which does IX)t hold for BSP. The use 
of a hepatic vein catheter enables the measurement of concentration decrease 
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of ICG over the 1 iver, and on the basis of certain assumptions HBF can be 
calculated from this. 
Hepatic function tests. 
The hepatic clearance of ICG was detennined on four occasions in patients nos. 
20, 21 and 22 While undergoing WEHI'. The patients all had normal liver func-
tion as detennined by routine laboratory tests and HIDi'\ (isotopic 1 iver func-
tion test). Following introduction of a catheter into one of the hepatic 
veins, a 15 rng "loading" dose of ICG was administered and this was followed by 
continuous intravenous infusion at the rate of 0.167 or 0.333 mg.min-1 • The 
infusion rate was controlled by use of a Hospal KIO infusion pump. 
After allowing at 1 east 20 min for equilibration, paired blood sarrpl es were 
withdrawn simultaneously from the hepatic vein and brachial artery at various 
times during the treatment (preinduction, start of heating, start of plateau 
phase, midplateau, and 15 min after initiation of cooling) for ICG and oxygen 
determinations. Infusion of ICG was continued until 15 min after tennination 
of W1HI', giving a mean total infusion time of 350 min (range 320-375) . There-
after, blood sarrples were taken every 2 hr to enable investigation of plasma 
disappearance of ICG following treatment. The total dose of ICG administered 
-1 
never exceeded 2 mg.kg body weight. 
ICG was prepared for intravenous infusion by dissolving the dye in sterile 
solvent to a concentration of 5 mg.m1-1 . The dye was stabilized by the ad-
dition of albumin to give a concentration of 1.8% albumin. 
Blood samples were collected in heparinized syringes. Due to the slow infusion 
rate of dye (necessary for such long infusion periods), detennination of ICG 
was done on undiluted plas:na. As the blank density appeared to change during a 
treatment session (Which usually lasted several hours), a blank correction 
according to the principle introduced by Gaebler (1945), and as adapted by 
Winkler and Tygstrup (1960), was applied. Dye concentration was thus calcu-
lated as: 
c = 
Where D is the optical density at 805 and 600 nrn respectively, E is the ex-
tinction coefficient of ICG in plasma at the same wavelengths and f is the 
blank factor, i • e., pl asrna blank at 805 nrn or pl asrna blank at 600 nrn. 
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Iije determinations were performed in a Carl Zeiss :EMQll spectro.tilotometer. 
Calculations 
a) Hepatic blood flows were calculated by the Fick principle, according to the 
method of Bradley et al. (1945), Where 
removal rate 1 
EHBF x--
(CA - S!v) 1-Ht 
Where EHBF estimated hepatic blood flow 
removal rate= infusion rate of ICG (under steady state) 
= arterial dye concentration 
= hepatic venous dye concentration 
= Haenatocri t. 
1/1-Ht is a correction for red blood cell volune 
b) Hepatic extraction ratios (E) were calculated from 
CA- 'mr 
E 
(Huet et al . 1981 ) 
c) Clearance (l"min-1 cleared by the liver) is derived fran the product of the 
extraction and the liver blood flow (Fick principle) 
Cl=EHBFxE 
d) Half-life (t1 ; 2 ) 
This was calculated from the formula: 
0.6931 x vol. of distribution 
Cl 
(Huet et al . 1981 ) 
(Huet et al . 1981) 
The volume of distribution is the plasma volume. This was derived from the 
-1 body weight (ml.kg , dependent on age and sex, fran IX:lcumenta Geigy, 1976, p. 
551) and the haematocrit. 
Evaluation of turrour resp?nse 
- Palpable tunours 
Tumour dimensions were measured at regular times with callipers in tw:J or 
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three directions. In patients with multiple superficial tumour lesions, a 
selection of at rrost 10 nodules was made. From the dimensions measured the 
tumour surface area or volune was calculated. 
-Non palpable tumours 
In lung tumours, tumour dimensions visible on antero.r:osterior and latera-
lateral x-ray photographs were measured and the volume was calculated. 
Intra:-abdaninal tunour dimensions were calculated on the base of cr scan-
ning. In tv.o patients (no. 19 and 24), the situation before and after WEHr 
was judged during laparotomy. In three patients (no. 9, 18 and 27, who died 
1, 3 and 1 week(s), respectively, following WEEn'), the tunour reaction was 
investigated histologically .r:ost rrortem. 
Tumour res.r:onse was determined using mo criteria (Miller 1981). Abbrevi-
ated, this encompassed the following res.r:onse levels: 
progression: 25% or rrore increase in tumour; 
NC "no change" : 1 ess than 25% increase and 1 ess than 50% 
decrease in tumour val ume; 
PR 
CR 
"partial res.r:onse" at least 50% decrease in tunour volume; 
"carpi ete res.r:onse" disappearance of the tumour; roth partial 
and carplete regression had to be maintained for at least one 
rronth. 
Tumour dimensions were measured before the start of the treatment (series) 
and at intervals of 1 week to 2 rronths after the end of the treatment. 
Case reports 
In a period of 3~ years 27 patients received 45 whole body hyperthermia 
treatments. In this paragraph a re.r:ort will be given on each of the patients. 
These case re.r:orts will be restricted to a description of the patient, his 
previous history and pre-treatment status, the kind of treatment given, the 
response to the treatment (objective and subjective), and the specific 
toxicity, if any, as a consequence of WEHr. 
During this 3~ year period, the method of WBHT induction, the level of 
pre-treatment screening considered to be necessary, and the policy with regard 
to the canbination of WEHr with other treatment modalities, i.e. treatment 
scheduling, were gradually changed on the basis of acquired experience. These 
matters wi 11 be discussed in other chapters. 
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CASE 1 
A 53-year-old female, with a 20-month-history of breast carcinoma, locally 
progressive despite extensive previous therapy. 
Histopatholo:y: undifferentiated carcinoma. 
Previous therapy: surgery; radiotherapy of both regional and various distant 
metastases; honronal therapy (megestrol, nolvadex, lynoral) and chemotherapy 
(combination endoxan, methotrexate and 5 FU, combination adriamycin and 
vincristin, topically applied 5 FU). 
Pretreatment status: extensive tl.l!OC)ur involvement of the horrolateral thoracic 
wall, surrounded by a zone of cutaneous lymphangitis carcinomatosa. Distant 
metastasis not demonstrated. 
Current treatment: 3 whole body hyperthermia (WEHr) treatments with time 
intervals of 1 and 2 weeks respectively with additional 433 MHz local hyper-
thermia of the thoracic wall. 
WEHr 1 : Maximum rectal terrperature (T rect .max.) 40.4°C; 
plateau 140 minutes at 40.1°C; 
maximum tl.l!OC)ur terrperature (T tum.max.) 43.8°C. 
WEHI' 2 T rect.max. 41.4°C; plateau 150 minutes at 41.2°C; T tum.max. 43.8°C. 
WEHI' 3 : T rect.max. 41.6°C; plateau 210 minutes at 41.4°C; T tun.max. 47°C, 
caribined with melphalan 25 mg given at T rect. 41°C. 
Toxicity: no special problems following first two treatments. During the third 
treatment a severe third-degree burn of the thoracic wall developed, diameter 
10- em and including ribs. This probably resulted from standing wave formation 
in the microwave field causing an unobserved hot spot. 
Objective tl.l!OC)ur response: the tumour was progressive following hyperthermia 
only. Ebllowing the caribination hyperthermia and melphalan, the tumour did not 
progress for 3 months. 
Palliation: none 
The patient died 12 months following the first hyperthermic treatment, due to 
local tumour progression. 
CASE 2 
A 62-year-old female, Who had undergone breast amputation 17 years previously, 
and in Whom the tumour recurred locally 20 months ago. 
Histopathology: poorly differentiated adenocarcinoma. 
Previous therapy: surgery; radiotherapy of the thoracic wall and the sternum; 
chemotherapy (caribination of endoxan, methotrexate, 5 FU) and honronal therapy 
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(niagestin). 
Pretreatment status: intracutaneous and subcutaneous turrour infiltration 
around the scar, extending in depth around the sternt.D.U and to the hetero-
lateral breast. Midsternal a large subcutaneous nodule was present. Liver-scan 
by 99Technetit.D.U (99Tc): suspect for metastasis; no increased sert.D.U levels of 
I iver enzymes. 
Current therapy: 2 WEHr treatments with a time interval of ~ weeks were 
given, the second in caribination with melphalan. 
WEHr 1 T rect.max. 41.9°C; plateau 2 hours at 41.8°C; 
WEHr 2 T rect.max. 4I.8°C; plateau 2 murs at 41. 7°C; 
melpbalan 25 mg was administered at T rect. 41°C. 
Toxicity: following first treatment, small third degree burns of both great 
toes occurred, which however caused no trouble to the patient. 
Objective turrour resp:?nse: following the first treatment the subcutaneous 
nodule rapidly regressed to 44%, but started growing again 3 weeks later, 
thus, following mo criteria, only "no change" was achieved. Fbllowing the 
second treatment "no change" was observed, for a duration of 2 months. 
Palliation: a 2-month relief of pain and dyspnea following the first 
treatment. The patient died 9 months after the first hyperthermia treatment 
due to local turrour progression. 
CASE 3 
A 30-year-old male, with a 5 years history of malignant melanoma, 
metastatized. 
Previous therapy: surgery; cherrotherapy (DriC and OCG). 
Pretreatment status: multiple intracutaneous and subcutaneous metastases, en-
larged liver, palpable 4 em below lowest rib during normal inspiration, prob-
ably due to turrour involvement; no increased sert.D.U levels of liver enzymes. 
Current therapy: 1 WJHr treatment. T rect.max. 41.8°C; plateau 2 hours at 
41.8°C; 
Toxicity: at the end of the cooling phase ventricular tachycardia suddenly 
developed. Blood chemistry revealed acidosis and electrolyte changes (a de-
crease in ca and K}. Fbllowing administration of NaHc:n3 , sinus nodal rhythm 
slowly returned. 
On the day following hyperthermia it became clear that all toes had incurred 
burns, with third degree burns of the first tv.u toes of both feet. This could 
have been caused by poor circulation in the feet of this very tall patient. 
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These burns rendered the patient inable to walk. 
Objective turour response: up to 20% regression of cutaneous metastases during 
the first 3 weeks, followed by regrowth, which thus means "no change". 
Palliation: not applicable, as the patient did not suffer pain previously. 
This patient died 3 rronths after WfHI' treatment. 
CASE 4 
A 50-year-old male, in whan excision of enlarged neck nodes of malignant 
melanana had been perfonned 6 rronths previously. Primary turrour unknown. 
Histopathology: malignant melanoma. 
Previous therapy: surgery; radiotherapy, interrupted when hematogenous met-
astasis appeared; chem::>therapy (Dl'IC, c parvun, MeCXNU). 
Pretreatment status: multiple neck nodes, multiple cutaneous and subcutaneous 
metastases, enlarged liver. Serum levels of liver enzymes were within the 
nonnal range. 
Current therapy: 3 WEHr treatments with time intervals of 1 week, were given 
within a series of radiotherapy (6 x 5 Gy in 3 weeks) of the supraclavicular 
1 ymph nodes. 
WfHI' 1: T rect .max. 41. 8°C, plateau 2 hours at 41. 7°C; 
WEHr 2: T rect .max. 41. 7°C, plateau 2 hours at 41. 7°C; 
WfHI' 3: Details on the temperature data were lost but the treatment was re-
corded to have been 2 hours at 41.8°c. 
Toxicity: following the first treatment, the patient was admitted to the 
Intensive Care Unit in a delirious state. This was ascribed to toxicity of 
atropin, which had been administered in high doses during WBHT. In this 
patient, the heating rate was relatively low (1.4°C/hr), which was probably 
related to the excessive sweating observed. High dosages of atropin were given 
to decrease the sweating. The mental status returned to nonnal during the 
night following WBH1'. Several second-degree burns were observed. These were 
located at sites where the skin had been directly exposed to currents of wann 
air from the electrical heaters beneath the patient. 
Objective tumour response: of the lymph nodes treated in caribination with 
radiotherapy, the previous! y irradiated group showed "no change", whi 1 e the 
previously non i=adiated group showed "partial response". The overall 
response in these lymph nodes was therefore recorded as "no change". The tu-
rrour metastases treated with hyperthennia only also showed no change. The 
patient was lost to follow-up after tv.o rronths. 
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Palliation: not applicable. 
The patient was reportei to have diei 3 rronths later. 
CASE 5 
A 51-year-old male, in whan a lung carcinana had been demonstratei 3 rronths 
previously. 
Histopathology: bronchial adenocarcinana. 
Previous therapy: none. 
Pretreatment status: central bronchial tumour, involvement of meiiastinal and 
h=lateral supraclavicular lymph nodes. 
Current therapy: 3 WIHI' treatments with time intervals of l week, within a 
series of radiotherapy (12 x 2 Gy in 3 weeks). 
WIHI' l: T rect .max. 41. 9°C; plateau 2 hours at 41. 7°C; 
0 0 WHn' 2: T rect.max. 41.9 C; plateau 2 hours at 41.8 C; 
WIHI' 3: T rect.max. 41.9°C; plateau 2 hours at 41.9°C. 
Toxicity: fOllowing the first WEST the patient developei fever and chills with 
cardial decarpensation and hypotension. The fever diminishei spontaneously, 
the circulatory problems disappearei fOllowing administration of lasix. 
Following the third WIHI' the patient showei clinical signs of lung emboli at 
the tumour site, although the lung scan perfOrmei on the third day fOllowing 
WEHT revealei no abnormalities. 
Objective tumour response: all known tumour deposits regressei completely 
within 6 weeks. After this period, various lyrr(!')h node metastases became ap-
parent in the heterolateral supraclavicular region. The patient receivei an 
additional series of radiotherapy: 8 and 9 fractions of 2.5 Gy on the meiias-
tinal and hc;m:)lateral lymph nodes respectively and 20 x 2.5 Gy on the hetero-
lateral lymph nodes. The heterolateral lyrr(!')h nodes showei a "partial response" 
lasting fOr 6 rronths, after vihich progression occurrei. The tumour treatei 
with the combinei therapy was still controllei 10 rronths later, vi.hen the 
patient died due to progressing brain metastasis, vihich had becane apparent 6 
rronths fOllowing the first WEHT. 
Palliation: not applicable. 
CASE 6 
A 42-year-old male, with a 1-rronth-history of bronchial carcinana. 
Histopathology: bronchial adenocarcinana. 
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Previous therapy: none. 
Pretreatment status: primary tumour in the apical region of the lung and horro-
lateral" mediastinal lymph nodes. The liver 99Tc scan showed a large liver with 
heterogeneous uptake; a biopsy shCMed no abnormalities, 1 aboratory values of 
liver enzymes were within the normal range. 
Current therapy: 2 WEHr treatments with a time interval of 6 weeks, each 
within a s&ies of radiotherapy (10 x 2.5 Gy in 2 weeks each) of the visible 
tumour. 
WEHr 1: T rect.rnax. 42.0°C; plateau 2 hours at 41.9°C; 
WEHr 2: T rect .max. 41. 9°C; plateau 2 hours at 41 .8°C. 
Toxicity: none. 
Objective tumour response: post-treatment X rays of the thorax, showed dis-
appearance of the turrour; no abnormalities except fibrosis resulting fran 
irradiation. The patient was free of disease for 9 months; he then developed 
brain metastasis. The patient was lost to follCM-up 11 rnonths after the first 
WIHr treatment, at which point he returned to his native country, Turkey. 
However, notification of death was received 28 months after the first WHir 
treatment. 
Palliation: not applicable. 
CASE 7 
A 58-year-old male, with a 2-rnonth-history of bronchial carcinana. 
Histopathology: moderately well differentiated squarrous cell carcinoma. 
Previous therapy: none. 
Pretreatment status: tumour in the median lobe of the lung infiltrating in the 
main bronchus. The liver was enlarged and tender, spontaneously and at pal-
pation but the liver 99Tc scan showed no abnormalities and serun levels of 
liver enzymes were within the normal range. X-ray photographs of the hetero-
lateral lung showed a round shadow suspicious for metastasis. 
Current therapy: the patient received 2 WEHr treatment with a time interval of 
5 weeks, each treatment within a series of radiotherapy (13 and 10 x 2 Gy 
respectively), of the macroscopic turrour and the mediastinun. 
WIHr 1: T rect.rnax. 42.1°C; plateau 2 hours at 41.9°C; 
WEHr 2: T rect.rnax. 41.8°C; plateau 2 hours at 41.8°C. 
Toxicity: no special problems. 
Objective tumour response: the turrour regressed partially; regrowth occurred 
after 1 year. 
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Palliation: the pain in the hepatic region disappeared for 3 weeks. 
The patient died 22 months after the first WBHT treatment due to tumour 
progression in both 1 ungs. 
CASE 8 
A 54-year-old female, with an 18-month--history of rectun carcinoma, locally 
recurring despite extensive previous therapy. 
Histopathology: rectal adenocarcinana. 
Previous therapy: surgery of the primary turrour and of recurrent turrour 5 
months later, with construction of a preternatural anus; che:rotherapy (5 FU 
and CCNU) ; radiotherapy. 
Pretreatment status: large recurrent turrour, fixed to the sacrum and the left 
pelvic bone with infiltration through the uterine and vaginal walls. This 
turrour was the cause of much pain, not controllable with morphine analgesics. 
No signs of distant metastasis. 
Current therapy: the patient received 2 WEHr treatments with a time interval 
of 1 week, within a series of radiotherapy, 10 x 2 Gy in 2 weeks. 
WEHr 1: T vagina max. 41.8°C; plateau 2 hours at 41. 7°C; 
WEHr 2: T vagina max. 41.8°C; plateau 2 hours at 41. 7°C. 
Toxicity: no special problems. 
Objective turrour resp:>nse: loss of a considerable amount of necrotic material 
via the pre-existing vaginal fistula; the turrour showed a rapid partial re-
gression, but progression started 6 weeks later. 
Palliation: the pain had disappeared canpletely at the m:ment that the patient 
regained consciousness foil owing the first WEHr treatment. This improvement 
lasted for only 3 weeks. 
The patient died 8 months following WEHr due to local tumour progression. 
CASE 9 
A 52-year-old female, with a 45-month-history of breast carcinoma, 
metastatized. 
Histopathology: highly infiltrating adenocarcinoma. 
Previous therapy: surgery of the primary turrour; radiotherapy of. the recurring 
tUIIOur and of various bone metastasis; ho:rnonal therapy (ovariectomy, 
niagestin, nol vadex) and che:rotherapy ( canbination of endoxan, methotrexate 
and 5 FU, canbination of adriarey"Cin and vincristin). 
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Pretreatment status: large metastatic tumour in the pelvis, fixed to the pel-
vic bone wall with infiltration of the bladder, the vaginal wall and the uter-
ine cervix. X ray photograph of the lungs suspect for carcinomatous lymphan-
gitis. The pelvic turrour caused considerable pain. 
CUrrent therapy: the patient received 1 WEHr treatment, T rect.max. 42.1°C; 
plateau 2 hours at 41. 9°C, within a series of radiotherapy, 9 x 2 Gy in 2 
weeks on the pelvic tunour. 
Toxicity: following WEHr the patient was dyspnoeic and was respirated arti-
ficially for 1 night. The dyspnoea was due to fluid accunulation in the lungs. 
The patient recovered slow1y; t"W:> weeks after WBHI' chemotherapy was started 
(caribination of prednison, vincristin, endoxan and 5 FU) but 1 week later the 
patient died. 
Objective tumour res_pJnse: at autopsy the previously large tumour in the pel-
vis had regressed completely and was macroscopically undetectable. Carcinoma-
tous lymphangitis of the lungs was evident and there was abundant pleural 
effusion. 
Palliation: the pelvic pain disappeared immediately following WEHr and did not 
return during the 3 weeks that the patient was alive. 
CASE 10 
A 44-year-old male, with an 8-year-history of colon carcinoma, locally r~ 
curring. 
Histopathology: adenocarcinoma. 
Previous therapy: surgery of the primary tunour and 7 years later radiotherapy 
of recurrent turrour. 
Pretreatment status: a large tunour in the al:domen, ulcerating through the 
al:dominal wall, causing considerable pain. No signs of distant metastasis. 
Current therapy: the patient received 3 WIHI' treatments, with time intervals 
of 2 and 10 weeks respectively. The first 2 w.EHI' treatments were given within 
a series of radiotherapy, 13 x 1.5 Gy; the third treatment was given in con-
junction with a course of 5 FU injections, the first of which was given during 
WEHr, at the m::ment that a rectal temperature of 41. 0°C was reached. 
WEHr 1: T rect.max. 42.3°C; plateau 2 hours at 42.1°C; 
WEHr 2: T rect.max. 42.1°C; plateau 2 hours at 41.9°C; 
WEHr 3: T rect.max. 41.8°C; plateau 2 hours at 41.8°C. 
Toxicity: no special problems. 
Objective tunour resp::mse: following WEHr canbined with radiotherapy, the tu-
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rrour showed a "partial response" lasting for 3 n:onths. FbllO!Ning WEffi' canbined 
with 5 FU, there was "no change" for a duration of 6 n:onths. 
Palliation: follO!Ning the first WEST, the pain disappeared for a period of 2 
n:onths. There was no palliative effect following the third WEffi'. 
The patient died 11 rronths following the first W1BI' due to local tumour pro-
gression. 
CASE 11 
A 55-year-old male with a 2-rronth-history of malignant pleural effusion. 
Histopathology: resaribl ing malignant mesothel iana. 
Previous therapy: none but a palliative draining of pleural fluid. 
Pretreatment status: pleural tumour nodules at various sites whidh were demr 
onstrated by thoracoscopy. There were no indications for distant metastases. 
Current therapy: the patient was treated with 1 WEHr treatment, T rect.rnax. 
42.1°C, plateau 2 hours at 41.9°C, within a series of radiotherapy, 13 x 1.5 
Gy in 2 weeks. 
Toxicity: following WEST, the patient developed atrial fibrillation, for which 
he was digitalized. 
Objective tumour response: the tumour was not measurable on X-ray photographs, 
but pleural effusions did not recur during the rest of the patient's life; he 
was disease-free for 21 rronths, after which period subcutaneous tumour nodules 
occurred in the hon:olateral thoracic wall, followed six rronths later by the 
occurrence of 1 ung metastasis. 
Palliation: not applicable. 
The patient died 31 rronths following WEffi' due to progression of metastasis in 
the thoracic wall and both lungs. 
CASE 12 
A 20-year-old male, with a 5-rronth-history of a bone tumour of the femur with 
lung metastasis. 
Histopathology: osteosarcoma. 
Previous therapy: radiotherapy of the primary tumour, charotherapy (metho-
trexate and cis-Platinum). The basal part of 1 lung was irradiated with a 
total dose of 49 Gy up to 1 week before WEffi'. 
Pretreatment status: multiple 1 ung metastases. The 99Tc 1 iver scan shOINed an 
enlarged liver with inhorrogeneous activity but the serum levels of liver 
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.. 1 99 b· d" lb enzymes were wrthrn noma ranges; the Tc rarn scan gave ubrous resu t ut 
no clear indication fOr metastasis. 
Current treatment: the patient received 1 WEHr treatment, T rect.max. 42.0°C; 
plateau 2 hours at 41.8°C, within a series of radiotherapy, 6 x 1.5 Gy, on the 
previously irradiated metastases. 
Toxicity: no special problems. 
Objective tumour response: the irradiated metastases showed a less than par-
tial regression ("no change"); the remainder of the tumour showed no pro-
gression during 6 weeks, after which time rapid progression occurred. 
Palliation: not applicable. 
The patient died 10 weeks after WEHr due to progression of 1 ung metastasis. 
CASE 13 
A 33-year-old female presenting a tumour initiating from the parapharyngeal 
space; complaints of trismus for 12 months, known with malignant tumour in-
cluding lung metastasis for 4 months. 
Histopathology: adenocystic carcinoma. 
Previous therapy: recent radiotherapy of the pharynx (40 Gy), of both 1 ungs 
(22.5 Gy) with boosters on the visible lung metastases (additional 18 Gy), 
corribined with misonidazole (total dose 10.1 g). 
Pretreatment status: primary tumour and lung metastases in regression. 
Current therapy: the patient received 1 WIHI' treatment , T rect.max. 41.9°C; 
plateau 2 hours at 41.8°C, within a series of radiotherapy (10 x 2.5 Gy of the 
pha.rynx and 5 x 3 Gy for the 1 ung metastasis). 
Toxicity: no special problems. 
Objective tumour resp::mse: complete disappearance of the primary tumour and 
the lung metastases; 44 months after WEHr a new lung metastasis occurred which 
was treated by radiotherapy. 
Palliation: not applicable. 
The patient is alive with presently no evidence of disease, 6 years after 
wmr. 
CASE 14 
A 35-year-old male with a tumour in the sacroiliacal joint; he had been 
suffering pain for 9 months, the tumour had been discovered only 2 months 
prior to referral to our unit. 
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Histopathology: fibrosarcoma. 
Previous therapy: none. 
Pretreatment status: a large osteolytic process in the sacroiliacal joint, 
which caused severe pain and restrictions in rrobility. There were no indi-
cations for distant metastasis. 
CUrrent treatment: The patient received 1 Wl3HI' treatment, T rect.max. 41.9°C, 
plateau 2 hours at 41.8°C, within a series of radiotherapy, 30 x 2 Gy in 6 
weeks. 
Toxicity: severe liver damage was observed following Wl3HI' with maximum sror 
and SGPI' values of 1328 and 1900 U/1 respectively and the patient developed 
icterus. The sror and SGPI' values decreased from 1 week after Wl3HI' and were 
normal 2 weeks after WIH!'. As a result of this toxicity it was decided not to 
proceed with the 2 additional WEST treatments that had been planned. 
Objective tumour resp:mse: at the rrment that only 20 Gy and one WEHr treat-
ment had been given, the tumour had already regressed by 50%. 
Palliation: the pain disappeared irrmediately following WEHr and the patient 
could once rrore use his leg as well as before his complaints started. 
2~ rronths after Wl3HI' had been given, the tumour once rrore started to grCM frc:m 
the margins of the radiotherapy field, and nrultiple lung metastases became 
visible. The patient died 4 rronths following WEHr. 
CASE 15 
A 39-year-old female with a 20-rronth-history of tumour of the uterine cervix, 
Which had locally recurred. 
Histopathology: poorly differentiated squamous cell carcinana. 
Previous therapy: radiotherapy of the primary tumour, charotherapy for recur-
rent tumour (a combination of bleomycin, mitarnycin-C and cisPlatinum). 
Pretreatment status: a large tumour in the pelvis, causing the al:dominal wall 
to protrude, and Which caused moderate pain. There was no evidence for distant 
1 ho h . . 1. 99 metastases, a t ug there were some abnormalities on the Iver Tc scans. 
CUrrent therapy: the patient received 2 WEHr treatments with a time interval 
of 1 week, within a series of radiotherapy, 10 x 2 Gy in tY.O weeks. 
Wl3HI' 1: T rect.max. 42.0°C; plateau 2 hours at 41.9°C; 
Wl3HI' 2: T rect.max. 42.0°C; plateau 2 hours at 42.0°C. 
Toxicity: no special problems. 
Objective tumour response: the tumour regressed by less than 50% ("no 
change") , and progression was observed after 2 rronths. 
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Palliation: the pain becane less severe but did not disappear. 
The patient died 4 rronths following WEHr due to local t=ur progression. 
CASE 16 
A 62-year-old female with a 2-year-history of malignant disease of the colon, 
which had locally recurred. 
Histopatbology: mucous producing adenocarcinoma. 
Previous therapy: surgery of the primary t=ur. The patient had received a 
full course of radiotherapy for a squarrous cell carcinoma of the uterine 
cervix 27 years previously, which made further radiotherapy imp::>ssible. 
Pretreatment status: a local recurrence with a diameter of 8 ern; the 1 iver was 
1 ed 99 . en arg but Tc scanning revealed no metastases. There were no signs of met-
astasis elseWhere. The tunour caused severe pain. 
Current therapy: the patient received 3 WEHr treatments with time intervals of 
2 weeks. Each of the WEHr's was canbined with 5 FU, 10 rng per kg bodyweight, 
administered at the time that rectal tanperature reached 41 °c. The adminis-
tration of 5 FU was continued by weekly injections following the third WEHr. 
WEHr 1: T rect.rnax. 41.9°C; plateau 2 oours at 41.8°C; 
WBHT 2: Details on the temperature data were lost but the treatment was 
recorded to have been 2 hours at 41.8°C; 
WEHr 3: T rect.max. 41.9°C; plateau 3 hours at 41.8°C. 
Toxicity: no special problems. 
Objective tunour resp::>nse: there was a partial regression lasting 2 rronths. 
Palliation: none. 
The patient died 10 rronths after the first WIHI' due to local tunour pro-
gression. 
CASE 17 
A 57-year-old male presented with a malignant tumour of the bronchus, diag-
nosed 2 weeks previously. 
Histopatb::>logy: p::>Orly differentiated bronchial adenocarcinoma. 
Previous therapy: none. 
Pretreatment status: a peripheral bronchial carcinoma with supraclavicular and 
mediastinal lymph node metastases on the hanolateral side. Liver 99Tc and bone 
99Tc scanning revealed abnormalities which may have been indicative of met-
astases, serum levels of liver enzymes were within the normal range. 
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Current treatment: the patient receive:l 1 WEHr treatment , T rect.rnax. 42.2°C; 
plateau 2 hours at 41.8°C, combine:l with 5 FU administere:l When the rectal 
temperature reache:l 41 °c. Radiotherapy was not considere:l because of the 
spreading of the turrour. 
Toxicity: in the imme:liate post-WEHr period there were ventilation problems, 
Which were resolve:l by the administration of oxygen. 
Objective tumour response: the previously rapidly progressing tumour showe:l 
same regression but started growing again 1 month later. 
Palliation: not applicable. 
The patient died 2 months following WEHr due to local tumour progression. 
CASE 18 
A 51-year-old female, with a 45-month-history of turrour initiating from the 
maxillary sinus. 
Histopathology: adenocystic carcinoma. 
Previous therapy: radiotherapy and surgery of the primary turrour. 
1 . 1 99 1. d Pretreatment status: mu tip e lung metastases. The Tc 1ver scan eron-
strated a space occupying process in the hilar region. A functional scintigram 
* of the hepatobil iary system (HIDA ) showed normal hepatocyte function and 
normal emptying of the gallbladder. 
Current therapy: the patient receive:l 1 WEHr treatment, T rect.rnax. 41.9°C; 
plateau 2 hours at 41.8°C, within a series of radiotherapy Which was stoppe:l 
after 6 x 1.5 Gy had been given, when serious toxicity became evident. INH was 
administered from 1 week before WEHr to avoid recurrence of tuberculosis. 
Toxicity: follc:Ming WEHr massive liver necrosis occurre:l, resulting in the 
death of the patient 5 days later. The autopsy showed an extensively damage:l 
haanorrhagic and necrotic liver with same vital liver cells in the periphery 
of the lobes only. 
Objective tumour response: The autopsy shc:Med some vital tumour metastases in 
the 1 ungs and in the 1 iver, which sh::>we:l no signs of necrosis. 
* HIDA: diethyl-iminodiacetic acid labelle:l with 99Technetium (Solco Basle 
Ltd) is administere:l intravenously. In normal subjects, maximum uptake within 
the hepatocytes takes place within 15 minutes and filling of the gall bladder 
can be visualize:l by scanning within 40 minutes following intravenous admin-
istration. 
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CASE 19 
A 44-year-old male, with a 2-rronth-history of tum::>ur in the retroperitoneal 
space. 
Histopathology: leiomyosarcoma. 
Previous therapy: a laparotomy was performed when ileus occurred. Because the 
turrour was judged inoperable during surgery, various anastorroses were o::>n-
structed to maintain gastrointestinal function. 
Pretreatment status: a large retroperitoneal turrour, dimensions (determined by 
computer tonography) 15x1Sx20 em, infiltrating the pancreas and 1 kidney, and 
comprising necrotic areas. 
Current therapy: the patient received 1 WIHI' treatment, T rect.max. 41.9°C; 
plateau 2 hours at 41.6°C, within a series of radiotherapy, 10 x 2 Gy in 2 
weeks. 
Toxicity: no special problems. 
Objective tumour resfX?nse: cr scanning 1 rronth following WIHI' showed some 
turrour regression and tv.o rronths following W1HI' the turrour could be surgically 
removed, including the spleen and parts of the pancreas, ileum and o::>lon. 
Histologic examination of the surgical specimen smwed vital turrour tissue 
with edema and haemorrhages. At one site a fistula had been formed from a 
intraturrour cavity through the intestinal wall • 
Palliation: the pain had disappeared irrme:liately following w:mr. 
The patient was free of disease for a period of 1 year, at which IX>int local 
recurrence and liver metastasis became evident. 
The patient died 14 rronths following WEHr due to turour progression within the 
abdomen (local recurrence and 1 iver metastasis) . 
CASE 20 
A 56-year-old female, with a 2-rronth-history of malignant tumour of the sig-
rroid. 
Histopathology: adenocarcinoma. 
Previous therapy: at laparotomy the tunour was judged to be inoperable and an 
entero-enterostomy was o::>nstructed. 
Pretreatment status: a large tumour involving the bladder wall and para-aortic 
lyrrph nodes. There was no evidence of distant metastasis. The patient suffered 
from frequently recurring cystitis. 
Current therapy: the patient received 2 WIHI' treatments with a time interval 
of 7 weeks, each within a series of radiotherapy, 15 x 2.3 and 15 x 2 Gy re-
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spectively. 5 FU was administereJ. daily on the first 4 days of each radio-
therapy series. Fbllowing the canbineJ. treatment series 5 FU injections were 
given once weekly. 
WIHl' 1: T rect .max. 41. 7°C; plateau 2 hours at 41. 7°C; 
WIHl' 2: T rect.max. 41.8°C; plateau 2 hours at 41.8°c. 
Toxicity: following both WlHI' treatments the patient incurreJ. multiple second-
degree burns of the extranities and the back. 
Objective tunour response: cr scanning 2 rronths following WIHl' showeJ. "no 
change". The turrour was progressive 7 rronths following WHlT. 
Palliation: none. 
The patient died 10 rronths following WIHl' due to local tunour progression. 
CASE 21 
A 51-year-old male with a 6-week-history of pleural tumour. 
Histopathology: fibrous mesothelioma. 
Previous therapy: none. 
Pretreatment status: a lobulateJ. pleural tumour Which canpresseJ. the bronchial 
tree. The patient suffereJ. severe pain in the thoracic wall • There was no evi-
dence of distant metastasis. 
CUrrent therapy: the patient receiveJ. 1 WlHI' treatment, T rect.max. 42.0°C; 
plateau 2 hours at 41.8°C, within a series of radiotherapy 12 x 2 Gy in 3 
weeks. 
Toxicity: 2 days following WIHI' the patient develope;l haniparesis. cr scanning 
of the brain deronstrateJ. that there were multiple brain metastases surroundeJ. 
by a oooanatous zone. 
Objective tunour resp:mse: the tumour continueJ. to progress. 
Palliation: the pain disappeareJ. imnediately following WIHI'. 
The patient died 1 rronth later. Autopsy showeJ. that there were extensive tu-
rrour masses in the pleural as well as in the al:rlaninal cavity. The turrour 
showeJ. agressive infiltration, which is not ccmron with this type of tumour. 
CASE 22 
A 57-year-old male, 9 years under treatment for a rectun tumour Which had 
locally recurreJ.. 
Histopathology: poorly differentiateJ. adenocarcinoma. 
Previous therapy: surgery of the primary turour with construction of a pre-
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ternatural anus, followed 6 years later by ·excision of recurrent tunour. 
Radiotherapy corribined with 5 FU for the area of recurrence. Ol6!0therapy 
(corribination of 5 FU, oncovin and CCNU) and radiotherapy for various met-
astases. 
Pretreatment status: large local recurrence within the pelvis, 'Which was the 
cause of considerable pain and restricted rrobility, and lung metastases. 
Current therapy: the patient received 1 WEHr treatment, T rect.max. 41.8°C; 
plateau 2 hours at 41.8°C, within a series of radiotherapy: 10 x 1.5 Gy on the 
pelvic tumour; 5 x 2 and 4 x 2.5 Gy on the lung metastases. 
Toxicity: no specific problens. 
Objective tumour response: the pelvic tunour and the lung metastases showed 
"no change" for 5 and 6 rronths respectively. 
Palliation: the pain largely disappeared; a palliative effect 'Which lasted for 
4 rronths. 
The patient died 7 rronths following WEHr due to tunour progression. 
CASE 23 
A 38-year-old male presented with a tunour initiating from the paravertebral 
muscle. He had been suffering pain for 2 years, the existence of a tU!!Our was 
known for 3 rronths. 
Histopathology: 1 eiomyosarcama. 
Previous therapy: irradical surgery. 
Pretreatment status: a large tumour of the dorsal abdominal wall, 'Which caused 
much pain. There was no evidence for distant metastasis. 
Current therapy: the patient received 2 WEHr treatments with a time interval 
of 2 weeks, within a series of radiotherapy 30 x 2 Gy. 
WEHr 1: T rect.max. 41.9°C; plateau 2 hours at 41.8°C; 
WEHr 2: T rect.max. 41.8°C; plateau 2 hJurs at 41.8°C. 
Toxicity: no specific problens. 
Objective tumour response: the tumour showed sane regression, recorded as "no 
change", lasting 9 rronths. 
Palliation: the pain disappeared canpletely following the first WEHr treatment 
a palliative effect 'Which lasted 7 rronths. The paresis of one leg was tran-
siently aggravated following WEHr. 
IJ.mg metastasis was discovered 10 rronths following WEHr and the patient died 
23 rronths after the first WEHr • 
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CASE 24 
A 56-year-old male with a gastric tumour, which was judged inoperable at 
1 aparotart¥. 
Histopathology: moderately differentiated adenocarcinoma. 
Previous therapy: none. 
Pretreatment status: a large tumour, infiltrating pancreas and colon. There 
was no evidence of distant metastasis. 
Current therapy: the patient received 1 W1HI' treatment, T rect.max. 42.0°C; 
plateau 2 hours at 41.8°C, within a series of radiotherapy, 10 x 2 Gy. 
Toxicity: no specific problems. 
Objective tunour resP?nse: the W1HI' was followed by surgery 6 weeks later, 
during which the tumour could be canpletely excised including part of the pan-
creas; tumour infiltration of the colon was not detectable anymore. 
The tumour recurred 2 years after surgery within the scar of the abdominal 
wall. 
Palliation: the previously moderate pain became less severe following WEHr. 
The patient died 44 months following WEHr due to local tumour progression. 
CASE 25 
A 65-year-old female with a 20-month-history of kidney tumour. 
Histopathology: adenocarcinoma. 
Previous therapy: irradical surgery of the primary tumour, followed by radio-
therapy. 
Pretreatment status: multiple 1 ung metastasis. 
Current therapy: the patient received 2 WlHI' treatments with a time interval 
of 3 weeks, within a series of radiotherapy 8 x 2.5 Gy on the mediastinum and 
10 x 1.5 Gy on the remaining parts of the lungs. 
WEHr 1: T rect.max. 41.9°C; plateau 2 hours at 41.8°C; 
WEHr 2: T rect.max. 41.9°C; plateau 2 hours at 41.8°C. 
Toxicity: following the first WEHr the patient developed herpes simplex of the 
lip, extending through the nose to one eye. The second WlHI' was delayed 1 week 
until this infection had healed. FOllowing the second hyperthermia, the punc-
ture site in the feroral vein continued oozing for 10 hours. It was found that 
thranbopenia had developed (lowest count 30.109/L), together with a decrease 
in fibrinogen serum level (lowest level 2.6 g/L), and an increased Prothranbin 
Time (21 seconds; standard 13 seconds). FDP ranained below 10 mg/L. This can-
bination of findings made the diagnosis dissaninated intravascular coagulation 
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(DIC) probable. (Kobayashi et al. 1983). Fbllowing transfusion of thrombocytes 
coagulation parameters rapidly recovered and the puncture site stopped bleed-
ing. 
Objective tumour resp:mse: there was less than partial regression of the met-
astatic nodules. This "no change" lasted for 3!.;z rronths at Which r:oint the 
patient developed carcinomatous pleuritis. 
Palliation: not applicable. 
The patient died 5 rronths following WEH1' due to progression of carcinomatous 
pleuritis. 
CASE 26 
A 51-year-old female with a 7-rronth-history of tumour of the kidney, which had 
metastati zed to the 1 ungs. 
Histopathology: adenocarcinoma. 
Previous therapy: radical surgery of the primary tumour, radiotherapy of vari-
ous metastases (excepting 1 ung metastasis), honoonal therapy (niagestin and 
prednison) . 
Pretreatment status: multiple 1 ung metastases. 
Current therapy: the patient received 1 WHIT treatment, T rect.rnax. 42.1°C; 
plateau 2 hours at 41.9°C, within a series of radiotherapy, 10 x 1.5 Gy. 
Toxicity: 10 minutes before the end of the plateau phase, the ECG started 
showing periods of asystole. After interruption of WEH1' and start of cooling, 
the ECG rapidly returned to nomal. After WHIT, sr:ontaneous ventilation was 
inadequate and artificial ventilation was necessary for a period of 36 hours. 
Objective tumour resp:?nse: the lung metastases showed "no change" for 2 
months. 
Palliation: not applicable. 
The patient died 10 weeks following WHIT due to progression of 1 ung met-
astasis. 
CASE 27 
A 69-year-old male with a 1-year-history of tumour initiating fran the pleura. 
Histopathology: malignant mesothelioma. 
Previous therapy: palliative draining of pleural effusion. 
Pretreatment status: a large ttm:>ur extending over the entire pleural cavity 
and in the thoracic wall, which caused much pain. The lung function was 
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reasonable. 
Current therapy: the patient received 1 WIHI' treatment, T rect.max. 42.1°C; 
plateau 2 hours at 41.9°C, combined with only 1 of the 12 planned 2 Gy frac-
tions of radiotherapy. 
Toxicity: fran a few hours following WIHI', the patient developed an adult 
respiratory distress syndrane, with fatal outcane 1 week after WIHI'. 
Objective tumour resp?nse: ,!X)St :rrortem investigation showej multiple distant 
metastases with central necrosis. The primary tumour had infiltrated the 
pericard and also showed necrotic areas. 
Palliation: the patient re,!X)rted that the pain in the thoracic wall had com-
pletely disappeared following WEHT. 
Sumnary of the patient series 
The first impression of this patient material is that WEHT appears worthwile 
especially When combined with radiotherapy and that in patients Who suffer 
pain of a tunour in a previously irradiated area. Fbllowing WEHT alone or in 
combination with cherrotherapy, no impressive results were observed. MJst 
patients had tolerated the WEHT treatment with minor problems only, but a few 
patients had to deal with severe toxicity. Two patients even died as a result 
of the treatment, Which made us decide to discontinue this clinical study. 
In this series of 27 patients it is curious to note that in the earlier 
patients the toxicity was relatively mild and seemed avoidable with growing 
experience and the therapeutic results were pranising, While in the second 
half the major toxicities occurred and the number of objective responses 
decreased. It was not possible to derronstrate a conclusive explanation fur 
this chronological Y.Orsening of results. 
In the fOllowing chapter, the results will be presented and discussed in 
detail. 
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RESULTS 
Chapter VI 
1) Efficiency of heating technique 
Efficiency of heating techniques can· be measured by the following parameters: 
the heating rate, Which has to be as high as possible in order to reduce 
treatment time and to minimize the induction of thenrotolerance; 
- the heat dose, Which has to be high enough to achieve a therapeutic effect, 
but should not exceed the body's tolerance; 
the temperature distribution, Which has to be as horrogeneous as possible in 
order to achieve an optimal dose at each tU!OClur localization. 
Three separate heating methods that have been explored can be distinguished 
in this series, i.e.: 
1) warm air (60-65°C) only; 
2) warm air corribined with water-impenneable plastic foil covering the 
skin; 
3) warm air caribined with plastic foil and warm water mattress (44-46°C). 
These techniques yield relevant differences with regard to the time required 
to increase the temperature and to the horrogeneity of temperature distri-
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but ion. 
Heating rate 
Fbr the evaluation of heating rate, the time required to increase the rectal 
terrperature from 38 to 41°C (in°C/hour) was chosen as the rrost representative 
for terrperature increase. This was done because the temperature at Which 
heating was started varied from 35.9 to 38.9°C. The lowest starting tempera-
ture was recorded at the first treatment of patient no. 2, Where no measures 
had been taken to prevent cooling. The highest starting temperature was ob-
served in patient 9-1, Where the time between induction of anaesthesia, iso-
lation with plastic foil, administration of wanned inhalation gases and in-
fusion fluids and the "start" of heating by closing the cabin, was much longer 
than usual due to technical problems. The temperature of 41°C was chosen as 
upper limit for this evaluation of heating rate, because over this temperature 
measures were taken to decrease energy input to the patient in order to avoid 
overshoot of temperature. The relevant parameters for heating rate are 1 isted 
in Table VI-I. Unfortunately, the temperature data of 3 treatments were lost 
and therefore lack in the evaluation. Patient no. 1, in Whom WEHr was ccmbined 
with additional local hyperthermia is also excluded from this analysis. The 
terrperature at Which heating was started was significantly higher in the 
patients treated with method 3. In fact, heating was already under way before 
the hood of the cabin was closed, i.e. during the period that all rronitoring 
lines were placed. This was by energy input from the water mattress to the 
skin of the back and by isolation of the body with an aluniniun blanket. 
There were no significant differences between the three groups of patients 
with regard to body weight or body surface area, so that differences in 
heating rates indeed can be judged as real differences. 
The heating rate was found to vary from 1.64 to 1.89 °C/hour with method 1, 
from 1.38 to 2.65 °C/hour with method 2 and from 2.00 to 3.60 °C/hour with 
method 3. (See table VI-I). The mean heating rate for method 1 is not sig-
nificantly lower than that for method 2. Using method 3, the heating rate was 
found to become significantly higher, reaching a mean value of 2.69 °C/hour. 
As the heating rate can be expected to depend on body weight as well as on 
body surface area, the degree of association between these factors was in-
vestigated by calculating the correlation coefficients, for methods 2 and 3 
(with method 1, the number of data pairs was only 4). These correlation 
coefficients are listed in table VI-2. 
In the group of patients treated with method 2 (n = 9), negative correlations 
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Table VI-1 PARAMErr'ERS RELEVANT 'IQ HEATING RATE ACHIEVED BY THE VARIOUS TECHNIQUES USED 
Technique 1 *l Technique 2 *l Technique 3 *1 
s.d. *2 s.d. *2 s.d. *2 mean n mean n mean n 
-- -- -- -- -- -
tanperature at start heating {°C) 36.6 0.5 4 36.9 0.5 g*3 37.4 0.5 25 
body weight {kg) 65.5 7.7 4 67.2 7.3 12 64.7 11.1 26 
2 body area {m ) 1.77 0.22 4 1.77 0.14 12 1.77 0.16 26 
heating rate {°C/min; 38 ...-. 41°c) 1. 78 0.10 4 1.97 0.49 9 2.69 0.45 24 
time to reach 41. 5°C fran start heating {min) 203 29 4 171 26 9 116 23 24 
m:rnber of patients 3 5 18 
*l technique 1: warm air only; technique 2: warm air and plastic foil; technique 3: warm air, plastic foil and warm 
water mattress. 
*2 
n: the nunber of data available. 
*
3 1 treatment with starting tanperature of 38.9°C excluded. 
Table VI-2 ASOOCIATION EEI'WEEN HEATING RATE 1\l:i!D PATIENT PARAME"I'ERS 
correlation teclmique 2 (n=9) teclmique 3 (n=24) 
investigated r 2p r 2p 
---
HR vs B\"1' -0.763 <0.05 -0.154 >0.1 
HR VS BSA -0.672 <0.05 -0.069 >0.1 
HR vs BW/BSA -0.642 <0.1 -0.206 >0.1 
- - - - - -
HR = heating rate (°C/hour); BW = l:xrly weight (kg); BSA = l:xrly surface area 
(m2 ); BS/BSA = ratio of "tody weight and "tody surface area (kg/m2 ); r = 
correlation coefficient. 
-
(r = - 0.642 to - 0. 763) were fotmd between heating rate and body weight, body 
surface area and the ratio between body weight and body surface area, respect-
ively. These correlation coefficients were statistically significant for the 
association between heating rate and body weight, and heating rate with body 
surface area, respectively. In the larger group however, treated with method 3 
(n = 24), these relations were, surprisingly, less clear; correlation coef-
ficients varied from - 0.069 to - .206. This last, largest, value was fOtmd 
fOr the relation between heating rate and the ratio of the t....o patient par-
ameters, but this was not statistically significant. 
These insignificant relations between heating rate and patient parameters 
could also be demonstrated by the values for heating rate of individual 
patients, which showed ranges as large as 2.25 - 3.27 °C/hour for two 
successive treatments in one patient (case no 20, first and second treatment). 
The overall time required to reach 41.5°c fran the start of heating was fotmd 
to show even rrore variation. The mean overall time in patients heated by 
method 1 (mean starting temperature 36.6°C) was 203 minutes, 32 minutes rrore 
than with method 2 (mean starting temperature 36.9°C) and even alrrost 90 
minutes rrore than with method 3 (mean starting temperature 37.4°C). 
Heat dose 
The heat dose achieved, expressed as mean rectal temperature during plateau 
phase, had a mean value of 2 hours at 41.8°C fOr 40 of 45 treatments. The 
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Fig. VI - I TEMPERATURE DISTRIBUTION DURING PLATEAU PHASE 
Temperature distribution during the plateau phase of WBHT achieved with thE. 
various techniques used. Technique 1: warmed air only; technique 2: warm air 
and plastic foil; technique 3: warm air, plastic foil and warm water 
mattress. The figure shows the means and s.d.'s, the number of treatments are 
given in brackets. 
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Fig. VI - 2 TEMPERATURE DISTRIBUTION DURING THE HEATING PHASE 
Temperature distribution during the heating phase of WBHT achieved with the 
various techniques used (1: warm air only; 2: warm air and plastic foil; 3: 
warm air, plastic foil and warm tvater mattress). The figure shows the mean 
courses of temperature, with the number of treatments in parenthesis. 
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range in mean rectal temperature during plateau phase was found to be small, 
41.7-42.1°C, resulting in a standard deviation of only 0.09°c. 
During 5 treatments the heat dose administered was purposely differently. 
Patients nos 1 and 19 received lower heat doses. Patient no. 1 was given three 
treatments of 140 minutes at 40.1°C, 150 minutes at 41.2°C and 210 minutes at 
41.4°C, respectively. This was done as a way of precaution. Patient no 19 
received one treatment of 2 hours at 41. 6°C as we feared a toxic overload 
should his massive tumour which showed ill-perfused areas as judged by 
cr-scanning, suddenly might became necrotic. 
Patient no.16 received a third treatment of 3 hours at 41.8°C. The experience 
regarding toxicity obtained in previous patients and in this particular 
patient during the first and second treatment made us venture upon giving her 
a third WEHr treatment with prolonged treatment time. The short heating time 
achieved with method 3, made that this prolonged treatment =uld be performed 
within a normal working day. This last =ndition was important with regard to 
the post-WEHr care for the patient Which had to be provided by the intensive 
care unit and the 1 al:oratory staff. 
T~erature distribution 
The temperature distribution during plateau phase maintained by the various 
techniques is shown in figure VI-1 (A, B and C). Using warm air only the 
variation between temperatures at the various measuring sites is very large. 
The mean value for rectal temperature in this group is 41. 7°C. The 0.3°C lower 
oesophageal temperature is probably due to improper placement (insufficiently 
deep) of the probe in the oesophagus in 3 of the 4 treatments. At insufficient 
depth in the oesophagus, the temperature is influenced by the temperature of 
respiration gases Which were not warmed in these patients. 
The intramuscular and subcutaneous temperatures during plateau phase were 0.4 
to 1.1°C lower than rectal temperature. The situation was reversed during the 
heating phase in this group: muscle, subcutaneous and tumour temperature were 
found to be mean 0.5°C higher during heating than the rectal temperature 
(figure VI-2A). 
The sharp decrease in heating rate of the subcutaneous tissue after 20 minutes 
heating shown in this figure may be caused by the increase in blood flow 
through the skin. Figure VI-1B shows that temperature distribution is much 
more hanogeneous When plastic foil is used. The maximum temperature difference 
is that between rectum and subcutaneous tissue, being 0.3°C. The same is 
demonstrated in figure VI-1C for method 3. 
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With methods 2 and 3, during the heating phase the intramuscular temperature 
was found to be scrnewhat lower than the rectal te:nperature; 'Whereas the subcu-
taneous te:nperature was, again, higher. 
The te:nperatures measured in the tunour depend on the tumour localization; the 
te:nperatures of superficial tunours reflect subcutaneous te:nperature, 'Whereas 
tunours seated deeper than 1 em below the skin surface reflect rectal tempera-
tures, also during the heating phase. 
Liver te:nperature could be measured in one patient (no. 27). This was per-
formed with a custom-made small thenrocoupl e probe built into the tip of the 
hepatic vein catheter by the physicist of our department (Ing. G.C. van 
Rhoon). Unfortunately this probe broke 55 minutes after the start of plateau 
phase, 'When the catheter was manipulated to regain the possibility of draining 
blood from the hepatic vein. The 1 iver temperature measurements therefore were 
limited to the first 155 minutes of the WEHr treatment. The te:nperatures 
recorded from the oesophagus, the rectum and the 1 iver respectively are pre-
sented in figure VI-3. At the start of heating, no difference between rectal, 
liver and oesophageal te:nperature, respectively, was found (the 0.1°c higher 
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Fig. VI - 3 COURSE OF LIVER TEMPERATURE DURING WBHT 
Course of liver -, rectal - and oesophageal temperature during WBHT in 
patient no. 27. 
122 
terrperature in the oeso.J?hagus is within the accuracy range of the probes). 
During the heating phase, a difference between I iver and rectal tanperature 
was observed which increased with increasing heating time up to a maximum 
value of 1.0°C at 80 minutes fran the start of heating. During the heating 
phase, the liver tanperature was on the average 0.66 °C higher than the rectal 
tanperature. This difference was found to decrease again after the lowering of 
energy input. Fran the start of plateau phase the difference between liver and 
rectal t~erature decreased further to becane zero at 40 minutes after the 
start of plateau phase. 
The oesophageal tanperature was observed to be close to liver temperature 
during the heating phase (maximum difference 0.2°C, mean difference 0.09°C), 
but became =nsistently 0.2°C lower than the liver tanperature, fran the time 
that the energy input was decreased till the end of hepatic vein temperature 
measurement. Figure VI-3 also shows the rectal temperature lagging behind the 
oesophageal temperature during the heating phase, which was the =urse ob-
served usually. The maximum difference between rectal and oeso.J?hageal tanpera-
ture was 0.9°C, between 60 and 75 minutes fran the start of heating. This dif-
ference had beccme zero again at 25 minutes after the start of the plateau 
phase. 
Additional local heating by means of 433 Miz microwaves indeed resulted in 
higher turrour temperatures, as was deronstrated in patient no. 1. The mean 
turrour tanperatures achieved were 1.0 - 1. 7°C higher than the mean rectal 
tanperature during the plateau phase (see table VI-3). Figure VI-4 gives an 
example of the additional local tumour heating and the tanperatures achieved 
during the ·se=nd treatment of patient no. 1. This caribination of WHiT and 
local hyperthermia =uld be performed without complications during the first 
and se=nd treatment of patient no. 1. During the third treatment however I 
strldenly a sharp increase in tumour surface tanperature, as measured by I...CXlF I 
was observed. This happened following a period of uneventful treatment. Up to 
381 minutes of treatment, being 160 minutes at pi ateau the tumour temperature 
had not exceeded 43.4°C. The following 14 minutes, turrour tanperatures in-
creased up to 45.0°C, and then in the next one minute, the I...CXlF reading sud-
denly increased to values above its calibration range. The =rresponding tern-
perature was estimated to be about 55°c. The treatment was stopped and the 
patient later developed a severe third degree burn of 10 an diameter. This 
lesion incltrled necrosis of an area of rib cartilage. 
The cause of the strlden high tanperature increase may have been a standing 
wave, while the increased tanperature in turn may have caused a se=ndary 
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Table VI-3 TEMPERATURES ACEIEVED WITH IDCAL HI' Thl ADDITION TO WBH1' 
Rectal temperature (°C) Turrour temperatures 
1st treatment 
2nd treatment 
3rd treatment 
mean *
1 
maximum 
40.1 
41.2 
41.4 
40.4 
41.4 
41.6 
*1*2 *2 
mean (range) maximum (range) 
41.6 (41.4-41.8) 42.8 (42.3-43.3) 
42.9 (42.5-43.5) 45.7 (44.1-46.7) 
42.4 (42.2-42.5) 46.6 (43.4- >55) 
*1 
mean temperature over the "plateau phase" 
*2 
mean value for 2, 3 and 4 turrour temperatures measured during the 
st nd rd . 1 , 2 and 3 treab~ent respectively. 
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Fig. VI - 4 TEMPERATURE DISTRIBUTION DURING ADDITIONAL LOCAL HEATING 
Rectal temperature and tumour temperatures ( D and 1::.. : tumour center; X : 
tumour periphery) during plateau phase during the second WBHT treatment in 
patient no. 1. 
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stoppage of the local circulation. Obviously, tumour temperature control had 
failed. 
Surrmary 
Combining the original heating system of the cabin, e.g. warm air, with cover-
ing of the skin by plastic foil and extra energy input via the skin of the 
back yields a gain of about 1~ hour in achieving the set p::>int temperature. 
The use of plastic foil over the entire body area was found to result in a 
more harogeneous temperature distribution through the Whole body, Which is 
imp::>rtant during treatment of patients with metastatized tumours. 
Physiology 
Tumour rH 
Intratumoural fH was determined in 4 patients during 7 WEHr treatments. 
In case 9, one electrode was placed into the pelvic metastasis of a mammary 
carcinoma ulcerating through the vaginal wall. In case 10 (locally recurrent 
colon adena carcinana), 2, 1 and 2 electrodes were placed during the 1st, 2nd 
and 3rd WIHr session respectively, in the tumour ulcerating through the ab-
dominal wall . In case 13 ( adenocystic carcinoma), 1 electrode was introduced 
through the intact mucosa in the tumour protruding in the oral cavity. In case 
15 (locally recurrent squamous cell carcinoma of the uterine cervix), measure-
ments were done during both WEHT sessions within the tumour infiltrating sUb-
cutaneously in the abdaninal wall. The results of these fH determinations 
during plateau and cooling phase are given in figure VI-5. No significant 
changes in tumour fH values were observed during the plateau phase of the WIHr 
treatment. As mentioned before (chapter V) , the values obtained during the 
heating phase were considered unreliable. 
In patient 10, the tumour fH measured during the second WEHr treatment is con-
siderably higher than its value during the first and third treatment, respect-
ively. In patient 15, the mean of 2 measured tumour fH values was someWhat 
higher during the second treatment than during the first treatment. 
Eleven subcutaneous fH measurements were performed, in patients no. 9 (1 
measurement), 15 ( 1 measurement during the second treatment), 16 (2 measure-
ments during the first and third treatment, respectively), 17 ( 1 measure-
ment), 18 (2 measurements) and 19 (2 measurements). The fH of arterial blood 
samples was determined regularly as described in chapter V. A comparison of 
tumour Ifi, subcutaneous fH and arterial fH for each patient treatment is given 
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Fig. VI - 5 COURSE OF TUMOUR pH DURING WBHT 
Course of tumour pH in 4 patients during 7 WBHT treatments. Time = 0: start 
plateau phase; time= 120: start cooling. Patient number and treatment number 
is indicated with the curves. 
in table VI-4. Subcutaneous Iii was measured simultaneously with turrour Iii 
during the WEHI' treatments in patients no. 9 and no. 15 (second treatment), 
and was higher than turrour Iii in both cases (mean difference 0. 31). Sub-
cutaneous Iii (either the mean of 2 determinations or 1 determination during 
one treatment, respectively) was also higher than arterial pH (at start 
plateau) in all of the paired measurenents, the mean difference was found to 
be 0.21. This difference was found to be significant (paired T-test, 
2p<0.001). Subcutaneous Iii was observed to decrease during the plateau phase 
in 9 of 11 determinations. The difference between subcutaneous Iii at the start 
and the end of the plateau phase respectively was found to be 0.08 and was 
statistically significant (2p<0.025). The difference between arterial Iii and 
turrour Iii was also significant (paired T-test, 2p < 0.001). No changes in 
arterial Iii were observed during the plateau phase. A canparison of the mean 
Iii values measured at start and end of plateau phase in turrour, subcutis and 
arterial blood, respectively, is given in figure VI-6. 
126 
Table VI -4 ffi.IPARISCl'/ OF 'I'UM<XJR, SUBCUI'ANEOUS AND ARI'ERIAL PH OORING WBHT 
tunour pH subcutis pH arterial pH 
Patient No. Histology start start Start start start Start 
treatment no. plateau cooling plateau cooling plateau cooling 
9-1 breast adenoca 7.25 7.36 7.44 7.47 7.26 7.35 
10-1 colon adenoca 7.41; 7.27 7.28; 7.28 7.28 7.28 
-2*(1) 7.59 7.51 7.38 7.41 
-3*(2) 6.92; 6.66 6.97; 6.79 7.33 7.32 
13-1 pharyngeal 7.22 7.23 7.53 7.49 
adenocystous ca 
15-1 cervical squarrous 6.90; 6.69 7.04; 6.71 7.37 7.29 
-2*(3) cell ca 6.86; 6.96 6.86; 6.94 7.49 7.39 7.34 7.32 
16-1 colon 7.43;7.76 7.38;7.55 7.41 7.43 
-3*(4) adeno 7.50;7.84 7.43;7.75 7.36 
17-1 lung adenoca 7.47 7.40 7.32 7.31 
18-1 adenocystous ca 7.97;7.45 7.76;7.31 7.50 7.45 
19--1 leianyosarcana 7.74;7.50 7.67;7.54 7.54 7.53 
mean 7.066 7.088 7.599 7.514 7.387 7.378 
S.E.M. 0.091 0.078 0.047 0.045 0.029 0.024 
- - - - - - - - - - - -
'!here is no significant difference in pH values at start plateau and at start cooling for tunour and arterial blood; a 
paired T-test gave 2p values of 0.41 for the tunour pH and 0.84 for the arterial pH. 
'Ihe difference between tunour and arterial pH is significant ( 2p = 0. 0001) • 
'!he subcutaneously measured pH decreases significantly during plateau .Phase (2p < 0.025). Subcutaneous pH is higher than 
........ 
arterial pH (2p < 0.001) • 
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Fig. VI - 6 pH CHANGES DURING PLATEAU PHASE OF WBHT 
Changes in tumour, subcutis and arterial blood pH during the plateau phase of 
WBHT. In this figure the means and SEM • s are given. For details, see table 
VI-3. 
cardiovascular changes during WEST-treatment 
Changes in cardiovascular functions have been reported extensively elseWhere 
( Fai thfull 1983, Fai thfull et al. 1984) • Changes observed in sane of the par-
ameters can be surmnarized as follows: 
(1) the pulse rate increased from a mean of 63 beats/min before induction of 
anaesthesia to a maximum of 146 at the end of the plateau phase; (2) the mean 
systemic arterial pressure decreased from a mean of 88 rmHg to a mean lowest 
value of 61 rmHg after 15 minutes of cooling. Mbst patients were relatively 
hypotensive during cooling and for a few hours following WEHT; (3) the cardiac 
output increased from a mean of 5.75 L/min at the start of heating to a mean 
of 12.67 L/min during the plateau phase; (4) the arterial fH during the pla-
teau phase ranged from 7.24 to 7.53, with a mean value of 7.39. 
The large increases in cardiac output and heart rate were accanpanied by large 
decreases in peripheral resistance in l:x:>th the systemic and pulrronary vascular 
beds. The pulrronary arterial pressure rose whereas that in the systemic cir-
culation fell. This caused right ventricular work to increase proportionally 
rrore than left ventricular work. 
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Response 
Objective tumour resp:mse 
a) Following WEHr alone (Table VI-S) 
Follov.ring WEHr alone, none of the patients (cases 1,2,3,4,9 and 12) showed an 
objective tumour response, although sane regression was observed in a f~ 
patients. 
During the first WIHI' session in case 2, a change in the formerly red 
colour of the midsternal cutaneous nodule to blue was observed, probably 
due to stasis in blood vessels. This nodule showed an irranediate regression 
of 56%, but three weeks later regrowth at the margins of the tumour was 
observed. 
In case 3, 20% regression in the size of cutaneous metastatic nodules was 
observed, but progression occurred also after 3 weeks. 
Table VI-5 RESULTS FDUDWING WlHI' AIDNE 
tumour case result 
breast ca 1 no effect 
2 "no change" 3 weeks (56% regression) 
9 no effect 
mal ignant mel anana 3 "no change" 3 weeks (20% regression) 
4 "no change" 3(+) months 
osteosarcana 12 "no change" 6 weeks 
b) Following WIHl' and cherotherapy (Table VI-6) 
Two patients with breast adenocarcinana (cases 1 and 2) were treated in 
combination with melphalan. In both patients "no change" was observed 
lasting for 3 months and 2 months, respectively. 
Two patients with colon adenocarcinana (cases 10 and 16) and one patient 
with bronchial adenocarcinoma (case 17) were treated in canbination with 5 
FU. Only in patient no 16 a "partial response" was observed which lasted, 
during continuous administration of 5 FU once weekly, for tv.o months. In 
cases 10 and 17 "no change" was observed for 6 months and 1 month, re-
spectively. 
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Table VI-6 RESULTS EDLLOWING WEHr AND rnEMJI'HERAPY 
melphalan: 
5 FU: 
case turrour 
1 
2 
10 
16 
breast ca 
colon ca 
result 
"no change" duration 3 rronths 
"no change" duration 2 rronths 
"no change" duration 6 rronths 
"partial resp::mse" duration 2 rronths 
17 bronchial adenoca "no change" duration 1 rronth 
c) Following WEHr and radiotherapy 
Turrour resr:onse following WEHr canbined with radiotherapy was evaluable in 
17 of 22 patients. An overview of the results is given in table VI-7. 
Turrour resr:onse was found not evaluable in cases no 9, 18, 19, 24 and 27. 
Patient no 9 died 3 weeks after WEHr treatment. At r:ost rrortem examination 
it was found that the previously large tumour in the pelvis had regressed 
canpletely and was macroscopically tmdetectable. 
Patients no 18 and 27 died 5 and 7 days, respectively, following WEHr as a 
result of the treatment. Post rrortem examination showed in patient no 18 no 
signs of tumour necrosis, whereas in patient 27 central necrosis was fotmd 
within the (many) distant metastases. 
Patients no 19 and 24 were both considered inoperable before treatment with 
WHIT and radiotherapy, 10 x 2 Gy. Two rronths and 6 weeks after WEHr, re-
spectively, in both patients the tumour could be surgically removed. 
Of the 17 evaluable patients, 8 had received WEHr in canbination with a low 
dose of radiotherapy (15-24 Gy). In 4 of these patients, the total 
radiotherapy dose given had to be low because of previous irradiation 
(cases 8, 10, 15 and 22). In the other half of this group, the radiotherapy 
was given to one or both lungs and the dose was therefore limited to 
maximum 24 Gy. In this low radiotherapy dose group, the results fotmd were: 
1/8 "CR" (mesothel iana); 2/8 "PR" (previously irradiated rectum and colon 
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Table VI-7 RESULTS FDLIDWlliG WEHr .AND RADICJI'HERAPY 
Turrour 
malignant melanoma 
1 illlg adenoca 
1 illlg squarrous cell ca 
uterine cervix squarrous 
cell ca 
mesotheliana 
adenocystous carcinana 
osteosarcana 
fibrosarcana 
1 eiomyosarcana 
breast adenoca 
kidney adenoca 
gastric adenoca 
rectal adenoca 
=Ion adenoca 
* (in)op : (in)operable 
case radiotherapy 
4 
5 
6 
7 
15 
11 
21 
27 
13 
18 
12 
14 
19 
23 
9 
25 
26 
24 
8 
22 
10 
20 
total dose 
(fraction size)(Gy) 
30 
49 
so 
46 
20 
19.5 
24 
2 
55-65 
9 
67 
60 
20 
60 
(5) 
(2) 
(2.5) 
(2) 
(2) 
(1.5) 
(2) 
(2) 
(2.5) 
(1.5) 
(2/1.5) 
(2) 
(2) 
(2) 
18 (2) 
15-20 {1.5-2.5) 
15 (1.5) 
20 (2) 
20 (2) 
15-20 (1.5-2.5) 
19.5 (1.5) 
64.5 (2.3/2) 
result 
NC 2 months 
CR 10(+) 
CR 11 (+) 
PR 12 
NC 2 
CR 21 
progression 
not evaluable 
CR 72(+)months 
not evaluable 
NC 1 month 
PR 3 months 
not evaluable( inop-op*) 
NC 9 months 
not evaluable 
(canplete regression) 
NC 4 months 
NC 2 
not evaluable (inop-op*) 
PR 1 month 
NC S/6 months 
PR 3 
NC 7 
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carcinoma), 4/8 ''NC" (1 uterine cervix squarrous cell carcinoma, 2 kidney 
adenocarcinoma and 1 rectum adenocarcinana) and 1 /8 progression (meso-
thelioma). 
Nine patients were treated in canbination with higher doses of radiotherapy 
(30-67 Gy). In this group the results were found to be as fOllows: 3/9 
"CR" (2 lung adenocarcinoma, 1 adenocystous carcinoma); 2/9 "PR" (lung 
squamous cell carcinoma, fibrosarcoma) and 4/9 "NC" (malignant melanoma, 
osteosarcoma, colon adenocarcinoma, leiomyosarcoma). SOme observations are 
noticeable in these patients: 
- in case 5, complete regression was observed already after only 24 Gy + 3 
WfHI' sessions; 
- in case 4, the previously irradiated group of lymph nodes showed "no 
change", whereas the previously non irradiated group of lymph nodes 
showed "partial response"; 
in case 14, partial regression was observed after only 20 Gy in combi-
nation with 1 WfHI' session. One month after completion of the radio-
therapy series however, the tumour was observed to start regrowth from 
the margins of the radiotherapy field. 
A sumnary of these results is given in Table VI-8. 
Table VI-8 SUMMARY OF RESULTS FDLIDWING WEHI' AND RADiarHERAPY 
dose of X-rays 
15 - 24 Gy 
30 - 67 Gy 
15 - 67 Gy 
Progression 
1/8 
1 (17 
NC 
4/8 
4(9 
8(17 
PR 
2/8 
2(9 
4/17 
CR 
1/8 
3(9 
4/17 
In 4 patients it was p:lSsible to make a comparison between radiotherapy 
only and radiotherapy combined with WIHl'. The radiotherapy only was mostly 
given in an earlier stage of disease. These results are given in Table 
VI-9. 
In all but one cases, the radiotherapy total dose given was considerably 
smaller when given in combination with WIHl' than when given without WIHI', 
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Table VI-9 RADIOI'HERAPY +-WHIT IN CDMPARISON WITH RADIOTIIERAPY AIDNE 
RE:crAL AIENOCARCINOMA 
case 22 primary 
local recurrence 
lung metastasis 
1\.mg metastasis 
case 8 primary 
local recurrence 
CDI.ON AIENOCARCINOMA 
case 10 primary 
local recurrence 
69 Gy + 5 FU 
15 Gy +WEHr 
30 Gy 
20 Gy + WEHI' 
60 Gy 
20 Gy +WEHr 
52 Gy 
19.5 Gy + WEHI' 
PR 3 rronths 
NC 5 rronths 
4% re:~ression 
14% regression 
NC 5 rronths 
PR 6 weeks 
PR 4 rronths 
PR 3 rronths 
(NC) 
(NC) 
------------------
-----------------
LtNG AIENOCARCINOMA 
case's 1 ymph nodes 
lymph nodes 
so Gy PR 6 rronths 
46.5 Gy + WEHr CR 10(+) rronths 
whereas the effects on the tumour obtained are about equal • In case 5, 
where the tumours treated are well ccxnparibl e (in both treatment re:~imens 
previously non irradiated supraclavicular lymph nodes were involved), the 
result of the ccmbined treatment is clearly superior to the result of 
radiotherapy alone. 
Palliative effect 
In 16 patients, pain was an important symptom of their disease. The palliative 
effect following WIHr alone and following WIHI' plus cherotherapy was evaluable 
in case 1. The palliative effect of WIHI' plus radiotherapy and of WIHI' pi us 
chenotherapy was evaluable in case 10. The patients and the palliative effect 
of treatment are listed in table VI-10. 
Severe or disabling pain was present in 12 patients. In 2 of these cases w.mr 
was given in corribination with cherotherapy. The palliative effect in these tw::> 
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cases was found to be none and minimal, respectively. 
Ten of the cases with severe or disabling pain were treated in canbination 
with radiotherapy. In 7 of these patients the observed pain rei ief was can-
plete, for a duration ranging from 1 week to 3 months. It was rEmarkable that 
all these patients experienced the absence of pain immediately after recovery 
'l' ab 1 e VI -1 0 PALLDTI' ION EDLIDWING WEH'l' 
case no WEHr . *2 severity palliative effect*3 irrrnediate 
combined with *I of pain and duration fo 11 OW'i ng WEH'l' 
1 + 
1 che:ro + 
2 + + 2 months + 
7 + +++ 3 weeks 
8 RI' +++ +++ 3 weeks + 
9 RI' +++ +++ 3 weeks (-t) + 
10 RI' +++ +++ 2 mJnths + 
10 che:ro ++ + 6 months 
14 RI' +++ +++ 3 mJnths + 
15 RI' ++ + 2 mJnths 
16 che:ro ++ 
19 RI' ++ +++ 2 months (surgery) + 
20 RI' + 
21 RI' ++ +++ 1 mJnth (t") 
22 RI' +++ ++ 4 months 
23 RI' ++ ++ 7 months 
24 RI' + + 2 years 
27 RI' ++ +++ 1 week (-t) 
*I RI': radiotherapy; che:ro: che:rotherapy; - WIHI' alone 
*2 
+ : vague; +: rroderate; ++: severe; +++: disabling pain 
+ 
+ 
+ 
*3 
no effect; +: sane effect; +: rroderate effect ; ++: considerable 
decrease; ++h ccmplete disappearance of pain. 
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fran the WEHr treatment. In 2 cases, pain decrease was considerable, but not 
canplete, for a duration of 4 and 7 rronths, respectively. In 1 case, there was 
sane decrease in severity of pain for a period of 2 rronths. 
In 6 cases, the pain was vague or at a rroderate 1 evel before treatment. The 
palliative effect in these cases was less outspoken. In only 1 case (case 7) 
the vague pain in the upper abdanen had canpletely disappeared inmediately 
after WEHr, for a period of 3 weeks. In case 24, the pain originating from his 
gastric t~ur, became less severe, but did not disappear, even not following 
surgical reroval. In the other 4 cases no palliative effect was observed. 
The occurrence of metastasis following WEHr 
In thirteen of the 27 patients no clinical evidence was found for distant met-
astasis When they were subjected to their first WBHT treatment. Six of them 
had developed metastasis 2~-29 rronths after their first WEHr. Six patients 
died with symptoms of locally progressing tumour only. In one case (no 11) it 
was not clear whether the malignant mesothel iana nodules in the thoracic wall 
resulted from metastasis or from local regrowth. The metastasis pattern 
observed was not unccmron for the specific tumours: twice to the brain (cases 
5 and 6, lung adenocarcinana); three times to the lungs (cases 14, 19 and 23 
with sarcanas) and once to the liver (case 24, gastric adenocarcinoma). 
Survival time 
The survival data are presented in figure VI-7. 
Only 1 patient (case no 13) is still alive at present, 6 years following her 
first WEHr treatment. 
Fbur patients died within 1 rronth following WEHr, of Whan tv.o as a consequence 
of the treatment (cases nos 18 and 27). The remaining 22 patients died 2-44 
rronths following WEHr, all due to tumour progression. 
Toxicity 
General Toxicity 
Clinical difficulties during the WEHr procedure were encoutered in 2 patients. 
Patient no. 3 developed acidosis with ventricular tachycaria during oooling, 
which was secondary to insufficient spontaneous ventilation. Administration of 
bicarbonate solved this problem. In patient no. 26 we were forced to interrupt 
the WEHr treatment session and start oooling 10 minutes before schedule When 
the ECG showed periods of asystole. The patient showed no further cardiac 
problems during and following oooling. 
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27 
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survival 
26 % 
12 
50 % survival: 8 months 
18 24 30 36 42 48 72 
Months following first treatment 
Fig. VI - 7 OVERALL SURVIVAL OF PATIENTS FOLLOWING WBHT TREATMENT 
Fbllowing cooling, the patients were transferred to the intensive care unit 
where they remained until the next rrorning if their general condition allowed 
transfer to a standard ward. During this period in rrost patients ~eurological 
disorders were observed, in the form of hyperexcitability and agitation. We 
initially considered that these behavioural changes might be caused by a mild 
degree of cerebral oedema, but no obvious oedema was ever present on inspec-
tion of the optic fundi. Therefore it was inferred that the neurological dis-
2+ 
orders were probably related to the low Mg serum level (table VI-11). 
Gastrointestinal disorders such as vaniting and diarrhea were observed in 23 
of 27 patients. Decreased levels of pJtassium (K+) and Ca were corrected by 
intravenous supplementation. Electrolyte losses in the urine did not fully ex-
plain the decrease in serum levels (data are given in table VI-11). 
The loss of K+ may be explained by losses via the sweat and that of the elec-
+ 2+- 2+ 
trolytes K , M;J , P and Ca by loss of fluids via vaniting and diarrhee. 
The canposition of these fluids was however not measured. In sane patients the 
haroglobin level had decreased to such low values ( 6 - 6.5 mool/1) that 
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Table VI -11 CHANGES IN REIEVANr MFAN IABORA'IDRY VALUES DURING AND FOII.aVING 
WBHI' 
-24 hr Mid-plateau 1/4 hr cooling+ 24 hr + 48 hr 
Electrolytes 
Na + (nmol/1) 
Cl- (nmol/1) 
K+ (nmol/1) 
total ca (nmol/1) 
free ca (mmol/1) 
~2+ (nmol/1) 
P- (nmol/1) 
H:l.enatology 
139.9 
100.9 
4.29 
2.34 
1.39 
0.92 
1.12 
haenoglobin (nmo1/l) 7.8 
leucocytes (109/1) 9.0 
Cbagulation 
< platelets (109/1) 
fibrinogen (g/1) 
Glucose (mrnol/1) 
Total protein (g/1) 
Enzymes 
alk. phospbatase U/1 
acid phosphatase U/1 
soor U/1 
SGPI' U/1 
LDH U/1 
-iso 5 (liver) (%) 
CPK U/1 
Kidney functions 
urea (mrnol/1) 
creatinine (urol/1) 
262 
4.5 
6.6 
71 
29.7 
5.71 
12.9 
13.6 
157 
3.9 
21.7 
4.8 
81 
Oltput in urine (mrnol/24 hr) 
ca 
Na 
K 
-~-
134.5 
104.7 
* 4.61 
* 2.02 
* 0.65 
* 6.4 
222 
'* 8.6 
* 56 
134.0 
102.8 
3.50 
2.00 
1.32 
0.66 
0.58 
* 6.5 
17.2 
* 127 
* 2.8 
13.0 
* 54 
6.2 
142 
* 
* 
* 
* 
* 
* 
24 hr before WBHl' 
2.61 
93 
51 
2.22 
Ralarks: All -24 hr values were within nomal range. 
137.6 
107.9 
* 3.74 
* 2.08 
* 1.30 
0.69 
0.91 
* 6.7 
9.0 
* 89 
* 2.9 
7 
* 58 
31.6 
5.11 
* 
* 
* 48.4 
* 27.9 
* 243 
* 9.0 
* 156 
* 7.2 
91.8 
139.6 
105.4 
3.72 
2.14 
1.30 
0.85 
0.81 
* 7.2 
8.8 
100 
3.9 
5.7 
* 62 
* 
34.3 
5.73 
* 210 
* 141 
* 437 
11.6 
* 99 
* 5.8 
87.2 
* 
* 
* 
* 
* 
* 
day of WBHI' 
2.55 
186* 
* 89 
1.12 
*Significant change with regard to -24 hr values (Student's T-test, 2P<0.05). 
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transfusion of red blcod cells was given. 
Patients with no complications could be mobilised from the first day fOllowing 
whole body hyperthermia. Coagulation parameters were found to shClW" evidence of 
a low-grade disseminated intravascular coagulation in 6 patients, i.e., a 
decreased fibrinogen 1 evel , a decreased nunber of thraribocytes and an increase 
in fibrinogen degradation products (FDP) above 20 m;:r/1, which was maximal 24 
hr follClW"ing W1Hl'. The partial thromboplastin time was more than doubled in 
only 3 patients. There was only 1 patient with clinical evidence of coagu-
lation problems following the second WEHr treatment; the puncture in the fem-
oral vein, through which a hepatic vein catheter had been introduced, hae-
morrhaged for several hours. This patient had, however, no increase in FDP 
levels. 
Some degree of liver damage was observed in most patients. Serun glutamate 
oxaloacetate transaminase (S<DI'), serum glutamate pyruvate transaminase (SGPI') 
and lactate dehydrogenase (LIH) levels increased significantly, with maximun 
1 evel s at 48 hr post-treatment. The relevant 1 aboratory values are presented 
in table VI-ll. 
Circunoral Herpes simplex infection was observed in 10 of 27 patients follow-
ing their first WIHI' treatment and in 4 of 13 patients following subsequent 
treatments. In one patient (no. 25), the Herpes infection spread to the eye. 
This Herpes keratitis could be controlled and did not cause permanent damage. 
Second degree burns developed in 9 patients; decubitus was seen at the site of 
the coccyx in 2 patients and on the occiput in 2 others. Burns occurred at 
pressure sites caused by infusion lines, thermocouple lines or sites where the 
skin was directly exposed to hot air streams. The risk of developing burns 
could be reduced by careful insulation and cushioning. 
A generally experienced subjective side effect was fatigue, lasting from 1 to 
14 days, similar to that following a period of febrile disease. 
Severe toxicity 
Two patients died fOllowing treatment. These patients and the treatment pro-
cedure will be described here in more detaiL 
Patient no. 18 
The pretreatment examinations in this patient had not shown contraindications 
fOr W1Hl' treatment, althoU3h there were some abnonnalities on the liver scan. 
The static 99Tc liver scan revealed a decreased activity at the site of the 
liver hilus, indicative for a space occupying process. A supplementary 
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functional 99Tc scan was perfonned (HIDA), which showed good functioning of 
the hepatocytes but a scmewhat retarded excretion of bile into an enlarged 
gall bladder. Laboratory values for liver enzymes were found to be within 
nonnal limits, and so the overall functioning of the liver appeared good. The 
patient was medicated with INH (isonicotinhydrazide), fran one week before 
WIHI' treatment in order to prevent flare-up of an old tuberculous process in 
the 1 ungs by irradiation. 
The WIHI' treatment was given according to standard procedure. Anaesthesia was 
maintained by a mixture of 33% oxygen and 66% nitrous oxide, to Which 0.5 -
1.5% halothane was added. The body terrperature was raised from 37.8 to 41.8°C 
in 90 minutes. The highest rectal te:nperature measured was 41 . 9°C, the hyper-
thermia dose 2 hours at 41.8°c. Cardiovascular parameters showed "nonnal" 
values, i.e. within the range observed during other WIHI' treatments, for 
example during plateau phase: the mean arterial pressure varying fran 50 to 80 
rmHg, the cardiac output varying fran 8 - 12 1/min and the heart rate was 
maximally 125 beats/min. Total fluid administration was 3 1 iter in 5~ hours, 
urine production was reasonably constant with a mean output of 50 ml/hr. 
Cboling fran 41.8 to 39.6°C (rectal terrperature) was achieved in 35 minutes. 
The evening and night following WIHI' were uneventful. On the first day fol-
lowing WEHr laboratory values were indicative for disse:ninated intravascular 
coagulation. When this had not recovered on the second day (platelet nunber 
29.000/rrm3, fibrinogen 0.4 gm/L, FDP 40-80 mg/L - pretreatment levels of 
230.000, 2.6 and < 20 respectively), treatment with fresh plasma and low 
dosage of heparin was started. This resulted in improving coagulation par-
ameters. Fran the second day following WEHT, ever increasing serum 1 evel s of 
liver enzymes (SGJI', SGPI', LIE) and bilirubin were observed, indicating severe 
liver damage. The patient's condition continued to deteriorate; at 3 days fOSt 
WEHr the SGJI' had risen to 1738 U/L, the SGPI' to 2002 U/L and the LDH to 2185 
U/L. She became icteric and unconscious and died on the 5th day following W1HI' 
in hepatic ccma. Post morte:n examination showed that death was caused by mass-
ive liver necrosis, with only a few vital hepatocytes left at the periphery of 
the liver lobules. 
Patient no. 27 
Also in this patient pretreatment examinations had not revealed contraindi-
cations for WEHT treatment. His lung function had been re:narkably good con-
sidering his age (69 years) and considering the tumour localization and extent 
(mesotheliana over the surface of 1 lung). Vital capacity (VC) was 3400 ml 
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(93% of normal value) and the forced expiratory volume in 1 second was 72% of 
VC (54% is the normal value) • 
Bicycle erganetry was performed up to 120 Watts without evidence of coronary 
insufficiency, with only minor and acceptable rhytrn disorders and with a 
normal course of blood pressure. 
From a feN days before hospitalization, one day before WEHI' treatment, the 
patient had becane bedridden due to severe pain in the affected part of the 
thorax. 
WEHr was administered following the standard procedure, except for an ad-
ditional terrperature measurement within the liver via the catheter advanced 
into one of the hepatic veins. Rectal temperature was increased from 37.9 to 
41. 7°C in 110 minutes. The highest rectal terrpetature achieved was 42.1°C, the 
hyperthermia dose was 2 hours at 41.9°c. Cooling fran 42.1 to 39.3°C was 
achieved in 40 minutes. The procedure was uneventful. 
In the evening of the day that WEHI' had been given, the patient's temperature 
increased up to 39.6°C, attended with chills. Blood collected at that time for 
bacteriologic culture appeared sterile. Treatment with antibiotics was 
started. On the following days, the patient remained feverish and became 
increasing dyspnoeic. X-ray photographs showed inhomogene:::ms infi 1 tration of 
the upper and middle part of the turrour-free lung, Which did not w::>rsen much 
during the following days. The patient however, became that much dyspnoeic 
that artificial respiration was judged necessary fran the second day following 
WEH!'. Despite ventilation with positive end-expiratory pressure and a high 
percentage of oxygen, and continuing treatment with antibiotics, the patient's 
condition deteriorated gradually. 
cardiovascular function also became insufficient and the patient died on the 
7th day following WIH!'. 
Post rrortem examination showed massive oedema of both lungs, with deposition 
of hyaline fibers within the alve::>lar merribranes and in the alve::>li, with 
beginning of organization. This picture was indicative for adult respiratory 
distress syndrome (AROO). The resulting insufficient lung function was judged 
to have caused death. 
Extensive retrospective analysis of both patients yielded no indications in 
either the previous histories or the pretreatment examinations that could have 
alerted us to the possibility of these calamities occurring in these patients. 
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b) other severe toxicity: 
Patient No. 14 experiencerl considerable liver damage, with a maximum SCDI' of 
1380 U/1 (norm < 19 U/1) and clinical jaundice, but recovererl from the third 
day. Three other patients (Nos 12, 13, 21) had SCDI' levels > 300 U/1 but no 
clinical symptoms. Tl.\0 patients, Nos 9 and 26, were seriously dyspnoeic irn-
merliately after WEHI' and had to be artificially ventilaterl for 12-36 hr. Poth 
of these patients suffererl from carcinomatous lymphangitis of the lungs and 
had impairerl ventilation before hyperthermia. 
Two patients, Nos 1 and 3, developerl third-degree burns during WEHI'. In the 
first patient this could be attributerl to the additional local tumour heating 
with microwaves during anaesthesia, which probably as a result of "standing 
waves" cornbinerl with circulation stoppage causerl an unobserverl hot spot. 
Patient No. 3 had burns on his toes, probably due to poor regional circulation 
and an excessively high local temperature in the exposerl skin. 
Patient no. 21 appearerl to have brain metastasis following treatment. This was 
suspecterl when he developed a hemiparesis 48 hr after WEHI'. cr scanning showerl 
rnul tipl e oerlenatous brain metastases. Brain scanning had not been incl uderl in 
Table VI-12 INOOCYANINE GREEN-<JJNriNT.DUS INEUSION ])l{['A. 
T1 is the plasma half-1 ife of ICG at the start of heating (s.h.). The 
'2 
clearance values and arterial concentrations of ICG showerl no trends with time 
and are thus expresserl as mean concentrations 2:_ SD. Liver damage following 
treatment is expresserl as maximum serum transaminase (SG:JI'), the normal range 
being up to 19 u. 1-1 
Patient, t~ at Arterial Infusion Clearance SG:JI' 
2 
-1 treatment s.h. concentration rate ( 1.min ) max 
(min) -1 (rrg .1 ) -1 (rrg .min ) (U.l-1 ) 
20-1 5.04 0.52+0.07a 0.167 0.47+0.08a 18 
21 2.29 0.48+0.01 0.333 1.02+0.01 336 
22 3.96 0.67+0.06 0.333 0.73+0.07 72 
20-2 2.06 0.29+0.09 0.333 1.80+0.69 29 
- -
a Mean+ SD 
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the pretreatment examinations of this patient as we errone:msly assume:l that 
the likelihood of the presence of brain metastasis fran a pleural mesotheliana 
was ne.:Jligible. Cbrticosteroid therapy and subsequent radiotherapy of the 
brain gave however a rapid recovery. 
Hepatic clearance of ICG 
During wmr 
The use of the Fick principle to estimate hepatic blood flow (HBF) requires 
the attainment of a stable arterial concentration of ICG. The assumption can 
then be made that dye r60C>val by the liver is equal to input by infusion. Over 
the infusion period (5-6 h per patient), arterial dye concentrations were 
relatively stable (see table VI-12). From these and the hepatic venous con-
centrations, the extraction ratios were calculate:l. 
In all four patients, the extraction ratio decrease:l once the patient was at a 
Relative 
ICG extraction 
(%) 
100 
80 
60 
40 
20 
induction 
0 
pi sh 
heating 
Fig. VI - 8 ICG EXTRACTION DURING WBHT 
mp 
plateau 
15'pt 
Course of treatment 
Changes in indocyanine green (ICG) extraction during WBHT. The graph shows 
the changes in ICG extraction (E) relative to E at the start of heating (sh) 
during four WBHT treatments. Patient number and treatment number are 
indicated with the curves. 
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core tenperature of 41.8°C (see figure VI-8). All three patients with PJSt-
treatrnent measurenents also showerl a considerable decrease as comparerl with 
prewarming values. The increase in extraction seen at "start heating" in the 
two patients with preinduction values correlates with the (expecterl) decrease 
in hepatic blood flow (see table VI-13) following induction of anaesthesia. 
The values obtainerl for estimaterl hepatic blood flow (EHBF) before the in 
duction of anaesthesia and at "start heating" represent about 35% of the 
cardiac output (CO) but once heating had started these values increased 
greatly, in two cases they were found to amount to more than 50% of the co. 
During treatment, the variation in flow values also increaserl. The patient 
suffering the greatest PJSt-treatment liver damage (patient 21; see table 
Table VI-13 A OOMPARIOON OF ESriMm:'ED HEPm'IC BIOOD FlDW (EHBF) AND CARDIAC 
ODrPUI' ( 00) DURING V\HBI' • 
EHBF and 00 are expresserl in 1 min-1 00 was measurerl by thermodilution using 
a 8wan-Ganz catheter. 
Patient, Foint in treatment 
treatment p. i. 
-=----
s.h. s.p. 
EHBF 00 EHBF 00 EHBF m 
20-1 2.30 6.1 1. 35 4.7 1.96 10.5 
21 2.25 6.0 
22 2.18 6.1 1.38 4.5 4.02 12.0 
20-2 1.88 4.9 3.41 10.2 
mean 2.24 6.1 1. 72 5.0 3.13 10.9 
SD 0.08 0 0.43 0.67 1.06 0.96 
- - - - - -
p.i.: pre-induction of anaesthesia 
s.h.: start heating 
s.p.: start plateau 
m.p.: mid plateau 
15' p.t.: 15 minutes after start cooling 
m.p. 
EHBF m 
2.58 12.0 
7.64 13.4 
6.89 14.1 
5.90 11.3 
5.75 12.7 
2.23 1.28 
15' p.t. 
EHBF CO 
2.47 9.5 
5.22 12.1 
3.05 10.8 
3.58 10.8 
1.45 1.30 
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VI-12), as evidenced by serum transaminase (SGJI') elevation, was also the one 
in "Whan the highest flow value was estimated at midplateau, and in "Whan the 
lowest hepatic vein oxygen saturation values were measured after reaching 
plateau (see figure VI-9). 
Once cooling had been initiated, the estimated flow values were found to 
decrease to varying extents and flow expressed as a percentage of the m 
returned to nonnal values (mean = 33% of the m) • Extraction ratios ranained 
low. 
Fb ll owing WEHr 
Analysis of the plasna disappearance of ICG following WEHr (after cessation of 
continuous infusion) revealed an initial rapid phase and, at lower ICG 
Hepatic vein 
oxygen saturation 
(%) 
80 
70 
60 
50 
40 
<> 
0 
A 
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pi 
<> 
sh 
A 21 
0 22 
<> 20-1 
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Fig. VI - 9 HEPATIC VEIN OXYGEN SATURATION 
0 
plateau 
C:. 
sp mp 151pt 
Course of treatment 
DURING WBHT 
The oxygen saturation of blood in the hepatic vein at various times during 
four WBHT treatments is shown. The solid line represents the mean. Patient 
numbers and treatment numbers are given in the figure. 
144 
concentrations, a slower disappearance rate (see figure VI-10). It can be seen 
that a 50% reduction occurred only after about 104 min., although all patients 
had normal plasma half lives (2-5 min.) before heating (see table VI-12). 
ICG retention 
(%) 
100 
50 
10 
0 500 
"' 21 
0 22 
0 20-2 
0 
1000 
Time after cessation of ICG infusion (min.) 
Fig. VI - 10 ICG PLASMA DISAPPEARANCE FOLLOWING WBHT 
The plasma disappearance of ICG following WBHT is shown as a percentage of 
the arterial concentration determined at the termination of ICG infusion. 
Data fitted with the Weibull distribution (Weibull 1951), a statistical 
distribution which can be applied to processes with exponentional segments 
(Campos 1975). Patient numbers (and for patient no. 20 the treatment number) 
are given in the figure. 
Cbst and benefit 
The overall result of the treatment has to be judged for each individual 
patient. An attempt to weigh profit for each patient, following 30 separately 
assessable treatments, is represented in table VI-15. 
The results Which were judged p::>sitive and negative, respectively, are given 
in table VI-14. 
The (canbined) treatment was considered lf.Urthwile When there were none or only 
min::>r ccmplications of the WIHl' treatment and When at least one of the re-
sp::>nses listed as p::>sitive in table VI-14 was achieved. It was considered 
further that the patient had no benefit When the patient's survival fOllowing 
treatment was l ess than 2 nonths. 
The final overall results of the estimation fOr profit score, listed in table 
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Table VI-14 FDSITIVE liND NEGro:'IVE RESULTS EOLI.DWING WIH1' 
positive 
"no change" ~ 2 rronths 
"partial response" ~ 2 rronths 
"complete resp:Jnse" ~ 2 rronths 
inoperab 1 e - operab 1 e 
palliation> 2 months 
death 18 27 
negative 
survival < 2 months 
complications fOllowing WBHT 
varying fran 
- 0 (no complications) 
- minor-m:::derate-severe (depending 
on how much the patient had 
suffered fran the canpl ication) 
- death 
1-
:c 
11) 
~ 
f- -------- ----!----------------~ ____ ...., 
0) 
c 
3: 
0 
1- 0 en ,.__ 
0 en 
0 c 
0 
+-' 
ctS 
(.) 
0. 
E 
0 
(.) 
severe 3 18 
f ----- ----- -- ---:-- -;,; --- -- --- : ---- --- -- - -- -
I I 
moderate 9 21 : : 
14 
r--------------: --------------~--------------
minor 17 2A42025 1 5 11 
I 
-------------- --------------,--------------
0 12 
0 
28 lOA 108 15 
16 19 22 23 24 : 
+ 
6 7 13 
++ 
BENEFIT 
Fig. VI - II COST AND PROFIT "BALANCE" 
A schematic representation of the cost and benefit for each individual 
patient (indicated by patient number) following treatment with WBHT, either 
given alone or in combination with radiotherapy or chemotherapy. The solid 
line indicates the division between "positive" and "negative" overall result 
of the treatment. 
146 
-1. 
~ 
-....j 
Table VI-15 PROFIT SCORE 
Patient no treatment 
la 
-b 
2a 
-b 
3 
4 
5 
6 
7 
8 
9 
lOa 
-b 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
H 
H+C 
H 
H+C 
H 
H+R 
H'+R 
H+R 
H+R 
H+R 
H+R 
H+R 
H+C 
H+R 
H+R 
H + R + miso 
H+R 
H+R 
H+C 
H+C 
H+R 
H+R 
H+R 
H+R 
H+R 
H+R 
H+R 
H+R 
H+R 
H+R 
POSITIVE 
*1) turour response 
progression 
NC 3m 
NC 3 w 
NC 2m 
NC 3 w 
NC 2(+)m PR 2(+)m 
CR lO(+)m 
CR ll(+)m 
PR 12m 
PR 1m 
complete regression 
(autopsy) 
PR 3m 
NC 6 m 
CR 21m 
NC 1m 
CR 72(+)m 
PR 3m 
NC 2m 
PR 2m 
NC 1m 
NE 
inoperable - operable 
NC 7 m 
progre,;sion 
NC5m/6m 
NC 9 m 
inoperable - operable 
NC 4 m 
NC 2m 
NE 
The abbreviations used in this table are: 
NroATIVE 
palliation *l) toxicity 
+2m 
+++ 3 w 
+++ 3 w 
+++ 3(+)w 
+++2m 
+6m 
+++3m 
+2m 
+++ 2(+)m 
+++ l(+)m 
++ 4 m 
++ 7 m 
+24m 
+++ l(+)w 
severe 3rd degree burn 
non-disabling burns of toes 
disabling burns of toes 
atropin toxicity ? 
lung embolia ? 
respiratory problems 
atrial fibrillation 
liver damage 
respiratory problems 
death (liver necrosis) 
2nd degree burns 
evidence of brain metast. 
Herpes simplex spreading to the eye 
respiration problems 
death (ARDS) 
profit score 
- *2 
(+)*3 
+ 
(+) 
+ *4 
+ 
+ 
+ 
+ 
+ 
+ (+) 
(+) 
(+) 
+ 
+ 
+ 
+ 
+ 
(+) 
H = whole body hyperthermia; C = cherrotherapy; R = radiotherapy; NC = "no change"; CR = "canplete response"; 
PR = "partial response"; NE = not evaluable. 
*1 including duration in months (m) or weeks (w); -, +, +, ++, +++: see table 10 
*2 negative *3 weakly positive *4 positive -
VI-15 and schematically presented in figure'VI-11, are that WEHr, either given 
alone or in catibination with radiotherapy or cherotherapy, had resulted in 
- a weakly to clearly positive effect fOllowing 19 treatments; 
- a ne:rative effect following 11 treatments. 
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Effi~iency of heating technique 
Heating rate. 
DISCUSSION 
Chapter VII 
'!he highest mean heating rate of 2. 7°C/hr (range 2 - 3.6) 'Which was achieved 
by us was achieved with method 3. '!his value is within the range published by 
other authors using techniques of transcutaneous energy input (see table 
VII-1). Pettigrew et al. (1974A) (heating with wax) report to achieve a 
heating rate of 3-6°C per hour by using an epidural block Which induces vaso-
dilatation. Vasodilation in the skin increases the heat conductance and by 
this way increases the energy transport through the skin into the body. 
Blair and Levin (1978) Who also used wax for energy transfer found a consider-
ably lower heating rate of 1. 7 to 3.1 °C/hr, the highest value was found When 
an epidural block was given. '!he major difference between the t-wo techniques 
used is that Pettigrew covered the patient with molten wax in irrrnediate con-
tact with the skin, Whereas Blair and Levin used wax in bags 'Which made the 
method cleaner but also may have resulted in in an isolating layer between the 
wax and the skin of the patient. 
For the methods using water-perfused blankets or suits, heating rates of 
l-3.3°C/hr are published, the mean of all values being 2.29°C/hr (s.d. 0.73). 
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Table VII-1 C!)MPARISJN OF EFFICIENCY OF HE:lfi'ING TECRNIQUES 
non-invasive techniques 
-wax 
Pettigrew et al. (1974A) 
Blair and Levin (1978) 
- water-perfused blankets 
Larkin et al. (1977) 
Barlo:Jie et al. (1979) 
Moricca et al. (1979) 
Bullet al. (1979) 
Herman et al. (1982) 
- water-perfused suit 
Gerad et al. (1984) 
-water bath 
Versteeg-h (1980) 
- infrared 
Robins et al. (1984) 
- hot air and RF 
Engelhard et al. (1982) 
present study (rnetb:>d 3) 
invasive techniques 
- faroral AV shunt 
Parks et al. (1979) 
Lange et al. (1983) 
Herman et al • ( 1 982) 
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heating rate (°C/hr) 
3 - 6 
1.7- 3.1 
2.5 - 3.3 
1.9 
1.6 - 2.5 
2.5 - 3.3 
1.8 
1 - 2.5 
6 - 10 
4.8 
3.5- 5.3 
2 - 3.6 
13.4 
2.5 - 4.9 
3.8 
As these methods include isolation of the skin and heating via the front and 
the back of the patient, these are canparable to our method 3. An irrp:)rtant 
advantage of our method is that the patient is constantly under visual con-
trol, and that rronitoring lines can be placed easily and without causing 
pressure points. 
Versteegh (1980) found a mean heating rate of 7.3°C/hr using water-bath 
heating in 4 patients, who received 10 treatments. 
The caribination of hot air with radiofrequency as used by Engelhardt et al. 
(1982)' results in a higher heating rate (3.5-5.3°C/hour), but has the dis-
advantages of disturbance of electronical rronitoring systems and the risk of 
developing burns where sweat accumulates. Considerably higher heating rates 
than those generally found with non-invasive methods were reported by the 
users of heating by femoral arteriovenous shunts. Parks et al. (1979) even 
report a heating rate of 13.4°C/hr (a temperature of 41.8°C was reached in 
only 22 minutes), but this finding is relativized by the heating rates 
reported by Lange et al. ( 1983) and Hennan et al. ( 1982) , being 2. 5-4.4 and 
3.8°C/hour, respectively. The major disadvantage of the invasive technique is 
that surgery is required before heating sessions can start. 
'!he conclusion can be made that the Rotterdam method for WBHT induction in its 
final form (method 3) is clinically useful. The time necessary to raise the 
rectal temperature to 41. 5°C is canparable to the time mentioned by rrost other 
authors using non-invasive techniques. The plateau temperature of 41.8-42°C 
could be well controlled by adjusting the air and water temperatures. 
Heat dose 
'!he heat dose achieved in rrost patients was 2 hours at 41.8°C. This heat dose 
was proven to be efficient to kill part of the turrour cell population as in-
ferred from the observation that same tumour regression took place in those 
patients treated with WBHT alone (cases 2 and 3). This effect, however, did 
not result in much benefit to the patients: the regression was minor and 
short-lasting. 
'!he time to reach 41. 5°C varied from 70-230 minutes and may have influenced 
the biological effect through the induction of therm:::>tolerance. This phenom-
enon, however, is not quite well understood nowadays. Although in the patients 
treated with method I and II the heating phase was considerably longer than in 
the patients treated with method III, the results in the iatter group (5 
objective responses in 16 cases) were not better than those in the first group 
(5 objective responses in 10 cases). Hennan et al. (1982) also canpared the 
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results of WBHT with various duration of heating phase. Terrperature increase 
to 42°C was accomplished in on the average 2.8 hrs when heating blankets were 
used (6 patients, 16 treatments) and in 1.3 hrs with the extracorporeal 
heating method (5 patients, 14 treatments). 'Ihey also could not demonstrate 
improved results with faster heating rates. As therrrotolerance is not detect-
able under these conditions, the duration of heating phase is probably not 
very important when WBHT is used for tumour heating. 
'Ihe heat dose to the tumour may be different frcm that delivered to the whole 
patient when the tumour is located superficially. In fact, we measured tumour 
temperatures at less than 1 em depth which were up to 1.1°C lower than rectal 
temperatures during plateau phase in the group of patients treated without 
plastic foil (fig. VI-lA). During the heating phase, however, tumour tempera-
ture was higher than rectal temperature in this situation (fig. VI-2A). Above 
40°C, where hyperthermia becanes effective, this difference was max:irrally 
Q.5°C, but the duration of this profitable difference was only 70 minutes and 
therefore considered insufficient for campensation of the opposite situation 
during plateau phase. 
'lhe situation was improved when plastic foil was used. During the heating 
phase the tumour temperature was higher than rectal temperature (fig. VI-2B,C) 
whereas no difference was observed during plateau phase (fig. VI-lB,C). 'Ihe 
use of plastic foil thus also adds to the therapeutic value of WBHT for 
tumours located superficially. 
T~rature distribution 
With the use of plastic foil a rather homogeneous temperature distribution 
through all tissues was achieved. M:>st authors report only the measurement of 
core (rectal, oesophageal, bladder) temperatures during WBHI'. Searching 
through literature on human WBHT, we found only Barlogie et al. (1979) and 
Robins et al. ( 1985) mentioning skin ternperatures. With the use of water-
perfused blankets, skin temperature was close to rectal and oesophageal 
temperatures during the heating phase, but became considerably below those 
temperatures after lowering of perfused water ternperature for the maintenance 
of core temperature at 41.9-42.0°C during plateau phase (Barlogie et al. 
1979). 'lhis pattern is sanewhat different frcm the radiant heat method. Here 
skin temperature is up to 2°C higher during the heating phase, but 0.4-0.8°C 
lower than core temperature during plateau phase (Robins et al. 1985). These 
differences can became critical for superficially located tumours, especially 
when WBHI' is corribined with cherrotherapy, since usually the drug is admin-
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istered at the start of plateau phase. 
'!he use of radiofrequency or microwave heating may result in higher local 
temperatures (present study: dog experiments (chapter IV) and patient 1 
(chapter VI)), which is advantageous when the tumour is located in that 
particular area, but we found the disturbance of the electronic read-out parts 
of the monitoring equipnent too disadvantageous and the risk of severe burning 
too high to use these parts of the original Pomp-Siemens cabin. 
More information about temperature distribution during WBHT is given in re-
ports on animal experiments. Temperature distribution during WBHT in pigs, 
induced by humidified heated air, is described by Dickson et al. (1979). 
Subcutis, muscle and bone marrow temperatures were consistently lower than 
rectal temperature at normothermia and during hyperthermia. Kidney temperature 
was similar to that found for rectum and oesophagus, which were close 
together. The highest brain temperature was about equal to rectum temperature 
but the side on Which the animal lay almost invariably maintained a tempera-
ture difference of +0.3- +0.5°C above the other side (Dickson et al. 1979). 
We observed similar, although insignificant differences in our experiments 
with dogs: one side of the brain was +0.1 - +0.2°C higher in temperature than 
the other side. This difference may be explained by the cooling mechanism: 
venous blood draining from the skin of the head into the cranium is cooler 
than core temperature and thus functions as a heat exchanger. The same mech-
anism may play a role in human subjects (Truex and Carpenter 1969) . 
Liver temperature, in Dickson's experiments, was at "start heating" saneWhat 
(+0.4 - +0.2°C) higher than rectal and oesophageal temperature, respectively, 
but the difference became less with increasing time at hyperthermia. This 
finding agrees partially with the only measurement of liver temperature in our 
patient series, Where a difference with rectal temperature of maximum l.0°C 
was observed during the heating phase, Which difference was reduced to zero 
after 40 minutes at plateau temperature. 
Robins et al. (1983), heating pigs with the radiant heat method, find a liver 
temperature-time pattern which is "qualitatively similar to that found for 
rectum". Another experiment in which liver temperature is reported (Macy et 
al. 1985) indicates a liver temperature 0.3°C lower than rectum temperature, 
during plateau phase. This was found during heating of dogs using humidified 
heated air. We have no explanation for this different finding. 
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Tumour pH 
Tumour pH was considerably lc:Mer than arterial pH in 4 of 7 paired determi-
nations. During plateau phase we observed no changes in tumour pH. The 
measurement during heating phase was considered unreliable, as experience with 
tumour pH determinations in other, unanaesthetized, patients has learned that, 
following introduction of the electrode, a recovery phase of 50-90 minutes is 
required before stabilization (of the physiological status) is achieved. 
(Wike-Hooley et al. 1985). 
This absence of change in pH may be a matter of temperature. Vaupel et al. 
(1983) suggest that hyperthermia-induced changes in tumour pH occur only at 
temperatures of 43°C and higher and, indeed, Song et al. (1980B), Bicher et 
al. (1980) and Vaupel (1982), Who observed pH changes, all used temperatures 
of 43°C or more. Experiments on Yoshida sarcoma at 42°C sh<Med no change in pH 
(Dickson and Calderwood 1979), although changes were seen in this tumour £01-
lc:Ming hyperthermia at 44°C for 60 minutes. 
For the increased tumour pH value in patient 10, 2 weeks foll<Ming his first 
WBHI' treatment within a series of radiotherapy, t'WO explanations are avail-
able. Follc:Ming his first WBHI', the tumour has regressed excessively. The 
increase of pH may reflect either a "nonnalization" of tumour tissue, i.e., an 
improved blood fl<M, or the opr:osite: necrosis. A shift in tumour pH to more 
alkaline values with tumour necrosis has been derronstrated in experimental 
sttrlies. For exarrple Busse et al. (1981), Who investigated DS sarcana in rats, 
found that When tumours were very necrotic, the pH increased with increasing 
size - rising from 7. 2 to 7. 4 as tumours increased from 1. 7 to 25.7 g. Vaupel 
et al. (1981) have also found alkaline values in very necrotic CH3 rrouse 
manmary adenocarcinanas. 
In another group of patients in Whom tumour pH was measured before and after a 
series of radiotherapy caribined with local hyperthermia, a highly significant 
increase in tunour pH was seen (Wike-Hooley et al. 1984A) . This rise in pH is 
probably a result of improved oxygenation and blood circulation. Such changes 
in oxygenation have been rer:orted follc:Ming clinical radiotherapy only, for 
exarrple by Mantyla et al. (1982) and Papr:ova et al. (1982). 
'As we did not perform histological studies of the tumour, both explanations 
are plausible. Patient 10 was referred for a third treatment t'WO rronths after 
the second, When the tunour was progressing again. By that time tumour pH had 
reached a very acidic level. 
In patient 15, tunour pH values shc:Med only a minor change 1 week after the 
first WBHI' treatment. The tumour size had hardly changed by that time. 
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In view of the fact that we did not observe a decrease in tumour pH during 
WBHT, no additional therapeutic effect through this mechanism can be expected 
during the treatment with the method used by us. 
The subcutaneous pH was found to be higher than tumour pH in the t'M:l paired 
measurements performed during WBHT. This is in accordance with the findings in 
unanaesthetized patients, Where a mean difference between subcutaneous and 
tumour pH of 0.34 was found (Van den Berg et al. 1982). 
Tunour response 
Orr tumour response data fit well in those reported by other investigators. In 
table VII-2, the results obtained and published are surrmarized. 
Following WBHT alone "canplete response" was never achieved by these authors, 
inclt.rling the present stt.rly. "Partial response" was observed in 0-49%, overall 
32% of the patients. In the present study, sane regression was observed in t~ 
cases (no. 2 and 3) and no change in t'M:l other cases (4 and 12). The rapid 
partial regression observed in patient no. 2, in Whan vascular stasis in the 
tumour was visible already during the first WHBT session, reserribles the circu-
lation stoppage and central necrosis as was dem::mstrated by Reinhold et al. 
(1978) in experimental tumours. The "no change" effect in cases 3, 4 and 12 
can be interpreted as a certain amount of cell kill in the poorly perfused 
parts of their tumour, rapidly overgrown by proliferation of the undamaged 
cells in the well perfused areas. 
This agrees with the findings of experimental studies: a hyperthermia dose of 
2-4 hrs at 41.5 to 42.2°C may be sufficient to kill tumour cells in a thermo-
sensitizing environment including hypoxia and lar.r pH but not the more heat-
resistant cells at the, well perfused, tumour margins. However, two cases in 
Whan "canplete response" was (almost?) obtained follar.ring WBHl' alone were re-
ported by warren (1935) and Wlist (1975). Warren describes how all visible tu-
mour nodules in a patient with metastatized hypernephrana had disappeared over 
a period of 5 months following 3 WBHT treatments of 5 hrs at 41.5° C. At that 
time regrar.rth of brain metastases had occurred. Wlist reports on a canplete 
remission of 5 months duration obtained in a, previously not treated (!), 
patient with :Ebdgkin's disease, follar.ring 12 WBm' treatments of 1 hr at 40°C. 
The results in 11 other patients were not that irrpressive, and he suggested 
that higher treatment terrperatures would be necessary. 
Fbllar.ring WBHT caribined with chemotherapy, we found no "canplete response" 
either and only 1 of 5 patients showed a "partial response" . Other inves-
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'!able VII-2 TLMOUR RESPONSE FOIUmiNG WBHI' 
WBHI' alone 
CR response pain relief 
Pettigrew et al. 1975 22/49 24/49 
Priesching 1976 
Levin and Blair 1978 
Parks et al. 1979 
Moricca et al. 1979 
Bull et al. 1979 0/13 1/13 
Barlogie et al. 1979 0/5 0/5 
Herman et al. 1982 
Engelhardt et al. 1982 
Lange et al. 1983 
Kbga et al. 1985 
Hinke1bein et al. 1981 
present study 0/6 0/6 2/3 
OVerall 0/24 23/73 26/52 
% 0 32 50 
WBHI' + chemotherapy WBHT + radiotherapy 
CR response pain relief CR response pain relief 
12/15 10/15 3/3 3/3 
6/16 
1/14 8/14 ++ 
3/25 13/25 25/25 
0/15 1/15 11/15 
0/6 0/6 
0/10 6/10 
8/15 13/15 
0/13 1/13 
0/13 3/13 
2/11 4/11 2/9 4/9 
0/5 1/5 1/3 4/17 8/17 11/12 
13/113 60/144 47/58 7/40 23/43 14/15 
12 42 81 18 53 93 
tigators report "cc:rrplete response" percentages varying frcm 0 to 53. 
'!he highest "ccmplete response" rate (53%) was reported by Engelhardt et al. 
(1982), CCI!lbining WBHI' (1 hr, 40.5°C) with multidrug therapy (adriarnycin, 
cyclophosphamide and oncovin (ACO}), in treating 15 patients with oat cell 
carcinoma of the lung. The 50% survival time in these patients was 12.3 
rronths, which means a prolongation of 4. 7 rronths in carparison with a his-
torical control group treated with ACO under nonnothermic conditions. 
As most investigators have used reduced drug dosages when administered during 
WBHI', the therapeutic possibilities of the canbination WBHT and cherrotherapy 
may be underestimated at the time. For the time being, however, insufficient 
data are available on the increased toxicity of chemotherapy under hyper-
thermic conditions. It is unlikely that the simultaneous CCillbination will be 
without increased toxicity. It is possible that the results of further ex-
perimental investigation will indicate ways to improve treatment of patients 
with rnetastatized tunours with the CCI!lbination of WBHT and chemotherapy. 
Therapeutic gain can be expected when the tw::> treatment rrodalities with dif-
ferent mechanisms of action are administered additionally, e.g. with a time 
interval long enough to exclude the possibility of erihancing or resistance-
inductioning effects of hyperthermia on cherrotherapy. In this case hyper-
thermia will kill the cells in the poorly perfused areas of the tunour whereas 
the drug(s) should attack cells in the well perfused areas. 
The CCI!lbination of WBHT and radiotherapy results in the highest response 
percentages: in the present study the "cc:rrplete response" rate is 24%, the 
overall "ccmplete response" rate is 18%, and response is obtained in about 
half of the patients. Responses and even "complete response" have been 
obtained using radiation dosages as low as 24 Gy or less (present study). The 
effect of WBHT in this combination, however, is only an enhancement of local 
radiotherapy efficacy. For the patient's benefit (see chapter VI, "'Ibxici ty") 
the CCillbination of radiotherapy with local hyperthermia is therefore prefer-
able. There are, however, many problems in inducing local hyperthermia in deep 
seated tumours which have not yet been solved. 
We once obtained the impression that previously irradiated tumours responded 
better to WBHT and radiotherapy than previously non-irradiated tumours. This 
was especially the case in patients with intestinal tunours. Patients no's 8 
and 10 both showed partial response following WBHT and low dosages of radio-
therapy on a tumour which had recurred after previous radiotherapy, whereas 
the primary treatment of patient no. 20 with WBHT and a high dose of radio-
therapy resulted only in "no change" for a duration of 7 rronths. '!he remark-
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able complete regression however of the previously not irradiated pelvic met-
astasis of breast carcinoma in patient no. 9 does not fit in this impression, 
just like the observation in patient no. 4. In patient no. 4 the previously 
irradiated melanoma lyrrphnode metastasis sh~d "no change" following WBHT and 
30 Gy whereas the previously non-irradiated metastasis showed "partial 
response". The explanation for these contradictory observations is probably 
that turrours respond differently depending ·on various specific characteristics 
such as, for example, histology and physiology. 
Pain relief following WBHI' treatment has been observed not only by us but by 
many authors, whether WBHT is given alone or in ccmbination with radiotherapy 
or cherrotherapy. The percentage of patients experiencing pain relief reported 
is the highest in the ccmbination with radiotherapy group: 92-100%. Sane 
authors mention that pain disappeared immediately following treatment, even in 
patients in whc:m the turrour failed to respond {Levin and Blair 1978, Parks 
1979, Pettigrew et al. 1974B). In our series, this was the case with patient 
no. 23. The, previously present, paresis of one leg, due to canpression on the 
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corresponding nerve root by the turrour, transiently aggrevated following WBHT, 
which was probably caused by oedema in the turrour. Yet in contrast to the ag-
grevation of this symptom, the irrmediate pain relief was remarkable in this 
patient. 
It has been suggested that the increase in Beta endorphin blood levels, which 
was observed to be induced by WBHT {Robins, personal carmunication), might be 
responsible for this palliative effect. Beta endorphin is released by the 
pituitary gland under conditions of stress and has a strong analgetic action. 
Whatever the cause, for the patients this effect of pain relief means a worth-
wile improvement of quality of life. 
'Ibxicity 
General 'Ibxicity 
'Ibxicity following WBHl' does not only depend on heat dose administered during 
treatment, but on other factors as well, such as: 
the general condition of the patient; the condition of his organ 
systems {heart, lungs, liver, kidney, haematology); 
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physiologic conditions during treatment, Which may be influenced by 
anaesthesia measures, artificial respiration, infusion schedule, 
heating rate; 
canbination with {prior) charotherapy or {prior) radiotherapy; 
post-hyperthennia care; 
tumour necrosis. 
The heat dose administered during WBHT is important with regard to toxicity, 
as illustrated by the experience of investigators Who treat patients with 
"rroderate" WBHT. BelCJW' a treatment terqperature of 41°C, toxicity is minimal. 
The group in Freiburg experienced cardiac problems during WBHT in two 
patients. A 68-year-old patient developed left ventricular decanpensation 
during her 13th WBHT, Which was controlled without further problems 
(Hinkelbein et al. 1981). In another patient, cardiac arrhytmia was observed 
during WBHT Which necessitated tennination of treatment. This carplication was 
probably due to enhancement of the cardiotoxicity induced by Adriamycin, as 
the patient had received a cumulative dose of 620 rng (Neumann et al. 1982). 
Nonnal rhythm returned When the patient was cooled to nonnothennia. 
other side effects include 2nd degree burns (wallach et al. 1982), Herpes 
simplex (Heckel and Heckel 1979) and neuropathy (Neumann et al. 1979). 
laboratory data for haernatology and electrolyte blood levels did not shCJW' 
significant changes during and follCJW'ing WBHl' at this lCJW' terrperature and 
there were no indications for liver or kidney damage. 
With treatment terqperatures above 41°C, toxicity was much more marked. In our 
series, few problems were encountered during the treatment. In patient no. 3 
the cardiac arrhytmia during cooling was due to acidosis caused by respiratory 
insufficiency. This could be prevented in subsequent patients by artificial 
ventilation. The cardiac arrythmia in patient no. 26 was unexpected but ap-
peared to be rapidly reversible by cooling. other authors also report the 
necessity of termination of treatment due to cardiac arrythmia or circulation 
failure in several cases (larkin et al. 1977, Priesching 1976). Hypotension 
during and follCJW'ing WBHT was a camronly observed phenanenon. Though in cases 
Where the cardiac output was measured there was not usually any indication of 
de=eased whole-body oxygen flux (Faithfull 1983). The problems during the 
first few hours follCJW'ing WBHT were the same as observed by many other authors 
(Pettigrew et al. 1974A, Mackenzie et al. 1975, Priesching 1976, larkin et al. 
1977, Barlogie et al. 1979, Bull et al. 1979, Moricca et al. 1979, Herman et 
al. 1982, Gerad et al. 1984). 
Gastrointestinal disturbances such as diarrhoe and vomiting were sequels to 
almost every treatment, indicative for damage to the intestinal mucosa. 
+ 2+ 2+ - . Decreased levels of K , Ca , Mg and P were found follOWlllg every treat-
ment. During WBHl' an increase in potassiun level was observed, followed by 
de=eased levels in the post-treatment phase. In most cases only K+ and ea2+ 
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were corrected for by intravenous administration. In general, nonnal levels 
V~ere again reached by 72 hours following WBHT. The decrease in total serum 
calcium gave no clinical sequelae, as the ionized calcium remained within 
nonnal limits. The decreased total calcium concentration probably resulted 
from the decrease in total protein concentration. Transient hyperexcitability 
and agitation were seen in 19 patients follONing 23 WBHT treatments and were, 
retrospectively, probably the result of a magnesium deficiency. It was necess-
ary to administer diazepam to 12 patients to subdue them. other than this 
restlessness and the clinical manifestation of brain metastasis in patient no. 
21, VIe found no neurological disorders. 
other authors report peripheral nervous system problems in the fom of neuro-
pathy, in sane cases prol::Jably due to "recall" Vinca-toxicy (Barlogie et al. 
1979, Bull et al. 1979), and acute myelopathy, prol::Jably due to synergism of 
prior radiotherapy and hyperthemia canbined with cherrotherapy (D::mglas et al. 
1981). Complications concerning the central nervous system such as epileptic 
insults, brain oedema and haerrorrhage and oedema fran brain metastasis have 
also been reported (Priesching 1976, Barlogie et al. 1979, Heman et al. 1982, 
Gerad et al. 1984). Kidney function changes are generally not a problem; 
durin:! treatrrent oliguria rray occur, but diuresis recollerS scon after ccoling. 
Decreases in the concentration of haemoglobin were seen by Pettigrew et al. 
(1974A), and in our patients significant falls were seen during waming and 
also at the onset of cooling. These changes were al.rrost certainly at least 
partly due to haemodilution consequent upon vasodilatation and net movement of 
fluid into the vascular space. This view is also held by Larkin et al. (1977). 
The Hb values in our patients remained significantly lowered till 48 hours 
after the ccmnencement of cooling. 
Many authors report a leucocytosis following WBHT. Pettigrew et al. (1974A) 
reported a mean rise of 67% in white cell counts following 4 hours WBHT, re-
turning to nonnal with 24 hours. There would appear to be an absolute rise in 
the polyrrorphonuclear cells acccmpanied by decrease of lynphocytes. In our 
patients, total white cell counts were significantly raised for up to 4 hours 
after cooling ccmnenced and lynphocyte counts were depressed for 3 days fol-
lONing WBHT. 
Disseminated intravascular coagulation (DIC) was observed by Pettigrew et al. 
(1974B), who described 4 patients who died following WBHT with evidence of 
DIC. Barlogie et aL (1979) also reported prolongation of the prothraribin and 
partial thrariboplastin times with mild to moderate decrease of fibrinogen 
levels and increases in fibrin degradation products (FDP). Although we did 
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indeed find a decrease in the number of platelets and in the fibrinogen levels 
follo.ring every WBHT treatment, these were accompanied by an increase in FDP 
above 20 rng/1 in only 6 and above 40 rng/1 in only 3 of 45 treatments. The only 
patient with clinical coagulation problems had no elevation of FDP, although 
the canbination of bleeding and the changes in levels of coagulation par-
ameters made the diagnosis DIC probable. 
Same degree of liver damage occurred in most of our patients, as judged from 
the increase in liver enzyme serum levels. Impairment of liver function is a 
frequently observed sequel of WBHI' treatment. As liver damage caused the death 
of one of our patients, this complication is separately discussed below. 
Respiratory problems follo.ring WBHT occurred in two patients (nos 9 and 26) 
with carcinomatous l:yrnphangitis of the lungs; they had to be artificially 
ventilated for 24 hours. Oedema of the tumour metastases -diffusely spread 
over both lungs-, resulting in increased obstruction of the airway, had proD-
ably occurred. Patient no. 27 died as a result of adult respiratory distress 
syndrane, which canplication is discussed belo.r. 
Sites of decubitus developed in patients nos. 7,8 10 and 11. At pressure 
sites, hypoxia may result from the diminished circulation. Hypoxia sensitizes 
cells to hyperthermia damage through a f'H-de=ease, as is discussed in the 
chapter on thermobiology. Therefore pressure sites have to be avoided, which 
can be done by the careful use of cushions. 
Circumoral Herpes simples infection occurred in 10 of the 27 (37%) patients 
following WBHT. This is within the range reported by others (40 - 50%, 
Pettigrew et al. 1974A, Barlogie et al. 1979, Ivbricca et al. 1979). Sane 
authors report that Herpes simplex flares up only after the first WBHT treat-
ment, but our experience is that also after subsequent treatments Herpes 
simplex may recur ( in 4 of 13 cases) . 
Severe toxicity 
When we started investigating WBHT, we expected to have to deal with same de-
gree of toxicity, but that we would be able to avoid major toxicity by exclud-
ing patients who were in a poor general condition. Nevertheless, we encoutered 
severe toxicity, including fatalities. This major toxicity is discussed belo.r, 
in order of appearance. 
a) Third degree burns 
In two patients third degree burns developed during WBHT which required inten-
sive medical care afterwards. Patient no. 3 was even disabled for several 
weeks of his short-lasting life, due to the burns of his toes. 
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In case no. 1, the cause of the third degree burn was obviously the simul-
taneous induction of local hyperthermia by E.M. radiation. As we have experi-
enced IIDre recently during local hyperthermia treatments, not any aitDunt of 
thermometry probes placed within the heated tissue can guarantee the absence 
of unobserved hot spots (Van der Zee, et al. 1986) . When the patient is con-
scious, cooperative and has normal pain sensation in the area treated, (s)he 
warns so that the local energy input can be reduced by either changing the 
applicator position or by reducing the overall energy output. Patient no. 1 
however was under general anaesthesia during her third treatment and the 
thermometry probes were apparently not located at the site of the hot spot. 
There are two probable causes for the development of a hot spot in this 
patient. Firstly, the area locally heated was the chest wall with ribs under-
lying the tumour. Micro.r.e.ves can be reflected by bone and, when they are in 
phase with incaning waves, form a standing wave. In the area of a standing 
wave the electrical field amplitude doubles, which results in a quadri-
plication of the energy level. Secondly, hyperthermia can induce stoppage of 
circulation when the dose administered is sufficiently high, as discussed in 
the thennobiology chapter. Either one of these, or both factors together may 
have resulted in the severe burn. This event made us decide to never again use 
E.M. heating in an anaesthetized patient unless sufficient temperature ItDni-
toring systems are developed. The developnent of the severe burns in patient 
no. 3 can be, retrospectively, explained plausibly as follo.vs. The feet of 
this tall man (length 1.90 m) were lying in the air current imnediately coming 
fran the electrical heater below the mattress, of which the tel!]perature may 
have been over 60°C. Although skin circulation in general increases during 
WBHl' as a consequence of the attempt of the heat regulating system to maintain 
nonnothermia, this may have been not the case in the toes. Circulation to the 
toes may have been reduced due to local blood pressure insufficient to over-
cane the difference in height. The canbination of resulting hypoxia and high 
local temperature can have caused the burns. As a consequence of this event, 
all subsequent patient's feet were isolated fran the air by a piece of cotton, 
or later in the series, by plastic foil. Following this procedure, toe burns 
were not observed anymore. 
b) Liver damage 
Two patients suffered post-treatment clinical jaundice and one of them died 
with massive liver necrosis (no. 18). Pettigrew et al. (1974A) related liver 
damage to the height of the applied temperature; they observed no increases in 
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SGOT levels with treatment temperatures below 41.8°C. Levin and Blair (1978) 
also reported that they saw no liver problems after they had restricted the 
treatment temperature to a maximum of 41.5°C. We could not find a correlation 
between liver damage and hyperthermia dose in our patient series. Larkin et 
al. (1977) observed SGOT increases in many patients, but they treated patients 
Who already had increased SGCYI' levels before treatment. One of Levin and 
Blair's (1978) patients died with massive liver necrosis, but this patient had 
used phenobarbital for many years and the authors attributed the liver failure 
to this. 
In contrast to the experiences mentioned above, Barlogie et al. (1979), Bull 
et al. (1979) and Moricca et al. (1979) found no significant changes or only 
minor elevations in SGOI' levels in a total of 48 patients at treatment tem-
peratures of 41.8-42°C. 
After the death of patient no. 18, exhaustive analysis of her case history and 
of all of the treatment parameters was performed. A number of mechanisms Which 
could have lead to liver damage was extensively discussed, as listed below. 
- viral hepatitis. Australia antigen, determined as part of the pre WBHT 
screening, was negative; this however does not exclude viral hepatitis. 
- hyperthermia dose. This had certainly not been higher in this patient 
than in the other patients treated. 
-disseminated intravascular coagulation (DIC). Platelet numbers and blood 
levels of fibrinogen and FDP following WBHI' were indicative for DIC, but 
histological examination had not revealed DIC within the hepatic vessels. 
- endotoxins. It is thinkable that the absorption of endotoxins from the 
intestinal tract is increased under hyperthermic conditions, and that the 
liver reticuloendothelial system functions at a decreased level, 
resulting in endotoxin overload of the circulation. The clinical course 
in this patient however was not typical for that of endotoxin toxicity, 
Which includes shock and kidney failure. 
- isoniazid. Hepatotoxicity following administration of isoniazid has been 
reported but the incidence is low (0.1 %; Ellis 1980) and the prognosis 
is almost always good (Meyer and Hoign~ 1980). 
- insufficient oxygen delivery to the liver. The cardiovascular and 
respiratory parameters measured during WBHT in this patient largely were 
within the range measured in previously treated patients (Faithfull 
1983). From the evidence available it was not considered that hepatic 
hypoxia had occurred. 
- halothane toxicity. other patients had also received halothane but at 
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lower maximun (0.25 - 1%) concentrations than this patient (1.5%). The 
conclusion of the "National Halothane Study" ("Subcomnittee" 1966) fran a 
retrospective analysis of 254.896 halothane - anaesthesia cases, was that 
halothane is a safe anaesthetic, but that in rare cases a hypersensi-
tivity to a metabolite of the drug could develop. our patient however had 
never before receive:'i this drug, which excludes hypersensitivity as 
cause. 
The question is canpl icate:'i by other factors. The patient had use:'i Iso-
niazid from 1 week before WIHI'. Isoniazid has been describe:'i to enhance, 
following 7 - 20 days administration, in vitro hepatic defluorination of 
various fluorinate:'i ether agents (Rice et al. 1980). Furthernore, hepato-
toxic metabolites can be produce:'i during halothane metabolism, expecially 
in the hypoxic 1 iver (Keeling and Thanpson 1979) Although the parameters 
measure:'i did not indicate that hepatic hypoxia had occurre:'i, this could 
not be excl ude:'i either . 
Benumof et al. (1976) describes two cases in whom the occurrence of a 
rnarke:'i selective decrease in hepatic arterial bloodflow was docunente:'i by 
arteriography during halothane anaesthesia. It can not be exclude:'i that a 
caribination of these factors - e.g. hypoxia induce:'i by halothane-induce:'i 
decrease:'i hepatic bloodflow, hypoxia-induce:'i and isoniazid-enhance:'i pro-
duction of hepatotoxic metabolites of halothane, this all further comr 
plicated by hyperthermia - may have resulted in massive 1 iver necrosis. 
But, as listed above, other causes of liver necrosis could not be 
excl ude:'i. 
All together, this problan could not be solve:'i. As a result of this event, it 
was decided to attanpt to measure 1 iver bloodflow (HBF) during WIHI' with indo-
cyanin green (ICG) extraction. 
These attempts to estimate HBF with ICG under WIHI' were not successful, the 
values obtaine:'i being inprobably large (Wike-Hooley et al. 1983). Once heating 
had started the estirnate:'i values rose to levels that in same cases should be 
rrore than 50% of the cardiac output. This is considere:'i improbable in view of 
the rnarke:'i peripheral vasodilatation that occurs during W!HI'. Lees et al. 
(1982) have calculated that more than 50% of the cardiac output flows through 
the skin during WIHI' at 41.5°C. The hepatic flow values were derive:'i from ICG 
extraction of which the values dropped to levels normally found only in 
patients with cirrhosis or jaundice (Cherrick et al. 1960; Caesar et al. 1961, 
Reantsma et al. 1960, Wiegand et al. 1960, Leevy et al. 1962). A decrease in 
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ICG extraction is indicative either of an increase in flow or of a diminished 
hepatocyte function. In this case, an increase in flow is unlikely. M:::>reover, 
it was observed that the decrease in extraction was greatest in the two 
patients with pronounced post-treatment SGOT elevations; thus, it w:::>uld appear 
that, during the hyperthennic treatment, liver function was changed such that 
a reduction in the extraction of ICG by the hepatocytes occurred. This change 
may also account for the liver damage seen following treatment. Recent exper-
iments with pigs (F.aithfull 1983) indicate that extraction of ICG is reduced 
at 39°C and Pettigrew (1975) reported a reduction in BSP metabolism as a re-
sul t of WBHT. If, however, the liver is extracting less ICG while the infusion 
rate is unchanged, an increase in the arterial concentration is to be ex-
pected, but this was not seen in our patients. ICG is known to bind strongly 
to plasma albumin and Keys and Taylor (1935) claim that albumin passes rapidly 
though the capillary walls during severe exercise, thus presenting the possi-
bility of extrahepatic removal routes for ICG during WBHI'. D:creases in blood 
haematocrit which we observed during treatment is likely evidence of haerno-
dilution. A red blood cell volume correction was made in the calculations, but 
this assumed that the total blood volume remained constant, which may not have 
been the case. A third possibility is that ICG crosses the intestinal mucosa 
during WBHT (Nielsen 1963) • M:::>st patients suffer fran gastrointestinal 
distress to sane extent following treatment (diarrhoea, vaniting), indicating 
irritation of the bowel. 
The question remains however as to 'ilihat caused the changes in extraction. The 
effects of heat on the liver have been studied experimentally by several in-
vestigators and the results are confusing. If liver metabolism were to in-
crease at higher temperatures as seen by sane 1.\0rkers (cavaliere et al. 1967), 
this INOuld increase the need for oxygen and therefore for blood. It is likely 
however that HBF decreases rather than increases during WBHT. Certainly, the 
induction of anaesthesia reduces HBF, as has been measured by the same 
technique as used by us (Epstein et al. 1966, Price et al. 1966, Kennedy et 
al. 1970, Coopennan 1972), and this is aggravated by the use of mechanical 
ventilation (Coopennan 1972, Lees et al. 1980). Hyperthennia also reduces HBF 
(Kennedy et al. 1970, Lees et al. 1980), particularly as a result of the 
shunting of large volumes of blood through the skin (Lees et at 1982). A 
catibination of an increase in metabolism and a reduction in HBF represents a 
double risk to the liver. Firstly, extra metabolic heat produced by the liver 
will not~. rernoved as efficiently, and this could result in selective heating 
I 
of the liver'. Indeed, several INOrkers have measured higher liver terrperatures 
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as carpared with "=re" temperatures during WBHT in experimental animals 
(Dickson et al. 1979, Cetas et al. 1980, Fletcher et al. 1982). This suggests 
the possibility of local heat damage in the liver which would not necessarily 
=rrelate with a representative "=re" temperature. The one measurement of 
liver temperature (within a hepatic vein) in our series, which was 0.1 - 0.2°c 
above oesophageal temperature during the plateau phase, is not necessarily 
contradictory to this suggestion. Secondly, there is the possibility of 
hypoxic conditions occurring in the liver. Lees et al. (1982) warn that hep-
atic hypoxia may occur during WBHT. Although the human liver can withstand a 
long period of anoxia at nonrothennia (N::>rdlinger et al. 1980) , this period is 
likely to be considerably shortened at higher temperatures. Experiments on 
animal livers (Brauer et al. 1963, Skibba and Collins 1978, Collins and Skibba 
1980, Collins et al. 1980) indicate that liver function is diminished at 
higher temperatures, an effect that OJuld be due to factors other than a 
direct effect of heat alone. streffer et al. (1979) have derronstrated a change 
in metabolism during hyperthennia which results in the production of large 
quantities of Beta hydroxybutyrate, a strongly acid product that could disturb 
normal functioning of enzymes as a result of unfavourable pH. There is also 
evidence that the hyperthennic liver is rapidly depleted of glycogen (Brauer 
et al. 1963, Streffer et al. 1979), although energy requirements necessary to 
maintain metabolic processes are increased (Collins et al. 1980). 
The slow plasma disappearance of ICG following WBHT indicates that liver func-
tion did not return directly to normal at normothennia. Our data are insuf-
ficient to detennine how long the effects of treatment on the liver lasted, 
but Pettigrew detennined a mean value of 3. 8 days on the basis of BSP ex-
cretion tests (Pettigrew 1975). others have also found reduced clearance of 
ICG following periods of continuous infusion and there is evidence for 
saturation of the liver (Reemtsma et al. 1960, Kennedy et al. 1970). Plasma 
disappearance rates as slow as those seen by us (figure VI-10) however, have 
been reported only in patients with serious disturbances of liver function 
(OJ.errick et al. 1960). '!he curvilinear decay is a normal phencmenon and 
occurs after about 20 min of monoexponentional decay in normal individuals 
(Cherrick et al. 1960, Wiegand et al. 1960, Leevy et al. 1962) but later in 
abnormal subjects (Wiegand et al. 1960). 
In conclusion, the reduced extraction of ICG during and following heat treat-
ment indicates that WBHT disturbs liver function. This makes the use of ICG 
unsuitable in the measurement of HBF during WBH.T, although extraction can 
still be used as an indicator of liver function. The lack of correlation be-
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tween heat dose or T max and liver damage suggests that WBFIT' results in a 
caribination of physiological and metabolic changes rather than a direct action 
of heat alone. 
Respiratory distress syndrane 
Patient no. 27 developed an adult respiratory distress syndrane (ARDS) and as 
a result died 7 days after WBFIT'. As far as we know, this syndrane following 
WBFIT' has been observed earlier only by Greenlaw et al. (1980B). A hypothetical 
explanation for the developnent of this canplication is that, When one lung is 
rrostly taken up by tumour, the greater part of the pulrronary circulation 
passes through the other lung. When the cardiac output increases during WBFIT', 
the blood flow in the healthy lung reaches a very high velocity, the endo-
thelial barrier is injured and protein leaks into the alveoli causing the 
respiratory distress syndrane (Staub 1981). our patient and Greenlaw et al. 's 
patient both had one lung canpletely replaced by turrour. The pretreatment 
ventilation parameters in patient no. 27, however, were only slightly dim-
inished; we had therefore considered that he should be able to withstand the 
treatment. 
WBHT resulting in death of patients has been described by several other 
authors. Death was ascribed to cardiac failure (Pettigrew et al. 1974A, 
Priesching et al. 1976), respiratory failure (Pettigrew et al. 1974A, 
Priesching 1976, Parks et al. 1979, Herman et al. 1982, Kbga et al. 1985), 
massive liver necrosis (Larkin et al. 1977, Levin and Blair 1978, Herman et 
al. 1982, Kbga et al. 1985), disseminated intravascular coagulation (Pettigrew 
et al. 1974A), massive tumour necrosis causing an overload of toxic products 
in the circulation (Pettigrew et al. l974A, Priesching 1976), brain oedema 
(Priesching 1976), and to haem::>rrhage of (regressing) tumours (Priesching 
1976, Levin and Blair 1978, Koga et al. 1985). With proper pretreatment 
examination, sane patients Who are at high risk for serious canplications 
following WBFIT' oan be excluded fran treatment, for instance, those patients 
Who have decreased cardiac and/or respiratory reserve, or patients with tumour 
involvement of the liver or brain. Unfortunately, our experience has shown 
that even extensive pre-WBHI' screening may not be always sufficient to prevent 
serious canplications or even lethality. 
Alrrost all investigators reporting results of WBHT were confronted with some 
fonn of toxicity. It should be mentioned here that recently, there have been 
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more optimistic reports fran a group in Wisconsin, treating conscious patients 
with WBHT using radiant heat to in=ease body terrperature up to 42°C, almost 
on an "out patient" basis. In over 170 treatments, no toxicity was observed 
(Robins, 1986). 
Induction of metastasis by WBHT? 
'Ihe data on metastasis induction by hyperthermia (whole body as well as local) 
are not conclusive. Several investigators have reported on an increase in met-
astasis rate following hyperthermic treatment of experimental animal tumours 
as well as on a change in metastasis pattern, whereas others could not dem:::m-
strate such differences. A review on this subject was given by Hill and 
Denekarnp (1982). WBHT was subject of 6 studies. Either earlier appearance or 
increased incidence of metastasis was found in 4 studies. Yerushalrni (1976) 
who studied local HT as well as WBHT in mice, assumes that a negative temr 
perature gradient between tumour and core may be responsible for increased 
metastasis. Simultaneous administration of cytotoxic drugs may nullify the 
in=ease (Oda et al. 1985). 
A highly increased rate of bone metastasis (86%) was found by I.ord et al. 
(1981) following WBHT in canbination with radiotherapy in dogs with spon-
taneous osteogenic sarcanas. In general, bone metastasis was observed in only 
5% of dogs with this type of cancer; the carm:m pattern shows lung metastasis. 
Bone metastasis was found even in one dog with controlled local disease fol-
lowing WBHT, Which excludes re-seeding as the origin. These results suggest 
that WBHT carries the risk of induction of metastasis. 
Local hyperthermia appears to be less risky, especially when given in can-
bination with radiotherapy (Hill and Denekarnp 1982). 'Ihe use of therroc:metry 
probes within the tumour appears not to increase the risk of metastasis 
(walker et al. 1978). 
It is not necessary to discuss here that the development of tumour metastasis 
is a canplex process. Factors Which may be involved in enhancement of met-
astasis rate are influenced by hyperthermia such as 
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increase in blood flow within the turnour, Which may facilitate the release 
of tumour cells into the circulation; 
loosening of the turnour vessel's endothelium cell lining with the same 
result; 
weakening of the host's immune defense, leaving more circulating tumour 
cells alive; 
damage of the recipient organs WhiCh may increase the chance of tumour 
cell lodgement; 
altered blood coagulability: the intravascular coagulation as observed by 
many WBHT investigators may take place around tumour cells - WhiCh may be 
the first step of metastasis (Hilgard 1980). 
In the list above, many uncertainties are included. In the present study, 14 
of the 27 patients had already metastatized tumours when they were referred 
for WBHT treatment and therefore are not evaluable for studying induction of 
metastasis. Of the 13 remaining patients, 6 developed metastasis in a period 
2 - 29 months following their first WBHT. In none of these cases metastasis 
was considered surprising, regarding the pretreatment status including large 
inoperable tumours and, in some cases, the long previous history. Neither the 
time period between WBHI' and the clinical evidence of metastasis nor the 
localization of metastasic lesions was uncc:mnon. 
In conclusion: the present study gives no indication that metastasis is in-
duced by WBHT. 
Survival time 
Survival time is a parameter too insensitive for the evaluation of WBHI' effect 
in a clinical study of the type presented here, because a control group could 
not be included. In the following, 4 patients will be discussed in whom the 
survival time was, or was suspected to be, negatively influenced by WBHT. 
'IWo patients died as a consequence of WBHT treatment. In one patient (case 18) 
this meant a considerable decrease in survival time. Although she was found to 
have occult liver metastasis, she could have lived without symptoms for quite 
some time. The second patient (case 27) who died was already in such a bad 
condition before treatment that he was expected to stay bedridden until death 
when untreated. 
Two other patients (nos. 9 and 21) died within one month following WBHT treat-
ment, due to progression of previously known tumour deposits. 
In case 9 it was suggested that WBHT had caused an increased progression of 
the carcinanatous lymphangitis of the lungs. This was based on the "WOrsening 
of her respiratory condition and on the increase in abnormalities on the X-ray 
of the Chest, following WBHT. As both the respiratory function and the X-ray 
picture had improved again one week later, we assume that the temporary 
"WOrsening most likely resulted from fluid accumulation around the tumour 
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deposits in the lnngs. In case 21, the findings during autopsy were considered 
nnusual: metastatic nodules of malignant mesotheliana were fotmd in both 
pleural cavities, within the lnngs, the pericardium and the abdaninal cavity. 
The primary turrour had grown continuous! y through the diaphragm into the 
abdaninal cavity resulting in a large retroperitoneal tumour. It was suggested 
that this ovenvhelming turrour metastasis could have l::leen caused by the hyper-
thermic treatment. Considering the short time available and assuming that the 
minimum turrour volume doubling time observed in humans is 312 hours and that 
tumour deposits l::lecane clinically identifiable when 108 cells are present 
(Hermens 1984), this cause-and-effect relationship is unlikely. 
The one-, tYK>- and three-year survival rates observed in our patient material 
are 26, 15 and 7%, respectively. These data are not canparable with any other 
list of survival rates; the history of each patient has to l::le judged indi-
vidually. As all patients were characterized by an inferior prognosis, the 
quality of life during the period of survival is of more relevant importance. 
Profit score 
A judgement of profit score cannot l::le discussed for the group of patients as a 
whole; there is no similar group of patients available for canparison. For 
eadh individual patient the balance l::letween beneficial effect and undesirable 
side effects has l::leen drawn up separately. Even for the individual patient -
and treatment - the weighing procedure is extremely difficult. In fact, the 
judgement of profit score represents the clinician's subjective view on the 
question if the treatment v.uuld have l::leen given if the outcane v.uuld have l::leen 
kno.vn l::lefore. Even with a remarkable objective tumour response, the final re-
sult can l::le judged negative. 
As an example patient no 9 can l::le mentioned. Che should judge ho.Y positive the 
achievement of complete regression following WBHT and 18 Gy is when the 
patient dies 3 weeks later of an tmexpected progression of carcinc:matous 
lJ!Illl?hangitis in the lnngs. We decided the profit to l::le negative. 
Another example given is patient no 8, who was very enthousiastic about the 
treatment when she left hospital canpletely free of pain, but considered this 
effect not v.urthwile anymore when the pain had returned three weeks later. '!he 
profit for this patient is therefore also scored negative. 
'!he stress of WBEf.r was also judged differently by eadh individual patient. 
Sane patients felt tired for weeks following WBHT, whereas others had ccm-
pletely recovered 1 day follo.Ning WBH!'. Ckle patient even asked for his second 
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"sauna treatment". 'Iherefore we decided the treatment was ~rthwile 'When there 
were no or only minor canplications of the WBHI'-treatment, and when there was 
at least a "no change" or a considerable palliation for a duration of 2 
rronths. 
The final conclusion is that the outcome for the patient was beneficial fol-
lowing rrore than half of the treatment regimens (19/30). On the other hand, 
the outcome was clearly negative following 11 treatment regimens. 
Profit fran WBHl' 
The judgement on profit score described above does not include a judgement on 
the additional effect of WBHT treatment on the clinical outcane. An estimation 
of this additional effect can be made by, again, looking at each individual 
patient. For rrost patients, the question whether WBHl' has added substan-
tionally to the result obtained, remains unanswered. lis an example, patient 
no. 13 (adenocystous carcinana. initiating from the parapharyngeal space) can 
be mentioned. In this patient the primary t1..ID10ur was already in regression 
following the first series of radiotherapy corribined with misonidazole. The 
contribution of WBHl' to the positive clinical outcome -this patient is the 
only really long-term surviving patient- cannot be assessed. Another example 
is patient no. 20 (inoperable adenocarcinana. of the sigrroid). The clinical 
outcane achieved -"no change" for a duration of 7 rronths- could also have been 
achieved by the high dose of radiotherapy only. 
For sane other patients, the clinical outcome was remarkable, which was not 
expectable following treatment with the conventional modality (i.e. radiot-
herapy or chemotherapy) only. In patient nos 5 and 6 for example (lung adeno-
carcinana.) , it was not expected a priori to achieve local t1..ID10ur control by 
radiotherapy alone and, furthenrore, in patient no. 5 a canplete regression 
had been achieved following WBHI' and 24 Gy only. The additional effect of WBHl' 
in patient no. 5 was established later in his history by canparing the effect 
of radiotherapy alone (SO Gy) and radiotherapy (46.5 Gy) + WBHT on t~ groups 
of previously non irradiated lymphnodes (table VI-9). The clinical outcome 
following the canbined treatment was better than that following radiotherapy 
alone. Remarkable results which we dare to ascribe to the additional effect of 
WBHl' were also observed in patients no. 10 and lL In patient no. 10 (locally 
recurrent colon adeno carcinana) , partial response and considerable palliation 
were achieved following WBHT and a radiotherapy dose as low as 19.5 Gy. 
Patient no. ll (mesotheliana.) was disease free for a duration of 21 rronths 
following WBHT and 19. 5 Gy radiotherapy, whereas mesotheliana. is known to be a 
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relatively radioresistant tumour (Brady 1981). In two other patients (no. 12: 
lung metastasis of osteosarcana; no. 14: fibrosarcana in the sacroiliacal 
joint), the additional effect of WBHT is also indicated by the clinical out-
cane. In patient no. 12, 49 Gy had been given up to 1 week before the caribined 
treatment, without any effect on tunour sizes, whereas the caribined therapy 
resulted in sane (less than partial) regression within t'-'U weeks. In patient 
no 14 ( fibrosarcana in the sacroiliacal joint) partial regression was observed 
following only 20 Gy and WBHT, plus inmediate palliation following WBHT. 
As this patient series was not included in a ccxrparative, prospective ran-
danized, study, the additional effect of WBHT cannot be proved. The results 
however indicate that (whole body) hyperthermia, if it can be administered 
with only minor toxicity, can provide a valuable treatment modality in ad-
dition to radiotherapy, for radioresistant tumours. 
Are there future indications for WBHT? 
The final conclusion fran this study is that WBHT at 41.8 - 42°C, in can-
bination with radiotherapy, can be an effective therapy regimen for cancer. 
Nevertheless, the WBHI' treatment procedure described in this report does not 
seem to be generally indicated since the possibility of the occurrence of 
fatal canplications is not predictable, even with extensive pretreatment 
examinations. This unpredictability of severe toxicity implies that the ap-
plication of WBHT with the described method is not indicated in patients 
without severe canplaints and with a relatively good prognosis. In patients 
with a poor short term prognosis, with disabling pain and with the possibility 
of additional treatment with a low dose of radiotherapy, the small risk of 
fatal canplications has to be weighed by the patient against the good chance 
of a palliative effect. It is questionable if this is a realistic indication 
in present society, where econanizing measures in public health service are an 
every day issue. calculations on the cost of WBHT were perfonned by Greenlaw 
et a!. (1980A). There were some differences in the application of WBHT by 
Greenlaw's group and ours: Greenlaw et al. used the technique of imnersion of 
the patient in molten paraffin and their monitoring schedule was sanewhat less 
extensive than ours. The total cost of 1 WBHT session was calculated to be US$ 
3.191. The costs of general anaesthesia and intensive monitoring of physio-
logic parameters arrounted to about 70% of the total cost. Fortunately the 
possibilities for treatment of pain have considerably improved, so that almost 
all patients suffering pain fran malignant tumours can be successfully treated 
172 
by methods which are less expensive and intensive than WBH!'. 
Therefore it bas to be concluded that WBHT using the procedure as described in 
this report bas no future indications. This does not :imply that WBHT should be 
abandoned altogether, but rather that different methods of administration 
should be explored. If it can be demonstrated that WBHT can be applied simply 
and safely, for instance by applying WBHT at moderate levels (< 41°C) or by 
using the "radiant heat method" (Robins 1986), WBHT may, indeed, play a 
greater role in future cancer therapy. There are at least two categories of 
patients which may benefit fran this approach. 
I Patients with localized radio-resistant tum::>urs. These patients may be 
treated with WBHI' at 40°C- 41°C to support deep local tum::>ur heating, in 
addi lion to radiotherapy, since one of the problems with deep local heating 
will be the cooling effect of the blood entering the tumour at core tem-
perature. Experimental and clinical studies bave derronstrated a correlation 
between the hyperthermia dose at the coldest spot in the tumour and the 
therapeutic result: the chance of carplete response and local control 
increases when this "minimum hyperthermia dose" increases (DeWhirst et al. 
1984, Oleson et al. 1984, Van der Zee et al. 1986). Preheating of the blood 
by means of WBHI' guarantees a given minimum hyperthermia dose. 
In these patients, addition of hyperthermia to radiotherapy may :improve 
both local control and cure. 
II Patients with metastatized tumours. These patients may be subjected to WBHT 
at 40 - 42°C, in corribination with, or in addition to, cherrotherapy. As 
described before ( cbapter II) , it is not yet clear Whether simultaneous 
administration of WBHT and cherrotherapy will result in therapeutic gain. 
However, the least therapeutic gain Which can be expected fran a can-
bination of both modalities is an additional effect of hyperthermia on the 
tum::>ur, without extra normal tissue toxicity, When the treatments are given 
sequentially. 
Conclusions 
The technique used for induction of WBHI' is clinically useful: its efficiency 
is comparable to the efficiencies mentioned by other authors who use a 
technique of transcutaneous energy input and the terrperature distribution 
achieved is satisfactorily hcmogeneous. The hyperthermia dose achieved with 
WBHT (2 hrs. at 41.8°C) does not influence tumour pH, so that no additional 
therapeutic effect through a heat induced acute pH decrease can be expected. 
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The WBHI'-dose kills only part of the tumour , cell p::>pulation so that WBHT has 
to be ccmbined with another treatment modality to achieve an effect which is 
valuable for the patient. In our series, the clinical outcane was beneficial 
in 63% of the cases. In sane cases however, lethal toxicity was induced by the 
WBHI' treatment unexpectedly. This unexpected toxicity, together with the 
canplexity, and therefore the high cost of the method used, implies that the 
application of "adapted Fbrnp-Siemens cabin method"-induced WBHI' will hardly 
ever be indicated. 
The p::>sitive therapeutic results, however, encourage continuation of research 
into better alternatives such as local hyperthermia and/or safer methods of 
WBHI'-induction. 
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SUMMARY 
Whole body hyperthermia is one of the methods available for the treatment of 
malignant turrours with heat. At the Rotterdam Radio-Therapeutic Institute this 
method was investigated in 27 patients in a period of 3!:2 years. 
This thesis describes the results of this investigation. 
In Section I a review is given of the background of hyperthermia in cancer 
treatment. The history of hyperthermia and the objectives of the study are 
discussed in Chapter I. Publications on this subject can be traced to ancient 
times, although upto the start of this century these deal mainly with cauter-
ization and fever therapy. 
In Chapter II the results of experimental research are discussed. Experimental 
research has resulted in irrportant starting points for clinical research: 
hyperthermia specifically damages tumour tissues but when hyperthermia is 
given alone, it will hardly ever be possible to obtain complete tumour re-
gression. The canbination with radiotherapy appears optimal: the tv.o treatment 
modalities have additive, conplernentary effects and hyperthermia enhances the 
effect of radiotherapy, which may result in therapeutic gain. This makes 
clinical investigation v.orthwile. 
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In Chapter III nonnal therrroregulatory mechani:;;ms and terrperature distribution 
within the body under various circumstances are discussed, resulting in 
guidelines for temperature measurement during WBHT. The various techniques 
available for the induction of hyperthennia in patients are described. 
'lhe investigations performed prior to the start of the clinical WBHI' treat-
ments are'-presented in Section II (Chapter IV). These encompass animal 
experimental 'WOrk done in our own department, as well as a search through 
literature in order to gain insight in potential toxicity. Sa:ne WBHT treat-
ments in another clinic were attended and active participation in some fever 
therapies took place. 
This "preclinical" research resulted in guidelines for patient selection 
before and rronitoring procedures during and following treatment with WBHT. 
In Section III the present treatment series in 27 patients is described. The 
treatment procedure, incltrling pretreatment examinations, rronitoring during 
and following WBHI' and sunmaries of the case history of each patient are 
presented in Chapter v. This is followed by the results in Chapter VI, which 
deals with the heating technique, tunour response and palliation, and 
toxicity. 
These results are discussed and compared to those of other investigators in 
Chapter VII, follawed by evaluation of the potential value of WBHT. 
The final conclusions from this study are: 
the technique used for induction of WBHT is clinically useful and its ef-
ficiency is comparable to the efficiencies mentioned by other authors Who 
use a technique of transcutaneous energy input; 
- WBHT at 41.8°C for 2 hours is effective, but has to be canbined with either 
radiotherapy or cherrotherapy to obtain a valuable effect for the patient; 
In sane cases the treatment may unexpectedly induce severe toxicity. There-
fore research should continue with regard to better alternatives such as 
local hyperthennia and/or a safer method of WBHI'-induction. 
178 
SAMENVATTING 
Tbtale lichaamshyperthermie is een van de mogelijke technieken am kwaadaardige 
turoren met warmte (hyperthermie) te behandelen. In het Rotterdamsch Radio-
Therapeutisch Instituut werd deze methooe onderzocht bij 27 patienten, in een 
periooe van 3~ jaar. 
In dit proefschrift worden de resultaten van dit onderzoek beschreven. 
In deel I wordt een overzicht gegeven van de achtergronden van wanntebehande-
ling. In hoofdstuk I wordt een kart overzicht gegeven van de geschiedenis van 
behandeling met hyperthermie, en van het doel van deze studie. De geschiedenis 
begint al heel lang geleden, al werd voor het jaar 1900 vooral gepubliceerd 
over resul taten verkregen met cauterisatie en koortsbehandeling. 
In hoofdstuk II wordt ingegaan op de resultaten van laboratoriurnonderzoek. 
Laboratoriunonderzoek heeft een aantal belangrijke uitgangspunten opgeleverd: 
hyperthermie beschadigt specifiek kanke:n.eefsel, maar met hyperthermie alleen 
zal het vrijwel nooit rnogelijk zijn am tumoren helemaal te laten verdwijnen. 
De ccnibinatie met bestraling lijkt de beste toepassing te zijn: beide behan-
delingen vullen elkaar aan en bovendien wordt het effect van bestraling ver-
sterkt door hyperthermie, wat kan resulteren in therapeutische winst. Deze 
bevindingen rnaken klinisch onderzoek de rooeite waard. 
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In hoofdstuk III wordt besdhreven hoe onder normale amstandigheden de 
lidhaamstemperatuur onder contr6le gehouden wordt en op welke plaatsen 
temperaturen gemeten moeten worden om de lichaamstemperatuur veilig te kunnen 
verhogen. Verder wordt aangegeven met welke technieken turroren, of patienten 
verwannd kunnen worden. 
In deel II (hoofdstuk IV) wordt ingegaan op het onderzoek dat werd verricht 
alvorens in het RRI'I met de behandeling van patienten begonnen werd. Dit was 
deels eigen onderzoek, o.a. het uitvoeren van experimenten met proefdieren om 
de techniek te leren beheersen en een eerste indruk van de bijwerkingen te 
krijgen, en deels literatuuronderzoek naar de bijwerkingen van hyperthermie en 
de behandelingsresultaten van anderen met totale lichaamshyperthermie. OJk 
werden hyperthermie-behandelingen in een ander centrum bijgewoond en werd er-
varing opgedaan met koortsbehandeling bij enkele patienten. Zo konden beleids-
lijnen opgesteld worden m.b.t. de patienten die binnen het RRI'I behandeld zou-
den gaan worden. In dit deel wordt ook de apparatuur beschreven die beschik-
baar was voor het verwannen van patienten. 
In deel III wordt ingegaan op de behandeling van de 27 patienten binnen het 
RRI'I. In hoofdstuk V worden de gevolgde procedure, het onderzoek voor, tijdens 
en na de beh~deling en de ziektegeschiedenissen van elke patient afzonder-
lijk, besdhreven. In hoofdstuk VI volgen de resultaten: de effectiviteit van 
de behandelingsmethode (met name de snelheid van op.vannen) , de gunstige ef-
fecten (het slinken van tunoren en/of het verdwijnen of verminderen van pijn-
klachten), en de- ongewenste- nadelige bijwerkingen. In hoofdstuk VII 
tenslotte worden deze resultaten vergeleken met die van andere onderzoekers en 
wordt de waarde van de behandeling besproken. 
De conclusies luiden als volgt: 
- de techniek van verwannen is bruikbaar en even efficient als andere technie-
ken waarbij warmte toegevoerd wordt via de huid van de patient; 
totale lichaamshyperthermie, waarbij een dosis van 2 uur 41.8°C toegediend 
wordt, is effectief, maar voor het bereiken van een zinvol effect voor de 
patient moet de behandeling gecorribineerd worden met bestraling of cherro-
therapie; 
- de behandeling resulteerde sams in onverwacht ernstige bijwerkingen; daarcm 
moet voor toekamstige toepassingen van hyperthermie gezocht worden naar 
betere alternatieven, zoals plaatselijke toediening van hyperthermie en/of 
een veiliger methode voor totale lichaamshyperthermie. 
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GLOSSARY OF ABBREVIATIONS 
AIIDS 
BCG 
BCNU 
BSP 
c 
ca 
Ca++ 
CCNU 
cGy 
cis pt 
Cl 
c parvurn 
CR 
CT 
DIC 
DI'IC 
ECG 
EHBF 
E.M. 
FDP 
SFU 
adult respiratory distress syndrane 
Bacille Calmette Guerin 
bis-chloroethylnitrosurea 
bransulpbalein 
chemotherapy 
carcinana 
ionized calcium 
cyclohexylchloroethylnitrosurea 
0.01 Gray (unit of absorbed radiotherapy dose, in J/kg) 
Cisplatinum = cis-diarrminedichloroplatinum (II) 
ionized chloride 
Cbrynebacterium parvurn 
complete response 
carputer taoography 
disseminated intravascular coagulation 
dimethyl-trianzeno-imidazole-carboxamide 
electrocardiogram 
estimated hepatic bloodflOW' 
electromagnetic 
fibrinogen degradation products 
5-Fluorouracil 
Gy Gray (unit of absorbed radiotherapy dose, in J/kg) 
H/Hr hyperthennia 
HBF hepatic blood flOW' 
HIDA 
ICG 
INH 
J 
K+ 
I.COF 
LDH 
LHI' 
Me<lllU 
MHz 
n 
Na+ 
N(2,6-diethylacetanilido)imino-diacetic acid 
indocyanine green 
isoniazid 
joule 
ionized potassium 
liquid crystal optical fiber 
lactic dehydrogenase 
local hyperthermia 
methyl CCNU 
MegaHerz 
number of data/patients 
ionized sodium 
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NC 
p 
PR 
pt 
r 
R/RT 
RHI' 
s 
s.d. 
S.E.M. 
SGCJI' 
SGPT 
S phase 
t 
T/ternp 
99Tc 
TER 
Trect 
Tttm 
T( )max 
WBHI' 
WHO 
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no change 
ionized phosphate 
partial response 
]?Cltient 
correlation coefficient 
radiotherapy 
regional hyperthennia 
surgery 
standard deviation 
standard error of the mean 
serum glutamic oxalacetic transaminase 
serum glutamic pyruvic transaminase 
synthesis phase (in cell cycle) 
time 
temperature 
99Technetium 
thermal enhancement ratio 
rectal temperature 
tumour temperature 
highest temperature recorded at site 
whole body hyperthennia 
W:>rld Health Organization 
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het manuscript. 
De samenwerking binnen de afdeling Experimentele Radiotherapie/Hyperthermie is 
al die jaren zeer plezierig geweest. Mijn speciale dank gaat uit naar de 
(ex-)collega's: 
-Gerard van Rhoon, vanaf het begin van het onderzoek mijn "maatje" en de motor 
achter alle techn=i;sche ontwikkelingen, voor zijn grote aandeel in de uit-
voering van het onderzoek en voor het mij bijbrengen van enige kennis op het 
gebied van toepassing van elektromagnetische straling; 
- Lucy Bonke-Spit en Jenny Wike-Hooley, voor het enthousiaste verzamelen en 
bewerken van patientengegevens, en Jenny verder voor het verbeteren van de 
Engelse taal in een deel van het manuscript; 
-Bram Felius, mijn voorganger, voor het opstarten van het onderzoek en voor de 
nagelaten gegevens; 
-Pia Broekmeyer-Reurink en Bas Cornet, voor het van mij overnemen van taken 
bij de behandeling van patienten met lokale hyperthermie, zodat ik tijd vrij 
kon maken voor het schrijven van het proefschrift; 
-Ad van den Berg, voor zijn computer-werk, zijn kritische opmerkingen en zijn 
hulp bij het schrijven van enkele belangrijke passages in dit proefschrift. 
Een aantal mensen van buiten de afdeling waren direkt betrokken bij de proef-
dier-experimenten en de patientenbehandelingen. Dank voor de prettige samen-
werking aan 
-Hilko Wiersema, allereerst voor de geduldige en efficiente manier waarop hij 
mij tijdens de experimenten in het Radiobiologisch Instituut in Rijswijk een 
simpele vorm van anaesthesie bij honden en enkele chirurgische technieken 
heeft weten bij te brengen, maar vooral voor de manier waarop hij in de daar-
opvolgende jaren onze gezamenlijke huishouding heeft weten te runnen zonder al 
te veel bemoeienis mijnerzijds, en voor zijn begrip voor alle tijd die ik 
achter mijn schrijftafel doorbracht; 
-de anaesthesisten die tijdens de experimentele en klinische behandelingen 
zorg droegen voor de veiligheid van de "patient". Met name wil ik noemen Dr. 
Y. Ahmed, ons tot steun bij de experimenten met proefdieren in het RRTI, en 
Dr. N.S. Faithfull, verantwoordelijk voor een groot deel van de patienten-
behandelingen en zeer enthousiast onderzoeker naar de veranderingen in hart-
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en longfunctie onder invloed van hyperthermie; 
-de anaesthesie-verpleegkundigen, gedurende de lange en warme dagen waarop de 
behandelingen plaatsvonden in touw om alles soepel te laten verlopen, van wie 
ik met name wil noemen Eveline Verbaten-Litz en Ine Snippe-v.d. Born. 
Vele collega' s en afdelingen van het Rotterdams Radiotherapeutisch Insti tuut 
hebben medewerking verleend aan de behandeling van patienten. Mijn dank aan 
-de internisten R.E. Treurniet en A.S.Th. Planting voor hun beoordeling van de 
algemene conditie van de patienten voor, en de intensieve zorg voor de pa-
tienten na de behandeling; 
-het klinisch chemisch laboratorium o.l.v. Dr. w.G. Haye, voor de inzet waar-
mee al het extra door ons aangevraagde onderzoek aan bloed en urine werd 
verricht; 
-de verpleegafdeling -destijds B2- o.l.v. hoofdverpleegkundige J. Snoek-
Liefrink, waar de meeste van onze patienten opgenomen waren in de week van 
behandelen, voor de plezierige manier van samenwerken; 
-de intensive care afdeling, voor de goede zorg besteed aan onze patienten en 
het voortzetten van verzameling van patientengegevens de avond en nacht 
volgend op de behandeling; 
-de afdeling Radiodiagnostiek, waarvan met name J. Samut Tagliaferro ons 
tot steun geweest is bij het inbrengen van de catheter in de vena hepatica. 
Voorts ben ik dank verschuldigd aan de collega's die patienten hebben verwezen 
voor behandeling met totale lichaamshyperthermie: de radiotherapeuten (Dr J.G. 
van Andel, s. Boulis Wassif, P.A. Helle, M.M. Qasim, J.J. Seldenrath, v. 
Sourek-Zikova, A.J. Subandono Tjokrowardojo, Dr. S.K. The, A.D. Treurniet-
Donker, Prof. Dr. B.H.P. van der Werf-Messing), en internisten (A.M. Hoff, Dr 
J.H. Mulder en A.S.Th. Planting) van het Rotterdams Radiotherapeutisch 
Instituut en de radiotherapeuten (J.H. Biesta en W.J. Hoogenraad) van het 
Radboudziekenhuis in Nijmegen. 
Uiteraard ook mijn dank aan alle anderen die op de een of andere manier bijge-
dragen hebben tot het onderzoek en die ik niet met name in dit dankwoord heb 
kunnen noemen (het ziekenhuis telt ongeveer 800 medewerkers!). 
Ook bij het schrijven van dit proefschrift en het gereedmaken voor druk hebben 
een aantal mensen mij geholpen. Dank aan 
-mevrouw E.L.A. Vonk-Neele en mevrouw M. Westerhout-Kersten van de Bibliotheek 
Oncologie, voor het vinden van -soms wel heel oude- publicaties; 
-Wim van Putten, voor zijn advies bij het vervaardigen van de moeilijkste 
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figuur uit dit proefschrift; 
-mevrouw A. Sugiarsi en Inge Dijkstra, die begonnen zijn met mijn handschrift 
om te zetten in leesbare vorm; en heel veel dank aan 
-Gerrie van den Bos, die het grote karwei van het uittypen van en vormgeven 
aan dit proefschrift uiteindelijk op zich genomen en ook afgemaakt heeft; 
-en de mensen van de afdeling Medische Fotografie: Johan Marselje, Stan Sliwa 
en Hans Vuik, die gezorgd hebben voor een uniforme en passende uitvoering van 
alle figuren en tabellen, en van wie Johan verder de "koppen", de titelpagina 
en de omslag verzorgd heeft. 
Tot slot wil ik in mijn dankwoord nog even teruggaan naar de basis: dank aan 
de heren H.Ch. Vogely en Drs. L.P. Kruithof, die mij gestimuleerd hebben naar 
de HBS, resp. de universiteit te gaan en vooral heel veel dank aan mijn 
ouders, die mij de studie mogelijk gemaakt hebben en mij al die jaren be-
moedigd en gesteund hebben. 
Dank ook aan alle familieleden en vrienden die mij regelmatig bemoedigend 
toegesproken hebben tijdens bet schrijven van dit proefschrift. 
202 

koorddartser = rope walker 
koord (k0:d) = rope 
koorts (kn:d3) = fever 
Uit "Clavnerietjes" van Toon Hennans, een uitgave van Elsevier. 
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CURRICUlllM VITAE 
De schrijfster van dit proefschrift werd op 4 juli 1954 te Zwartewaal geboren. 
In 1971 behaalde zij het diploma HBS-B aan de Chr. Scholengemeenschap "Blaise 
Pascal" te Spijkenisse en begon de studie Geneeskunde aan de Universiteit van 
Amsterdam. 
Na. het kandidaatsexamen in 1974 werd de studie voortgezet aan de Rijksuni-
versiteit te Leiden, alwaar in 1978 het artsexamen afgelegd -werd. Sindsdien 
werkt zij, binnen het Rotterdamsch Radio-Therapeutisch Instituut, aan klinisch 
onderzoek naar de toepassingsmogelijkheden van hyperthennie bij de behandeling 
van kanker. De eerste jaren als medewerkster van de afdeling Experimentele 
Radiotherapie van de Erasmus Universiteit Rotterdam, vanaf 1983 in dienst bij 
het Rotterdamsch Radio-Therapeutisch Instituut, echter steeds in de groep van 
prof. dr. H.S. Reinhold. 
Het onderzoek van de eerste jaren, financieel mogelijk gemaakt door het 
Koningin Wilhelmina Fbnds, heeft geresulteerd in dit proefschrift. 
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